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Abstract 
The observation, recording and appraisal of an individual’s vital signs, namely 
temperature, heart rate, blood pressure, respiratory rate and blood oxygen saturation 
(SpO2), are key components in the assessment of their health and wellbeing. 
Measurements provide valuable diagnostic data, facilitating clinical diagnosis, 
management and monitoring. Respiratory rate sensing is perhaps the most under-
utilised of all the vital signs, being routinely assessed by observation or estimated 
algorithmically from respiratory-induced beat-to-beat variation in heart rate. 
Moreover there is an unmet need for wearable devices that can measure all or most of 
the vital signs. This project therefore aims to a) develop a device that can measure 
respiratory rate and b) develop a wearable device that can measure all or most of the 
vital signs.  
An accelerometer-based clavicular respiratory motion sensor was developed and 
compared with a similar thoracic motion sensor and reference using exhalatory flow. 
Pilot study results established that the clavicle sensor accurately tracked the reference 
in monitoring respiratory rate and outperformed the thoracic device. 
An Ear-worn Patient Monitoring System (EPMS) was also developed, providing a 
discrete telemonitoring device capable of rapidly measuring tympanic temperature, 
heart rate, SpO2 and activity level. The results of a comparative pilot study against 
reference instruments revealed that heart rate matched the reference for accuracy, 
while temperature under read (< 1°C) and SpO2 was inconsistent with poor correlation.  
In conclusion, both of the prototype devices require further development. The 
respiratory sensor would benefit from product engineering and larger scale testing to 
fully exploit the technology, but could find use in both hospital and community-based 
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monitoring. The EPMS has potential for clinical and community use, having 
demonstrated its capability of rapidly capturing and wirelessly transmitting vital signs 
readings. Further development is nevertheless required to improve the thermometer 
probe and resolve outstanding issues with SpO2 readings. 
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Morbidity 
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(ii) The incidence or rate of sickness in a population 
Mortality 
(i) Subject or susceptibility to death 
(ii) The incidence or rate of death in a population 
Oldest old Over eighty-five years of age 
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ADC Analogue to digital converter 
ADLs Activities of daily life 
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BLE Bluetooth Low Energy, also known as Bluetooth Smart/v4 
BMI Body Mass Index -   
BP Blood pressure 
bpm Beats per minute (if referring to heart rate) 
bpm Breaths per minute (if referring to respiratory rate) 
CAP Community acquired pneumonia 
CAUTI Catheter-acquired urinary tract infection 
CHD Chronic heart disease 
CHF Congestive heart failure 
CNS Central nervous system 
COPD Chronic obstructive pulmonary disease 
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CRS Clavicular respiratory sensor 
CT scan Computed tomography scan 
CUHREC Cranfield University Health Research Ethics Committee 
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DAC Digital to analogue converter 
DBP Diastolic blood pressure 
DSP Digital signal processing 
ECG Electrocardiography 
EEG 
Electroencephalography, measurement of the brain’s electrical 
activity 
ED Emergency department 
EDR ECG-derived respiration 
emi Electromagnetic interference 
EPMS Ear-worn personal monitoring system 
EWS Early warning scoring (system) 
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HZ Herpes Zoster 
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RR Respiratory rate 
RSA Respiratory Sinus Arrhythmia 
SaO2 Blood oxygen concentration 
SBP Systolic blood pressure 
SNR Signal to noise ratio 
SpO2 Blood oxygen concentration measured via pulse oximetry 
SR Skin resistance 
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1 .  I n t ro d u c t i o n  a n d  L i te ra t u r e  Re v i e w  
The research reported in this thesis was inspired by a series of conversations with 
senior medical professionals, including leading consultants and researchers, who 
expressed an interest in technologies facilitating the collection of vital signs readings 
from outpatients and vulnerable individuals in the community, potentially by non-
clinical staff or the patients themselves. The remote recording of routine observations, 
normally taken by hospital-based nursing staff, would greatly assist in timely 
intervention for improved patient care. To meet this unmet need, a requirement was 
identified for the provision of a wearable monitoring device that could rapidly and 
simultaneously capture multiple parameter readings with minimal fuss. With no 
suitable commercial option available, research into vital signs monitoring and the 
development of a prototype device was initiated. 
This chapter reviews the literature to establish an understanding of medical 
physiological monitoring and its application, and comprises of sections discussing the 
vital signs, the clinical aspects of illness, vital signs monitors and telehealthcare. The 
vital signs (VS) are first defined and examined to uncover the range of normal resting 
readings in the general adult population and the significance of abnormal readings. 
Common diseases, infections, their symptoms and the impact of these ailments on 
morbidity and mortality are then reviewed, providing context for VS monitoring, which 
is considered next. This looks at a range of commercially available monitors, their 
application in patient care and considers recent developments in telehealthcare for 
remote VS monitoring.  
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The findings from the conclusion of the review helped to frame the aims and 
objectives that define the work performed and reported in this thesis. 
1.1. The Vital Signs  
It has been established since ancient times (reviewed by Stewart, 2003) that the 
observation and assessment of changes in a patient’s condition is of great clinical value 
and can protect them from harm (Ahrens, 2008; Rogers et al., 2008). Vital signs (VS) 
are a range of physiological measures, ideally taken at regular intervals, that form a 
key component in monitoring patient’s condition (Evans et al., 2001). 
The traditional vital signs are temperature, blood pressure (BP), pulse or heart rate 
(HR) and respiratory rate (RR) which are now well understood and accepted. The 
relationship between simultaneous measures was first noted and reported by Hunter 
in 1794 (pulse and temperature). This was followed by further work relating HR, RR 
and temperature by Cheyne (1818) and Donne (1835). The term ‘vital signs’ itself 
originates from an article published in the Chicago Medical Journal (1866) by Edward 
Seguin and William Draper (reviewed by Stewart, 2003).  
A number of parameters have been suggested as additional vital signs. Blood 
oxygen saturation (SaO2) has been widely accepted as the fifth vital sign; pulse 
oximetry, a non-invasive method of measuring both pulse rate and blood oxygen 
saturation, is now routinely used for monitoring the condition of the patient (Tierney Jr 
et al., 1997; Neff, 1988). In addition to pulse oximetry, Ahrens suggests that 
capnography (for respiratory and ventilation monitoring) and stroke volume (for heart 
evaluation) are superior to the traditional measures for rapid clinical assessment 
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(Ahrens, 2008). Pain and discomfort (Morita et al., 2008), emotional distress (Bultz and 
Carlson, 2006) and shock index (Zarzaur et al., 2008) have all been proposed for 
consideration as additional vital signs indicators. Elliott and Coventry propose eight 
vital signs, adding pain, urine output and level of consciousness to the accepted five, 
for adequate identification of a deteriorating patient (Elliott and Coventry, 2012). The 
Glasgow Coma Scale (GCS) is a popular method of assessing an individual’s level of 
consciousness; this scores their optical, auditory, verbal and motor responses to 
stimuli, giving a standardised classification (Teasdale and Jennett, 1974). The AVPU 
scale (alert, verbal, painful or unresponsive) fulfils a similar function, facilitating rapid 
assessment (Kelly et al., 2004). With the exception of the five accepted vital signs, 
capnography and urine output however, these additional factors cannot be easily 
quantified via physiological sensors, instead relying largely on observation and 
introducing subjectivity. 
1.1.1 Temperature 
The first recorded reference to the importance of body temperature to wellbeing 
dates ancient Greece (4th century BC) where a high temperature may be portent of 
disease (reviewed by Pearce, 2002). It would be the early part of the 18th century 
before Boerhaave, de Haen and Van Swieten started to measure patient’s 
temperatures at the bedside with Fahrenheit’s thermometer (reviewed by Stewart, 
2003). De Haen observed diurnal variation in healthy patients and that temperature 
monitoring could help track the progression of an infection. It was Wunderlich’s study 
(1868) of a million readings from the axilla of 25,000 subjects that helped establish a 
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normal temperature range (36.3 – 37.7°C) for healthy individuals (reviewed by Pearce, 
2002. 
Environmental effects aside (see pages 8-9) there are several factors which 
influence core body temperature. These include gender, body mass index (BMI), frailty, 
ADL status and dementia, all of which may indicate a lower core temperature, and the 
higher temperatures associated with those who are regular users of analgesics (Sund-
Levander and Wahren, 2002). Because of these factors and differences in 
thermoregulation there is both intra- and inter-individual variation in the core body 
temperature of older people (Güneş and Zaybak, 2008). As there is a temperature 
gradient of approximately 1°C for every 4 mm of depth between the body surface and 
the core (Sund-Levander and Grodzinsky, 2009), which is at its warmest in the 
abdomen, chest and brain, the measurement site is a huge factor in determining both 
normal and pyrexic values. For diagnostic purposes, an individual’s temperature should 
ideally be evaluated relative to their normal baseline readings taken at a consistent 
measurement site (Sund-Levander and Grodzinsky, 2009). 
Rectal thermometry is considered to be the gold standard in body temperature 
measurement (Varney et al., 2002) as it provides the closest approximation to true 
core body temperature. Despite the reported accuracy of rectal measurement, it is 
clearly not practical in many cases (such as the monitoring device proposed here) and 
thus other measurement sites must be considered. There is a long tradition of 
sublingual (oral) temperature measurement, although axillary (armpit), temporal 
(forehead) and tympanic (ear canal) sensing have gained in popularity.  
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In comparing oral and axillary measurement in the elderly, oral thermometry was 
found to offer a more reliable rectal surrogate (Downton et al., 1987). There are  
number of studies comparing oral and tympanic methods for febrile measurement 
with some favouring tympanic (Dzarr et al., 2009) and others oral thermometry (Lu et 
al., 2009). The latter is not without its faults - firstly it requires a compliant patient and 
secondly, there is the possibility of interference from mouth breathing or the prior 
ingestion of hot or cold food and drink (Norman, 2000). Additionally there is the 
suggestion that due to “the vasoconstriction that accompanies fever” (Darowski et al., 
1991b) and increase in respiratory frequency (Berman and Fox, 1985) oral 
thermometry may be a less effective febrile detection method; whether this is 
restricted to respiratory tract infections is not clear.  
A study by Dzarr suggests that tympanic thermometry is second only to rectal 
measurement for fever detection (Dzarr et al., 2009). It is certainly the quickest and 
most convenient method of body temperature measurement; ease of use is a key 
factor too as this reduces the probability of operator error. Studies have shown that 
used correctly (Evans and Kenkre, 2006), a repeatability of ±0.1°C is achievable (Childs 
et al., 1999). Childs describes best practice is to always use the same ear for 
measurements as there can be an inter-ear difference of as much as 0.6°C (Childs et 
al., 1999). Foot temperatures are sometimes monitored, but circulatory problems may 
limit its potential diagnostic value (Raymann et al., 2007). Axillary and temporal skin 
temperatures are sometimes used clinically. The former has been identified as 
relatively ineffective (compared with the methods previously discussed) in fever 
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detection, while the latter is reported to have a poor predictive capability (Hausfater et 
al., 2008).  
The results of comparative studies, examples from which are shown in Table 1-1 to 
Table 1-4, display clear deviations in both mean and range between the gold standard 
and alternative measurement sites. These demonstrate that the often quoted 37°C 
standard is perhaps inappropriate for measures other than core body temperature and 
relative adjustments should be considered for other measurement sites, which are 
typically cooler than rectal temperatures. Jensen’s comparative study (n = 200, 102 
male ,98 females, age range of 18 -93, mean = 56 years old) in Table 1-1 shows mean 
differences of –0.62°C (axillary), –0.53°C (sublingual) and –0.34°C ( the mean of three 
tympanic thermometers) to rectal mercury thermometer (Jensen et al., 2000). 
 
Mean SD Range 
Mean 
Difference 
SD of 
difference 
Tympanic Core Check 36.92 0.63 35.4 - 39.5 0.54 0.41 
Tympanic Diateck 37.17 0.76 34.5 - 39.5 0.29 0.51 
Tympanic Genius 37.27 0.68 35.4  39.6 0.19 0.45 
Oral Terumo digital 36.93 0.7 34.5 - 39.4 0.53 0.53 
Axillary Terumo digital 36.84 0.74 35.0 - 39.2 0.62 0.49 
Rectal Terumo digital 37.51 0.57 36.5 - 39.6 -0.05 0.12 
Standard Rectal mercury 37.46 0.56 36.4 - 39.5 - - 
(Jensen et al., 2000) 
Table 1-1: Temperatures (°C) measured by various medical thermometers - mean 
differences are measured relative to the standard rectal mercury thermometer’s mean  
The same trend is apparent in older people; the results of Darowski’s study on 
afebrile patients (n=50) shown in Table 1-2 again illustrates the variation in range and 
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mean readings at different measurement sites. Here differences in the mean results of  
–0.9°C (axillary), –0.6°C (sublingual) and –0.4°C (tympanic) were observed relative to 
rectal measurement (Darowski et al., 1991b). These results are in broad agreement 
with Jensen’s and may be explained by the relative blood flow, blood temperature and 
level of cooling in each locality. 
Measurement 
Site 
Body Temperature (°C) 
Range Mean Mean ± 2SD 
Rectal 36.7 – 37.5 37.2 36.8 – 37.6 
Auditory Canal 36.5 – 37.2 36.8 36.5 – 37.1 
Sublingual 35.6 – 37.0 36.6 36.1 – 37.2 
Axillary 35.5 – 37.0 36.3 35.5 – 37.0 
(Darowski et al., 1991b) 
Table 1-2: A comparison of temperature measurement sites in fifty elderly afebrile patients. 
With regard to the temperatures of febrile patients, Jensen’s study also included 
comparable measurements (n=85) (Jensen et al., 2000). As with the afebrile group, 
mean differences of –0.64°C (axillary), –0.62°C (sublingual) and –0.38°C ( the mean of 
three tympanic thermometers) were observed compared to rectal mercury 
thermometer (Table 1-3). A further study by Darowski et al investigated the efficacy of 
different measurement sites in their ability to accurately detect fever in an elderly 
cohort (n=74) of hospital inpatients who would be considered to have temperatures 
within the normal range (Darowski et al., 1991a). The results, expressed as 
percentages, are shown in Table 1-4. The temperature thresholds chosen are as 
suggested in an earlier study (Darowski et al., 1991b) and based upon observation and 
experimental data. Participants were classified according to their clinical presentations 
of infection – definite (13), probable (12), possible (32) or no clinical evidence of 
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infection (17). The findings show that rectal and tympanic are superior to sublingual 
and axillary in diagnosing fever in a single reading. A mean rectal temperature of 
37.5°C was observed in 86% of participants; hence Darowski et al suggest a lower mark 
of 0.5°C above the notional 37°C norm as a better indicator of fever in the elderly. 
Standard compared with: Mean SD Range 
Tympanic Core Check 0.64 0.38 -0.2 to 1.7 
Tympanic Diateck 0.27 0.49 -0.6 to 1.5 
Tympanic Genius 0.24 0.46 -0.8 to 1.8 
Oral Terumo digital 0.62 0.61 -0.3 to 2.9 
Axillary Terumo digital 0.64 0.48 -0.2 to 2.4 
Rectal Terumo digital -0.05 0.12 -0.3 to 0.4 
(Jensen et al., 2000) 
Table 1-3: The recorded temperature differences (°C) observed in a range of digital 
thermometers versus a standard rectal mercury thermometer in febrile patients (n=85) 
Infection 
Febrile at one 
or more sites 
Rectal 
> 37.5°C 
Tympanic 
> 37.2°C 
Sublingual 
> 37.0°C 
Axillary 
> 37.0°C 
Definite 100 92 92 58 17 
Probable 100 80 93 73 14 
Possible 81 69 72 47 31 
No clinical evidence 71 60 40 47 25 
Total 85 73 73 55 25 
(Darowski et al., 1991a 
Table 1-4: The percentages of patients regarded as febrile categorised by measurement 
site from a study on elderly individuals (n=74) 
Environmental effects can influence temperature measurement. At a basic level, 
measurements should ideally not be taken with the subject in a particularly hot, cold 
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or draughty environment, and the sensor should be allowed to equilibrate in-situ for a 
short length of time. It should be noted that the patient’s measurements taken in 
Darowski’s initial study (Darowski et al., 1991b) followed a twenty-four hour period in 
a hospital ward at 21-26°C. In a colder environment the readings are likely to be lower, 
showing a greater deviation from core temperature. Thus when considering body 
temperatures, however measured, a comparative reading of the ambient temperature 
should be made as a reference.  
Circadian Rhythm and Temperature 
Circadian rhythm is a natural physiological phenomenon involving rhythmic 
temporal changes in core body temperature every twenty-four hours; thus 
measurements made in the morning will differ from those made later in the day. When 
considering the detection of a fever, measurements should, ideally, be referenced to 
the subject’s normal circadian temperature. In healthy adults, the Oxford Handbook of 
Clinical Medicine quotes a mean daily amplitude variation of 0.5°C, with a minima at 6 
am and peaking at 6 pm (Longmore et al., 2009).  
In the elderly there is a distinct change in this cycle, which has decreased amplitude 
and is less stable (Van Someren et al., 2002; Gomolin et al., 2007); this is illustrated in 
Figure 1-1 and Figure 1-2. The relative difference in the core circadian temperatures of 
older people (aged 64-81, n =43) to young adults (aged 18 to 30, n=97) are shown in 
Figure 1 1; here a phase difference is apparent between the two groups with the nadir 
being both earlier and 0.25°C higher in the elderly cohort (Duffy et al., 1998).  
The design and evaluation of discrete wearable medical devices for vital signs monitoring 
DG Pitts 10 Cranfield University 
 
(Duffy et al., 1998) 
Figure 1-1: The mean recorded core body temperatures (°C) plotted with respect to time for 
young and older subjects: ● - Older subjects (n=43); ○ - young subjects (n=97). 
 
(Gomolin et al., 2005) 
Figure 1-2: A graph showing the circadian temperature variation in elderly people 
Gomolin’s study (Gomolin et al., 2005) found intra-age group variance in the daily 
temperatures of elderly nursing home residents (n=100) under controlled conditions. 
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Oral temperatures were taken at 6 am, 4 pm and 10 pm in three groups comprising of 
participants of 65 to 74, 75 to 84 and over 85 years of age; the results, shown in Figure 
1-2, demonstrate three times the variation in youngest (0.9°F /0.5°C) to oldest groups 
(0.3°F /0.17°C) in mean amplitude difference and an opposite trend. 
When looking at rectal surrogate measurement sites, direct comparisons are likely 
to prove difficult due to thermoregulatory, circadian and ambient temperature effects. 
This is illustrated in Figure 1-3 by the difference between daily oral and wrist 
temperatures (Sarabia et al., 2008) where wrist temperatures (taken with a 
semiconductor sensor placed over the radial artery) are noticeably cooler, have a 
greater range and a cycle that is almost in anti-phase with reference oral readings. 
 
(Sarabia et al., 2008) 
Figure 1-3: The mean daily variation in a study cohort of wrist and oral temperatures  
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As there is an overlap in the circadian temperature range of up to 0.8˚C (Kräuchi, 
2002) and the 1.0˚C rise above the norm indicative of fever, the combined effect must 
be considered. In conclusion, measurements referenced to the circadian cycle or taken 
at the same time each day, environmental conditions permitting, should result in an 
improvement in the determination of fever and reduce false positive outcomes.  
1.1.2 Heart Rate 
The frequency of the beating heart has long been noted as one of the key vital 
signs. There is evidence of its diagnostic use in ancient times (BC) by Chinese, Indian, 
Egyptian and Greek physicians (reviewed by Ghasemzadeh and Zafari, 2011), where an 
escalating pulse had precedence over temperature as a harbinger of fever (Pearce, 
2002). The introduction of watches with a second-hand in the late 17th century allowed 
accurate pulse rate measurement, in turn driving a demand for suitably equipped 
watches (reviewed by Stewart, 2003). 
Pulse, or pulse rate, is often used synonymously with HR (as in this thesis), but is, 
strictly speaking, a pulsatile manifestation of arterial blood circulation resulting from 
heartbeat, with pulse strength and regularity being additional health indicators.  
The normal heart rate in adults ranges from 60 to 100 beats per minute (bpm) 
(Longmore et al., 2009). Mean HR in neonates it is much higher (130 bpm), falling to 
just below 100 bpm aged 5 years and 85 bpm aged 10, until plateauing at around 70 
bpm when at the age of 18 (Fleming et al., 2011). In healthy younger adults HR is 
typically between 60 and 80 bpm with a resting subject, the frequency diminishing 
linearly with age at a rate of −0.126 bpm per year (Erikssen and Rodahl, 1979). A 
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resting HR of below 60 bpm is known as bradycardia while that exceeding 100 bpm is 
referred to as tachycardia (Palatini, 1999). 
A simple formula (Equation 1-1) is often given for calculating maximal heart rate 
(HRmax). Its accuracy is disputed as the sample population in the originating study were 
aged 65 or less, Tanaka offers instead an alternative formula (Equation 1-2) (Tanaka et 
al., 2001).  
Equation 1-1: Maximal HR formula 
𝐻𝑅𝑚𝑎𝑥 = 220 − 𝐴𝑔𝑒  
Equation 1-2: Tanaka’s alternative formula for HRmax 
𝐻𝑅𝑚𝑎𝑥 = 208 − (0.7 × 𝐴𝑔𝑒 ) 
 
Whichever meter is used, many hospitalised febrile individuals are often tachycardic 
(Marco et al., 1995), which may take them close to a twenty percent safety margin of 
HRmax. This is a noted risk factor in increased HR for coronary heart disease and 
mortality in middle-aged male subjects (Dyer et al., 1980) and in elderly males, where 
a heart rate of 81 to 120 bpm is strong predictor of cardiovascular mortality (Palatini et 
al., 1999). 
Before examining how HR may be used diagnostically, it is important to note that 
there are numerous factors that may determine an individual’s reading. In addition to 
age, these include ethnicity, the circadian cycle, posture, blood pressure, lifestyle 
factors (such as diet, drinking alcohol and smoking), physical activity, physical fitness, 
body mass index (BMI), anxiety and mental stress (Valentini and Parati, 2009).  
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The rise in febrile pulse rate is variously ascribed to be in the order of a 14.4 to 18.0 
bpm/deg C (Lyon, 1927) and 8.5 bpm/deg C (Karjalainen and Viitasalo, 1986) rise 
above basal temperature in otherwise healthy adults, to a difference of 8.8 to 21.6 
bpm/deg C between normal and febrile readings (Weinberg et al., 1989). Studies 
suggest that this is in fact temperature dependent, ranging from 2.9 bpm/deg C if 
below 39°C and 6.5 bpm/deg C above this threshold (Kiekkas et al., 2007). The range 
between these figures is quite high and whilst other data is evident, there have not 
been a significant number of studies in this area. It is possible that factors such as 
medication, stress or heart rate variability (Stein et al., 1997) are partly responsible. In 
elderly patients an HR >90 bpm is a strong indicator of infection, especially when 
combined with a febrile temperature (Pines et al., 2006).  
To summarise, resting HR measurement can aid in the diagnosis of coronary heart 
disease and may be regarded as a measure of cardiovascular wellbeing. It may also 
assist in the determination of febrile infection, especially in atypical presentations 
where febrile temperatures are absent. 
1.1.3 Blood Pressure 
This may be defined as a measure of the pulsatile pressure exerted on the arterial 
walls by circulatory blood flow (Stroke Association, 2012). Peak, or systolic blood 
pressure (SBP) occurs as the heart contracts at the end of the cardiac cycle, while the 
nadir, or diastolic pressure (DBP) arises at the start of the cardiac cycle as the heart 
relaxes once more. Each measurement therefore consists of a pair of readings and is 
normally quoted as SBP / DBP (Hypertension Influence Team, 2002). The units used in 
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BP measurement, millimetres of mercury (mmHg), relate to pressure readings from a 
mercury manometer as used in traditional instruments. Though these might be 
considered archaic they are, nevertheless, retained for modern electronic monitors. 
It was not until 1628 that William Harvey concluded that blood circulated around 
the body in a closed system and was powered by the heart. Blood pressure was first 
measured by Hales in 1733 after experimenting on a mare, he noted that pressure 
forced blood to rise nine and a half feet up a narrow glass tube connected to the 
carotid artery. The first non-invasive device measurement, the sphygmomanometer, 
was developed by von Basch in 1876, an improved design by Riva-Rocci appearing 20 
years later (reviewed by Stewart, 2003).  
Non-invasive BP measurement employs an inflatable cuff to temporarily impede 
arterial blood flow, the cuff pressure providing the two BP readings as air is gradually 
released and blood flow returns, giving a measurement relative to atmospheric 
pressure (Pickering et al., 2005). By convention the cuff is fitted to an arm (occluding 
the brachial artery once inflated) of a seated patient and positioned level with the 
heart. To ensure accurate BP readings they should be taken in a quiet and temperate 
environment once the subject has been seated for several minutes and is relaxed. A 
cuff of appropriate size should be fitted directly in contact with the subject’s skin while 
their arm is relaxed and fist unclenched. Subjects should refrain from talking or 
crossing their legs while measurements are taken. Ideally readings should be taken 
consecutively from both arms minutes apart, the higher reading being recorded 
(Hypertension Influence Team, 2002; British Hypertension Society (BHSOC). 2006; 
Pickering et al., 2005). 
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It should be noted that BP readings taken from the arm in supine subjects result in 
lower DBP readings (around 5 mmHg). Supine readings taken from the thigh (or calf), 
as may be necessary in hospital, present an increased SBP while DBP may be lower 
(Kirkendall et al., 1967). 
The normal healthy (normotensive) resting range of blood pressure in adults is 
90/60 to 120/80. Those consistently below this mark are considered to have low BP 
(hypotension). Readings from 120/80 to 140/90 are deemed to be higher than ideal 
(pre-hypertension) while readings beyond 140/90 indicate high blood pressure, also 
known as hypertension (Blood Pressure UK, 2008). Figure 1-4 shows a standard blood 
pressure chart of resting readings; in reality this provides a useful guide, but does not 
account for age and gender. Differences in normotensive BP may be observed 
between the sexes with males tending to have higher readings. There is also a 
noticeable increase in BP with age in both sexes as may be seen in Table 1-5 (Landahl 
et al., 1986). 
 
(Blood Pressure UK, 2008) 
Figure 1-4: A chart showing the ranges and classifications for systolic and diastolic blood 
pressure 
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 Males Females 
Age 
(years) 
No. 
SBP 
(mmHg) 
DBP 
(mmHg) 
No. 
SBP 
(mmHg) 
DBP 
(mmHg) 
38 - - - 369 123±14.4 79±9.1 
44 - - - 322 124±16.4 81±8.6 
50 841 138±20.5 91±12.8 284 133±19.4 84±9.8 
54 747 142±20.1 90±11.8 - - - 
56 - - - 298 134±18.8 84±9.1 
60 643 144±22.2 88±12.7 - - - 
62 - - - 259 143±19.8 86±10.0 
70 362 159±25.0 91±12.6 321 168±25.5 93±13.2 
75 234 158±24.5 90±12.4 209 166±22.5 89±12.9 
79 130 155±24.6 83±11.3 127 161±22.1 85±9.9 
(Landahl et al., 1986) 
Table 1-5: Systolic and diastolic blood pressure in adults without antihypertensive 
treatment – mean readings quoted as BP ± standard deviation 
There may be wide deviations in BP over the course of a day. Diurnal variation sees 
resting readings reach their zenith mid-morning, falling overnight to a low at around 3 
a.m. (White, 2007). In addition there are numerous factors that can influence BP; these 
include diet (Appel et al., 2006) and fitness; physical factors such as posture, activity 
and exercise; the intake of food ,drink, sodium salts, nicotine, caffeine and alcohol; 
medical factors such as disease, frailty and the taking of prescribed medication and 
psychosocial factors like anxiety and mental stress (Carels et al., 1998). 
Hypertension is a risk factor for cardiovascular disease and is directly attributable 
for two-thirds of global stroke cases and half those of ischaemic heart disease (Lawes 
et al., 2006). Hypertension has two forms - essential hypertension, which accounts for 
the majority of cases and has no specific cause, and secondary hypertension, which is 
due to an existing medical condition (Hypertension Influence Team, 2002). Both are 
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typically asymptomatic and therefore may lie undetected unless BP readings are taken. 
Sufferers are at an increased risk of ischaemic strokes, where arteries may be blocked 
due to atherosclerosis (hardening and narrowing of the arteries), or haemorrhagic 
strokes, where ruptured vessels cause bleeding in the brain (Stroke Association, 2012)  
Hypotension, or (abnormally) low blood pressure, can be a health risk. Although 
considered low compared to the population norm, it may be normal for some 
individuals and asymptomatic. For others it may lead to dizziness and fainting, which 
may exhibit when standing after sitting or lying down as the rate of change of 
circulatory blood flow is unable to match the change in posture (orthostatic 
hypotension). This may be caused by underlying medical conditions, such as heart 
disease or anaemia, dehydration, pregnancy, or medication prescribed for other 
conditions. Trauma-induced (or septic) shock can result in a particularly severe form of 
hypotension where pressure drops to a point where organ damage may occur, which 
can be fatal unless promptly treated (PubMed Health, 2014). 
In summation, outside of trauma cases in emergency medicine, the greatest 
application for BP monitoring is in assessing and managing cardiovascular health. This 
has seen a greatly increased acceptance for home monitoring over the last decade 
(Parati et al., 2010) with the market well served by a number of manufacturers. 
1.1.4 Respiration Rate 
Respiration rate (RR), the frequency at which breath is inhaled and exhaled, is 
considered one of the key vital signs. It is regulated by the medulla in the brain which 
controls the inspiratory and expiratory muscles that expand and contract to maintain 
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rhythmic ventilation, ensuring an adequate supply of oxygen to fuel the body while 
removing carbon dioxide from the system (Braun, 1990). 
The basics of respiration, the inspiration of air and its’ passage via the lungs into the 
bloodstream, were understood by physicians in Ancient Greece as long ago as the 4th 
century BC. It was not until 1687 that this was proved by Hooke who shows that 
inspired air was essential to life and transformed venous blood to arterial. The 
discovery of oxygen (Priestley) and carbon dioxide (Black) led to increased interest and 
understanding of the respiratory system in the 19th century (reviewed by Stewart, 
2003). 
The normal range for healthy adults is considered to be between 12 and 20 breaths 
per minute when at rest – a breath every three to five seconds. Febrile infection in the 
elderly tends to show an increase in resting RR to more than 20 breaths per minute 
(Marco et al., 1995); a frequency also quoted as marker for sepsis (Nimmo et al., 
2006). Rates in excess of 25 breaths per minute may be indicative of lower respiratory 
tract infections such as pneumonia (Mcfadden et al., 1982); here, the certainty of 
diagnosis of those presenting with these symptoms is greater if blood oxygen 
saturation falls below 90% (High et al., 2009).  
Rapid breathing (tachypnea), which may be accompanied by breathlessness 
(dyspnoea), can be symptomatic of a range of cardiac or respiratory conditions 
(Janssens and Krause, 2004) such as acute respiratory failure (Ray et al., 2006), 
respiratory dysfunction in cystic fibrosis patients (Browning et al., 1990), pulmonary 
hypertension, chronic obstructive pulmonary disease (COPD), asthma (Tobin et al., 
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1983) and a predictor of cardiopulmonary arrest if RR exceeds 27 bpm (Fieselmann et 
al., 1993). Shallow breathing in a recumbent patient (orthopnoea), where minimal 
thoracic movement and inspiratory and expiratory volumes of 250 to 350 mL are 
observed, could indicate an increase in pulmonary blood circulation (Haldane et al., 
1919) and heart failure (Ekundayo et al., 2009). 
As so many disparate diagnoses are possible from changes in an individual’s breath 
frequency, it should probably not be considered in isolation but as part of a larger 
dataset comprising the other vital signs. False positives may result from psychological 
reactions (Boiten et al., 1994) although it could be argued that anxiety due to ‘white 
coat syndrome’ should be reduced if monitored outside a clinical environment. 
Whilst monitored in hospital, RR is typically checked and recorded less frequently 
than the other traditional measures (Cretikos et al., 2008); this is, at least in part, due 
to a dearth of reliable automatic respiratory rate monitoring equipment (McBride et 
al., 2005).  
1.1.5 Blood Oxygen Saturation 
Oxygen from the lungs is absorbed into the bloodstream through small capillaries in 
the alveolar. Here it reacts with haemoglobin (Hb) in red blood cells to form 
oxyhaemoglobin (HbO), in which form it circulates around the body via the 
cardiovascular system until released to fuel metabolic processes. Blood oxygen 
saturation (SaO2, commonly known as ‘sats’) is a measure of the amount of HbO 
present in the bloodstream or tissue. This is typically 95 to 100% in a healthy individual 
at rest, with readings of 85 to 94% indicating moderate to mild hypoxia and those 
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below 85%, severe hypoxia (DeMeulenaere, 2007). This condition may be defined as a 
deficiency of oxygen in tissue and is not to be confused with hypoxaemia, which refers 
specifically to low arterial blood oxygen saturation and may be due to environmental 
or clinical factors. Hypoxia may be as a result of hypoxaemia or unrelated, and even 
localised, such as in the case of vascular ischaemia where blood flow is impaired or 
impeded (Samuel and Franklin, 2008). 
The measurement of SaO2 is an invasive procedure involving the collection of a 2 to 
3 mL specimen of arterial blood, which is then tested in the laboratory or introduced 
as a sample to an automated blood gas analyser (Trulock, 1990). A non-invasive proxy 
of SaO2 may be conveniently taken using a pulse oximeter, which employs optical 
sensing to determine the ratio of HbO to total haemoglobin and provides a capability 
for continuous measurement. SaO2 measurements taken with a pulse oximeter are 
known as SpO2 readings (Philips Medical Systems, 2003) 
Stimulated by the production of early photocells in the 1930s, Matthes introduced 
what might be recognised as the first (pulse) oximeter just before the outbreak of 
World War Two in Germany (reviewed by Severinghaus, 2007). Parallel research 
activities in England, Germany and the United States was driven by aviation medicine 
and the interest in high-altitude flight and pressurized cabins, as hypoxaemia was a 
frequent issue for pilots and aircrew (reviewed by Mendelson, 1992). Millikan, to 
whom the naming of the oximeter must be credited, developed a lightweight ear 
oximeter for use by pilots in 1942; this was then developed by Wood and Geraci, who 
overcame the requirement for individual calibration. Aoyagi’s patent application 
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describing the design of an oximeter was first disclosed in 1974, the first commercial 
devices appearing in the 1980s (reviewed by Severinghaus, 2007). 
In conclusion, modern pulse oximeters, offering pain-free and non-invasive 
measurement, have greatly facilitated the rapid assessment of blood oxygenation. 
Although the most recently accepted of the vital signs, SpO2 measurement has been 
universally adopted in the care of critically ill patients (Jubran, 2015), recommended 
for primary care (Schermer et al., 2009) and the self-management of COPD (MacNab et 
al., 2015). 
1.2 Disease and Infection 
The threat of disease and infection to mortality and morbidity is next assessed, 
together with the symptoms that may aid detection, diagnosis and ultimately, the 
treatment of patients.  
1.2.1 Disease 
This might best be defined as an internal condition where the body’s normal 
functional abilities are impaired, whether due to infectious agents, environmental 
factors (Emson, 1987) or inherited genes (Flint et al., 1993). Examples include many 
cardiovascular conditions, cancer, COPD, asthma and diabetes mellitus. 
Cardiovascular Disease and Heart Conditions 
Stemming from a narrowing and hardening of the arteries (atherosclerosis), 
cardiovascular disease (CVD) describes a family of related conditions with common risk 
factors. These include coronary heart disease (CHD), angina, hypertension, strokes and 
transient ischaemic attacks (TIAs, also known as mini strokes), diabetes mellitus, 
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chronic kidney disease, peripheral arterial disease (PAD) and vascular dementia, with 
sufferers of one condition being predisposed to develop one or more of the others 
(Department of Health, 2013). Atherosclerosis typically affects the great arteries 
supplying the heart (coronary artery), brain (carotid) and legs (peripheral) and is 
irreversible. It is caused by thickening plaque that lines the coronary and carotid 
arteries. This may break down or rupture, blocking an artery and stifling the flow of 
blood to the heart or brain and triggering a heart attack (CHD) or stroke respectively, 
which may damage or kill affected tissue in these organs and can be fatal (British Heart 
Foundation, 2014a). 
Risk factors for atherosclerosis are many: age, gender, familial genetics, high SBP, 
high cholesterol levels, kidney disease, diabetes mellitus and lifestyle (poor diet, lack of 
exercise, obesity, smoking and excessive alcohol consumption), the latter of which may 
add to the risk burden unless behavioural change is successful (Rydén et al., 2007; 
Department of Health, 2013). It is asymptomatic, unless hypertension is apparent, and 
may go unnoticed until angina or claudication (pain from PAD - restricted blood flow to 
the legs) is diagnosed or the subject suffers a stroke or heart attack. The condition is 
irreversible, but may be treated with pharmaceuticals or a range of surgical procedures 
to reduce its effects. These involve angioplasty and the use of stents to widen arteries 
and thus improve blood flow or a coronary bypass using a healthy blood vessel (British 
Heart Foundation, 2014a).  
In addition to CHD there are a range of other heart conditions. These include 
congenital heart disease (defects developed in the womb), inherited heart conditions 
(genetic abnormalities), heart failure (HF) and arrhythmias (British Heart Foundation, 
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2014b). HF results from a weakened or damaged heart that is no longer able to pump 
blood around the body and may be caused by CHD, previous heart attacks (myocardial 
infarctions) and cardiomyopathy, a disease of the heart muscle. (National Heart 
Foundation of Australia, 2012). It shares risk factors with CVD, with symptoms 
including breathlessness, fatigue (Royal College of Physicians, 2010) and rapid weight 
loss (Ho et al., 1993). Arrhythmias, such as atrial fibrillation or AF, are caused by a 
disruption of normal heart rhythm where HR may be irregular, or the pacing 
bradycardic or tachycardic, due to abnormalities in the electrical system that drive the 
heart. It may be asymptomatic, though can present with palpitations or 
breathlessness, and can be detected with an electrocardiograph (ECG) (Mitchell, 2015). 
Cancer 
This is caused by genetic mutations following normal cell division that can cause 
abnormal cancer cells to grow, multiply and cause malignant tumours (neoplasms). 
These can grow quickly, invading and damaging surrounding tissue and organs and 
spreading to other parts of the body. There are more than 200 different forms of 
cancer, which may be specific to certain parts of the body or gender (such as prostate 
cancer in men and cancer of the uterus in women. There are many potential causes 
including age, familial history, exposure to carcinogens (cancer-causing materials), 
infection and lifestyle (diet, obesity and smoking), the risks differing depending on 
cancer type. (Cancer Research UK, 2014).  
Figure 1-5 shows the number of cancer cases and deaths in Europe during 2002 for 
leading types of cancer. Lung, colorectal and breast cancers were the most common by 
a significant margin. By comparing the number of cases and deaths a measure of the 
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relative mortality of the respective conditions may be obtained. Of those shown in the 
two charts, the mortality rates of lung and oesophageal cancer were particularly high, 
with breast and prostate cancers having the best survivability (Boyle and Ferlay, 2005). 
 
 
(Boyle and Ferlay, 2005) 
Figure 1-5: The number of cancer cases and deaths in Europe in 2002 
Symptoms can largely depend upon the type of cancer, but can include the 
appearance of lumps (breast and testicular), a persistent cough (lung), breathlessness 
(leukaemia) and passing blood (bladder, cervical and colorectal). Diagnosis may involve 
testing for markers in blood or tissue samples and medical imaging (e.g. ultrasound, x-
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ray, CT scan or MRI) (Cancer Research UK, 2014). Treatment would vary according to 
the type of cancer, but could include prescribed drugs, surgery to excise the tumour, 
radiotherapy and chemotherapy (Cancer Research UK, 2014), a side effect of which is a 
reduction in the number of white blood cells (neutropenia). This can leave patients 
extremely vulnerable to infection (CDC, 2014). 
Respiratory Diseases 
These cover a host of conditions, including asthma, chronic obstructive pulmonary 
disease (COPD) and emphysema. Taken together with infections which impact the 
respiratory system (pneumonia and influenza), these are one the leading cause of 
death in the elderly (Meyer, 2004). Statistics for 2001-2002 (see Table 1-6) show the 
differences in impact between asthma and COPD on an average health district within 
the NHS. Here COPD is responsible for 20% more general practice consultations, 66% 
more hospital admissions and 5.33 times the number of inpatient bed days than 
asthma, which translates to an annual COPD hospital cost of £587 million. Data from 
health authorities in Merseyside shows that 12.5% of all emergency hospital 
admissions were COPD related (British Lung Foundation, 2003). 
 Hospital Admissions Inpatient Bed Days GP Consultations 
Chronic bronchitis, 
emphysema & COPD 
680 9,600 14,200 
Asthma 410 1,800 11,900 
(Data from British Lung Foundation, 2003) 
Table 1-6: The impact of respiratory disease on an average UK health district (2001–2002) 
Asthma is a debilitating condition with both hereditary and environmental risk 
factors; it causes a chronic inflammatory response that obstructs the airways and leads 
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to bouts of dyspnoea, coughing and wheezing (Todo Bom and Mota Pinto, 2009). With 
appropriate treatment, which includes anti-inflammatory drugs and bronchodilators, 
the effects, though severe, are reversible (Longmore et al., 2009). An estimated 6.5% 
to 17% of older people suffer from bronchial asthma, some of whom display late-onset 
with no apparent symptoms up to the age of 65 (Lindner et al., 2007). Asthma and 
COPD both display similar fixed airflow obstruction and consequently asthma may be 
under diagnosed; careful observation and analysis should reveal distinct differences in 
characterisation (Di Lorenzo et al., 2008). 
COPD is a progressive and irreversible pulmonary disease caused by an abnormal 
inflammatory response following prolonged exposure to airborne environmental 
toxins, such as the gases, volatile compounds and particulates found in tobacco smoke 
(Ramsey and Sullivan, 2004). This leads impairment to inhalation and exhalation and 
increasingly severe dyspnoea. Chronic bronchitis, a persistent cough with excess 
sputum caused by abnormalities in the mucus glands of the large airways, and 
emphysema, which sees the progressive decline and destruction of the alveoli, are 
both forms and causes of COPD. Sufferers can gain some respite through oxygen 
therapy; this may be used “on demand” to aid recovery from bouts of breathlessness 
or long term in the case of a chronic condition. Oxygen is normally supplied in the form 
of a small portable gas cylinder or by an oxygen concentrator depending on the 
severity of a patient’s condition (British Lung Foundation, 2003). 
There are a number of approaches to diagnosis; these may involve lung function 
testing using spirometry, medical imaging (chest x-ray or CT scan) or arterial blood gas 
analysis (Rabe et al., 2007). SpO2 monitoring may be used in the home to detect 
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worsening symptoms or exacerbations where bronchodilators, supplementary oxygen 
or hospital admission may be required (Decramer et al., 2012). 
1.2.2 Infection 
Infection results from transmissible pathogenic microbial agents - bacteria, viruses, 
fungi and protozoa. These may be airborne, passed via close personal contact or 
contact with infected material, animals or insects (NIH, 2009), entering the body via 
the respiratory or digestive systems, abrasions to the skin or through the urinary tract, 
where they multiply and affect the host (World Health Organization, 2001). 
Presentation can differ greatly, with latent effects or rapidly developing symptoms, 
with varying degrees of severity that may last days, months or a lifetime (NIH, 2009). 
 
(NIH, 2009) 
Figure 1-6: Some common diseases and infections and their microbial causes 
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Figure 1-6 shows the microbial sources of a number of common infections, some of 
which have multiple causation. In these cases the symptoms and treatment may be 
quite different. 
Pneumonia 
Pneumonia is an acute lower respiratory tract infection (LRTI) that normally 
presents with fever and chest or respiratory complications (Longmore et al., 2009) and 
of all the infectious diseases, is the leading cause of death (Garibaldi, 1985; Calverley 
et al., 2011). In its various forms (e.g. community acquired - CAP, hospital acquired - 
HAP, nursing-home acquired - NHAP), pneumonia has a particularly high morbidity in 
vulnerable groups. These include patients with diabetes (Ehrlich et al., 2010), COPD 
(Restrepo et al., 2006; Calverley et al., 2011), the immunocompromised (Couch and 
Englund, 1997; Camps Serra et al., 2008) and the elderly, pneumonia the most 
commonly reported lethal infection in older people (Gelfand, 1995).  
There are a number of microbes that are commonly responsible for infection. These 
are typically bacteria such as Streptococcus pneumoniae, responsible for up to 58% of 
CAP and 30% of NHAP cases, Haemophilus influenza, up to 14% of CAP and NHAP 
cases, Staphylococcus aureas, MRSA and enteric Gram-negative bacteria. Viral 
infections may account for up to 42% of acute LRTIs with up to 32% of hospital 
admissions being due to influenza, parainfluenza (PIV) and respiratory syncitial virus 
(RSV) (Janssens and Krause, 2004). These are serious enough pathogens in their own 
right and a cause of significant seasonal morbidity with up to 90% of all deaths being in 
the elderly (Thompson et al., 2003), but can cause further complications, including 
functional decline and frailty (Barker et al., 1998) and secondary infections, which can 
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lead to pneumonia (Fleming and Elliot, 2005). Selective vaccination of the at-risk 
groups affords some protection against pneumococcal infection if treated every five to 
ten years and influenza, if given annually (Janssens and Krause, 2004; Lim et al., 2009).  
The elderly are more predisposed to pneumonia due to a number of age-related 
changes; these include decreased mucociliary clearance caused by reduced lung and 
chest wall elasticity and poorer cough reflex, in turn leading to increased microbial 
colonisation of the respiratory tract which is exacerbated by a weakening immune 
response (Fung and Monteagudo-Chu, 2010). The risk of hospitalisation from CAP 
increases substantially with age until the eighth decade of life, those of 60 years-of-age 
or over account for 81.2% of all cases (Fung and Monteagudo-Chu, 2010).  
Diagnosis may use vital sign monitoring, chest x-rays, urea, electrolyte, liver 
function and blood tests, followed by an array of biological assays to determine the 
nature of the infection, bacterial, viral or fungal. Treatment is dependent on these 
findings, which can help in delivering targeted medication. For bacterial infections oral 
antibiotics are preferred for all but severe cases, where intravenous medication is 
given. The less common viral infections are treated with appropriate antiviral agents 
(Mandell et al., 2003; Lim et al., 2009). 
Skin Infections 
Skin and soft tissue infections cover a range of conditions that may result from 
microbial infection. These range from the mild, such as athlete’s foot and Herpes 
simplex virus (HSV) to severe, as with the microbial colonisation of wounds or 
decubitus ulcers (Stevens et al., 2005). The more severe outcomes can be a 
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consequence of infectious agents entering the body via cuts, abrasions, abscesses, 
wounds, ulcers, intravenous drug use or animal bites or scratches, cats being the main 
offender (Laube, 2004; Stevens et al., 2005; DiNubile and Lipsky, 2004). Polymicrobial 
colonisation of infected sites is not uncommon and can lead to unpleasant 
complications such as Necrotising fasciitis, a destructive infection resulting in rapid 
deep tissue necrosis (Scheinfeld, 2005).  
Diabetics are particularly susceptible to infection, most commonly in the feet or 
lower legs (Joshi et al., 1999; Lipsky et al., 2010) leading to a risk of gangrene, 
Necrotising fasciitis, amputation and death (Joshi et al., 1999). Immunocompromised 
patients are also vulnerable to severe infection (DiNubile and Lipsky, 2004; Perfect and 
Schell, 1996) as are the elderly (Gavazzi and Krause, 2002; Laube, 2004). Skin and 
tissue infections are common in older patients and could be due to a number of 
factors, e.g. sun damage, vascular disease and infected wound sites (Webster, 2001). 
Some have multiple skin conditions with varying degrees of severity. Age-related 
changes to the skin’s structure such as a thinning epidermis, diminishing cell turnover 
rate and a reduction in blood flow and perspiration, all affect susceptibility to damage 
and prolong wound healing. This, together with a decrease in the water-binding 
capacity of the epidermis and the function of the eccrine and sebaceous glands – 
leading to dry skin – all play a part in the propensity for infection. (Laube, 2004). 
Decubitus ulcers (pressure sores) are a particular problem for the frail or bedridden; 
two-thirds of cases occur in those aged 70 years or older, often as a consequence of 
hospitalisation. These can develop when tissue becomes compressed for long periods, 
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reducing local blood flow and increasing ischemic cell death through the accumulation 
of toxins and leading to ulceration and necrosis of skin and tissue (Bansal et al., 2005).  
Surgical site infections (SSIs) are another common source of infection and are 
considered a “major cause of morbidity and mortality” (Owens and Stoessel, 2008). 
SSIs are defined as infections arising within 30 days of a patient undergoing a surgical 
procedure (Owens and Stoessel, 2008) and occur in up to 17% of surgical patients who 
are up to six times more likely to be readmitted to hospital than their infection-free 
counterparts, adding to healthcare costs (Weigelt et al., 2010; Humphreys, 2009). 
These are examples of nosocomial (hospital-acquired) infections, which also include 
bloodstream infections (BSIs) (Karchmer, 2000), and occur as a result of clinical 
intervention or hospital admission and occur in 5 -10% of outpatients in the UK. 
Members in the aforementioned groups would be especially vulnerable to nosocomial 
infection (Breathnach, 2009). 
Symptoms may be determined, at least in the first instance, by the monitoring of a 
patient’s vital signs for signs of fever (Stevens et al., 2005). Infected patients are at a 
risk of sepsis, which can lead to organ failure and fatality unless promptly diagnosed 
and treated (Nimmo et al., 2006). 
Urinary Tract Infection 
Urinary tract infections (UTIs) are relatively common in the adult population and 
describe the pathogenic infection of the urinary tract, bladder, kidneys or the urine 
itself (Foxman, 2003). They are most common in women, with around 40% of those 
over 18 years experiencing at least one outbreak in their lifetime (Hooton, 2000; 
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Medina-Polo et al., 2015), which compares to an estimated 0.07% in men (Ulleryd, 
2003). Around a quarter of women are likely to suffer reoccurrence (Foxman, 1990), 
the likelihood of which may be determined by the type of infecting organism and 
sexual behaviour (Foxman et al., 2000). 
Uncomplicated infections - those occurring in a “normal genitourinary tract with no 
prior instrumentation” (Foxman, 2003) - are largely due to pathogens (commonly from 
rectal flora) entering the urinary tract, with Escherichia Coli being responsible for 
around 80% of cases (Ronald, 2003; Hooton, 2000). Complicated infections may occur 
as a result of abnormalities in the urinary tract or from clinical interventions (such as 
catheter use), the etiology being different to uncomplicated UTIs with a higher risk of 
polymicrobial colonisation (Hooton, 2000; Ronald, 2003). With almost two-thirds of 
patients receiving intensive care using urinary catheters (Tominaga et al., 2014), 
research has shown that as many as 75% of catheterised patients can suffer with 
asymptomatic bacteriuria if a device is in-situ for a few days (Cove-Smith and Almond, 
2007) and that catheter-acquired UTIs (CAUTIs) alone account for a third of all 
nosocomial infections (Tominaga et al., 2014). Acute infections can lead to sepsis and 
can be life threatening (Bjerklund Johansen et al., 2014). 
UTI is seen as a complication of diabetes with a marked increase in prevalence and 
in certain types of bacteria compared with non-diabetics (Ronald, 2003; Yu et al., 
2014). Other vulnerable groups with an increased susceptibility and risk include the 
immunocompromised, those with injuries to the spinal cord, with a permanent bladder 
catheter, recurrent UTI, multiple sclerosis patients and pregnant women (Foxman, 
2003; López and Cortés, 2012). 
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The greatest prevalence, and potential for morbidity, is in older people. UTIs in the 
elderly are the most common of nursing-home acquired infections (Garibaldi, 1999) 
and cause of sepsis and fever in hospitalised patients, having a mortality of up to 33% 
(Tal et al., 2005). A number of age-associated physiological changes increase the 
likelihood of UTIs. These factors include increased reduced urine flow rate, greater 
residual urine volumes (Gavazzi and Krause, 2002), bacterial colonisation of the skin, 
effects of dementia and the side effects of medication. Gender specific causes include 
a high intra-vaginal (alkaline) pH in post-menopausal women which can lead to 
increased pathogenic bacterial adhesion, and hypertrophy of the prostate in men 
(Cove-Smith and Almond, 2007). 
Symptoms can vary widely, from the frequency of passing water and an abnormal 
appearance of urine in milder cases to discomfort, fever and confusion in the most 
severe. Treatment is dependent on the nature of the diagnosed infection, which may 
be achieved via the use of urine dipstick tests and blood and urine assays (Gibson and 
Toscano, 2012).  
Fever and the Febrile Response 
Once thought to be brought on by an excess of yellow bile (one of the four 
humours) by physicians in ancient Greece or even demonic possession in the Middle 
Ages, fever results from pathogenic microbial infection (Mackowiak, 1998). The classic 
febrile response is an adaptive physical reaction to infection resulting from a complex 
of trigger responses and controlled by the hypothalamus. The most obvious 
physiological effect is a rise in core temperature (from 1 to 4°C above the norm 
(Blatteis, 2003) as the body’s thermostatic setting is temporarily increased (Hasday et 
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al., 2000). This is typically accompanied by increases in perspiration, respiration and 
pulse rate – three of the four vital signs commonly used as an aid to diagnosis.  
Fever is normally described as having three distinct phases as it runs its’ course: At 
onset blood concentrates in the body’s core leading to chills, shivering and a rise in 
core temperature; the second phase sees an equilibrium in heat loss and production as 
the temperature plateaus before the final phase, in which cutaneous vasodilation 
(leading to a redistribution of blood from the core) and sweating cause heat loss and a 
return to normal core temperatures (Aiyagari and Diringer, 2007; Romanovsky et al., 
2005). Febrile episodes are not, arguably, harmful to the host and may be seen as 
beneficial to the greater immunological response (Blatteis, 2003). The elevated 
temperatures when febrile have been suggested to reduce mortality with some 
infectious agents (e.g. CAP and E-coli) (Aiyagari and Diringer, 2007), but may be prove 
detrimental to those with brain injury or severe neurological insults. The 
unpleasantness of fever may be treated by antipyretic drugs; this can have a protective 
effect for brain injuries but may prolong recovery from some infections, e.g. rhinovirus 
and varicella (Mackowiak, 1998; Blatteis, 2003; Aiyagari and Diringer, 2007). 
Fever in the Elderly 
The febrile response is typically less pronounced in the elderly (Berman et al., 1987; 
Sund-Levander and Grodzinsky, 2009). In many reported cases there is little change in 
core temperature in the elderly despite the subject displaying other symptoms of 
infection (Norman, 2000). Arguably, both healthy adults (Kiekkas et al., 2007) and the 
healthy elderly (Darowski et al., 1991b) typically have core temperatures ranging from 
36.5°C to 37.5°C – a nominal 37°C. A core temperature of one degree or more above 
The design and evaluation of discrete wearable medical devices for vital signs monitoring 
DG Pitts 36 Cranfield University 
the norm is widely considered to be hyperthermic and thus, indicative of fever 
(Mackowiak, 1998).  
Studies show changes in thermoregulation in the elderly compared with their 
younger counterparts, but little difference in body core temperature between the two 
groups (Kenney and Munce, 2003). Thermoregulatory changes find older individuals 
more prone to suffer the effects of cold and heat stress as their ability to regulate body 
temperature is blunted. The normal response to cold stress, vasoconstriction and 
shivering, occurs at lower temperatures (< 1°C) – leading to an increased risk of 
hypothermia - a core body temperature of less than 35°C (Lien, 2002).  
 
(Kenney and Munce, 2003) 
Figure 1-7: A summary of age-related changes in thermoregulation during heat stress  
With heat stress, the normal control mechanisms show a diminished response 
(Figure 1-7) - cutaneous blood flow, sweating, and cardiac output are all reduced, 
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which would appear to suggest the elderly are at an increased risk from hyperthermia, 
however the ability to maintain core temperature is not usually unduly compromised 
(Kenney and Munce, 2003).  
Temperature assessment alone may not be sufficient for classifying febrile 
infection, leading to a late or incorrect diagnosis (Varney et al., 2002). Analysis of this 
in combination with respiration, pulse rate and skin resistance, the other characteristic 
responses, should facilitate early detection of infection and improve positive 
prediction.  
Aging and Infection 
The over sixty-fives are more predisposed to infection, the seriousness of which 
increases with age (Weinberger et al., 2008). The source of infection may be 
endogenous or exogenous microbes, but it has a far greater chance of progressing to a 
stage where the elderly host will require hospitalisation (Yoshikawa, 1981). Gavazzi 
and Krause note a general susceptibility of infection that is typically three times 
greater than the general population of contracting community-acquired pneumonia, 
extending to twenty times for urinary tract infection (Gavazzi and Krause, 2002) and 
three times higher for nosocomial infections (Yoshikawa, 1981). Frequently reported 
ailments include upper and lower respiratory tract infections (Janssens and Krause, 
2004), pneumonia, influenza, urinary tract infections, soft tissue infections, sepsis 
(Schmader, 2001) and a range of gastrointestinal infections (Gelfand, 1995). Treatment 
can be complicated by adverse reactions to drugs, especially antibiotics which may 
cause gastrointestinal intolerance in the form of nausea and diarrhoea (Gavazzi and 
Krause, 2002). 
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Immunosenescence  
The deterioration of the immune system with age is known as immunosenescence; 
this decline in the immune response results in an increased susceptibility to infection. 
Whether this is due to a general deterioration in the host defence system, a decline in 
a number of specific mechanisms or a combination of both of these factors is unclear 
(Gavazzi and Krause, 2002). Telomere shortening, where the repetitive DNA that 
stabilise and protect the ends of chromosomes (known as telomeres) shorten with and 
ultimately prevent replication, is one cited aging mechanism (Aubert and Lansdorp, 
2008). Another is a decline in the production of immunity-promoting naive T cells as 
the aging thymus gradually atrophies and becomes increasingly adipose (Grubeck-
Loebenstein, 2010). There is also evidence to suggest that persistent infections such as 
cytomegalovirus (CMV) can cause chronic stimulation of the immune system over 
time, and that accelerated immunosenescence may be due to an individual’s 
immunological history (Pawelec et al., 2010).  
Vaccination can be an important weapon in protecting the elderly from infection; 
vaccines for influenza and pneumonia are routinely given to those with comorbid 
conditions who are particularly vulnerable. The attenuated immune response in an 
aging population however presents challenges for vaccine developers (Chen et al., 
2009). As vaccines tend to be less effective this may necessitate changes to 
formulations, plus additional therapies such as boosting thymic output for an 
enhanced immune response (Aspinall et al., 2007). An increase in immunity duration 
may also be achieved by regular booster vaccinations (Kaml et al., 2006). 
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1.2.3 Comorbidity 
Comorbidity, the presence of other morbid conditions in addition to and 
independent of a primary disease, is a complication at any age and an added threat to 
vulnerable groups in which the prevalence and severity of comorbidities are greater 
(Wedding et al., 2007). It is a particular issue for elderly patients; an Irish study of the 
national pharmacy claims database of patients aged 70 years or older (n=316,928) 
reported 27% of the sample population with two chronic conditions, 19% with three 
comorbidities and 14% with four or more (Naughton et al., 2006). Another based on a 
review of literature on the MEDLINE database published between 1990 and 2002 puts 
the prevalence of ‘multimorbidities’ in 55 to 74 year-olds at 60% (Fortin et al., 2005), 
whilst the findings of an Australian survey of returns from general practitioners puts 
the incidence in the over 75 age group at 83% for two or more comorbid conditions 
(Britt et al., 2008). 
Those suffering from one or more common long-term conditions, such as diabetes 
mellitus, cancer, heart disease or COPD, face an increased risk of mortality from 
infection; examples include pneumonia, which may be both difficult to detect and 
particularly perilous to COPD patients (Garibaldi, 1999), and the danger posed by soft 
tissue infections to diabetics (Joshi et al., 1999). Comorbidity (especially COPD, 
cardiovascular disease and chronic heart failure) can also be problematic for elderly 
surgical patients as it may cause complications, delays or even prevent procedures and 
leads to a higher post-operative mortality rate (Roche et al., 2005). Comorbid patients 
are more predisposed to suffer cumulative deficits, leading to frailty and adversely 
affecting their activities of daily living (ADLs) and quality of life. There are also 
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complications with treatment; many may be too vulnerable to undergo radio- or 
chemotherapy, or may suffer side effects from prescribed drugs (Gijsen et al., 2001).  
1.2.4 Disease, Infection and Mortality 
An examination of the leading causes of death in the general population shows a 
range of common conditions. Table 1-7 shows the top fifteen causes of death in the 
United States from 2006; this is a comprehensive list that includes non-clinical data.  
Rank Disease/Infection 
1. Diseases of heart (heart disease) 
2. Malignant neoplasms (cancer) 
3. Cerebrovascular diseases (stroke) 
4. Chronic lower respiratory diseases 
5. Accidents (unintentional injuries) 
6. Diabetes mellitus  
7. Alzheimer’s disease 
8. Influenza and pneumonia 
9. Nephritis, nephrotic syndrome and nephrosis (kidney disease) 
10. Septicaemia 
11. Intentional self-harm (suicide)  
12. Chronic liver disease and cirrhosis 
13. Essential hypertension and hypertensive renal disease (hypertension) 
14. Parkinson’s disease 
15. Assault (homicide)  
(Heron et al., 2009) 
Table 1-7: The fifteen leading causes of death in the United States in 2006  
When historic data is considered and compared, trends in population mortality may 
be observed - this is apparent in Figure 1-8, which shows the changes in reported 
causes of death from 1958 to 2006. Here the gradual reduction in deaths from heart 
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and cerebrovascular conditions (strokes) and increases in mortality from Alzheimer’s 
and Parkinson’s diseases may be seen (Heron et al., 2009). When historic data is 
considered and compared, trends in population mortality may be observed - this is 
apparent in Figure 1-8, which shows the changes in reported causes of death from 
1958 to 2006. Here the gradual reduction in deaths from heart and cerebrovascular 
conditions (strokes) and increases in mortality from Alzheimer’s and Parkinson’s 
diseases may be seen (Heron et al., 2009).  
 
(Heron et al., 2009) 
Figure 1-8: The age adjusted death rates for leading causes of death: USA, 1958 - 2006  
UK-based studies show gender differences in the leading causes of mortality. Table 
1-8 ranks death rates in the over fifties (Ashton et al., 2010), showing heart disease 
(1st) and strokes (2nd) as the greatest risks. Neoplasms (3rd) show males more likely to 
suffer lung cancer than their female counterparts, where breast cancer is a threat. 
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Rank Males Females 
1 Ischaemic heart diseases Ischaemic heart diseases 
2 Cerebrovascular disease Cerebrovascular disease 
3 
Malignant neoplasm: trachea, 
bronchus and lung 
Malignant neoplasm: breast 
4 COPD, bronchitis, emphysema Pneumonia 
5 Malignant neoplasm: stomach Malignant neoplasm of colon 
(Ashton et al., 2010) 
Table 1-8: The leading five causes of mortality in men and women over fifty years of age in 
England, 2005  
Cause of Death in Males No. Cause of Death in Females No. 
Neoplasms  76512 Circulatory system diseases 71773 
Circulatory system diseases 69420 Neoplasms  68532 
Respiratory system diseases 33364 Respiratory system diseases 37168 
Miscellaneous conditions 14786 Miscellaneous conditions 24782 
Digestive system diseases 11735 
Mental and behavioural 
disorders 
24148 
Mental and behavioural 
disorders 
11709 Digestive system diseases 12784 
External causes 10500 Nervous system  diseases 11575 
Nervous system  diseases 9325 External causes 6309 
All causes, aged 20 years and 
over  
237351 
All causes, aged 20 years and 
over  
257071 
(Office for National Statistics, 2013) 
 Table 1-9: The leading causes of death in the male and female adult population (aged 20 
years or older) in England and Wales, 2012 
Table 1-9 shows 2012’s statistics and rankings for the leading causes of death in the 
wider adult (20 years or older) population (Office for National Statistics, 2013). These 
data show cancer (1st), heart and cardiovascular disease (2nd) and respiratory disease 
(3rd) as the main risks to males; that for females is similar though the ranking of cancer 
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and cardiovascular diseases are reversed. The study also reveals that the likelihood of 
females dying from mental disorders is more than twice that of males. In examining 
the three leading causes of death, age must be considered in addition to gender. Plots 
for each showing the age distribution for both genders are presented in Figure 1-9.  
Although there are differences between the death rates for each gender, it can be 
seen that there is a substantial increase in death rates with advancing years from the 
age of around 50 to 55. In the case of neoplasms (cancers) mortality rates are 
comparable up to age of 55 years when the male trajectory increases significantly until 
reaching a zenith at 80, then returning to comparable levels to the female figures at 
age 85 and beyond. Male deaths from circulatory (cardiovascular) diseases show a 
steady increase from the age of 35 to a peak at 80 years, whereas the rate of female 
deaths start to increase from 40 to 50 years then escalating and exceeding the male 
figures when peaking aged 85. Mortality for respiratory diseases are broadly similar 
between the sexes, the rates reaching parity by 80 years after which female deaths 
greatly outstrip those of males. 
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(Office for National Statistics, 2013) 
Figure 1-9: The three leading causes of death in adults (of 20 years or older) in England and 
Wales by age and gender, 2012. 
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(Office for National Statistics, 2013) 
Figure 1-10: The number of deaths from infectious diseases in adults (of 20 years or older) 
in England and Wales by age and gender, 2012. 
 
(High, 2004; Yoshikawa, 1997) 
Figure 1-11: Relative mortality in older adults vs. young adults with the same diagnosis  
It is clear from Figure 1-10 that infection in the elderly (over 65 years), as with other 
conditions, has a significantly higher mortality rate than the general population (Office 
for National Statistics, 2013) – typically around nine times higher than in patients aged 
25 to 44 years of age (Mouton et al., 2001). The relative mortality of some of the 
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leading infectious diseases in younger and elderly patients is depicted in Figure 1-11 
(Yoshikawa, 1997; High, 2004).  
1.2.5 Summary 
This section reviews the nature of disease and infection and the differences 
between them. It examines their causation, risk factors, impact, prevalence, morbidity, 
mortality and the range of methods employed in their diagnosis and management.  
Many diseases lead to the development of long term conditions, with many 
sufferers having comorbidities. This, together with the consequences of ageing (such 
as immunosenescence), can leave many individuals increasingly vulnerable to 
infection, which has a significantly higher mortality rate in these groups. 
With the exception of hypertension, where BP readings provide a valuable 
indicator, many diseases rely on methods other than VS monitoring for diagnosis. 
While abnormal HR, RR or SpO2 readings may be indicative of a heart or respiratory 
condition, more specific diagnostic tests (e.g. ECG, lung function tests etc.) are 
required to determine the precise nature of a patient’s condition, although VS 
monitoring does have a place in condition management.  
VS monitoring can be effective in the determination of infection, especially those 
with a febrile presentation. Rather than relying on an elevated temperature however, 
this should be considered in combination with the other VS for a more certain 
diagnosis – especially with elderly patients. This can also help in the diagnosis of 
respiratory infections, pneumonia and sepsis. 
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1.3 Vital Signs Monitoring 
In considering electronic health monitoring and its applications, it is clear that this is 
a diverse environment with a wealth of products from many manufacturers and 
vendors, with systems ranging from condition-specific devices such as glucometers (for 
diabetics monitoring their blood sugar levels) to vital signs monitors for general 
healthcare applications. Here, the next sections examine vital signs monitoring devices, 
which signs provide the best diagnostic information for a range of different medical 
conditions and how the monitoring is performed for the best patient benefit. 
1.3.1 Monitoring Devices 
These were developed in response to a need for assistive devices or instruments as 
a means of establishing verifiable vital signs readings in clinic, rather than relying on 
subjective observations. Whilst originally designed for clinical use, many products are 
now freely available in the high street and are purchased for home use by those 
managing a morbid condition and the “worried well” (Amies, 1996). 
Temperature 
Braun and Omron are well known digital thermometer brands, both supplying a 
range of products for medical temperature measurement. Together with numerous 
other brands, they produce non-contact (IR) forehead sensing devices as well as ear, 
oral, rectal and axillary thermometers (see Figure 1-12). While many of these allow 
readings to be stored, examples such as the Braun PRT2000 have age-adjusted 
thresholds for fever prediction in young children (Braun GmbH., 2015). 
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(OMRON Corporation, -) 
Figure 1-12: The Omron Eco Temp Smart digital medical thermometer 
Heart Rate 
This might be measured with a pulse oximeter or if more detail is required, via 
electrocardiography, which can display and record the heart’s electrical activity. The 
latter is more likely to be used in hospital, in the form of a bedside unit, where it is 
used as a diagnostic tool to determine heart conditions such as CVD, heart failure and 
arrhythmias (World Health Organization, 1981).  
For a more thorough analysis, patients may be asked to wear a Holter monitor 
(Figure 1-13) for 24 to 48 hours to record continuous ambulatory ECG readings. This 
device, named after its inventor, N.J. Holter (1914 – 1983), an American physicist 
(Ioannou et al., 2014), is a small wearable battery-powered ECG with a high capacity 
memory. It is able to capture heart signal transients acting as markers for heart disease 
while the subject goes about their normal daily life. Manufacturers include GE 
Healthcare, Philips Healthcare and Welch Allyn Inc. (Welch Allyn Inc., 2012), all of 
whom provide software applications to quickly identify anomalies and aid diagnosis.  
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(Welch Allyn Inc., 2012) 
Figure 1-13: Welch Allyn’s HR-100 Holter monitor for ambulatory ECG recording 
Many fitness monitoring products (fitness trackers) provide HR measurement 
capability, with examples available from manufacturers such as Garmin, Fitbit, 
Withings and Jawbone. There are also numerous smartphone apps that use the built-in 
camera and flash (LED) to produce a crude photoplethysmograph (pulse waveform) 
from which HR is derived. 
Blood Pressure 
Digital blood pressure monitors see widespread use in hospitals GP surgeries and 
increasingly, in the home for improved management of hypertension (Padfield, 2010). 
The majority of devices employ an inflatable pneumatic cuff worn around the arm or 
wrist to temporarily occlude blood flow during the measurement process (Babbs, 
2012). Leading manufacturers include Braun, Omron and A&D Medical, all of whom 
produce a range of wrist and arm cuff-based devices featuring battery operation, 
digital displays and data recording facilities. Over the last few years wireless-enabled 
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devices have appeared, both from established brands and newcomers such as Cardio 
and Withings (Figure 1-14). These integrate the electronics and batteries within the 
cuff design, using a smartphone to wirelessly control operation, then display, archive 
and chart readings (Withings, 2015b). 
 
(Withings, 2015b) 
Figure 1-14: A wireless-enabled blood pressure monitor by Withings 
Readings taken in clinic provide but a snapshot of a patient’s true blood pressure 
and are prone to the effects of “white coat hypertension”, in which readings may be 
elevated by as much as 12% to 50% due to anxiety and stress (Owens et al., 1999). 
Ambulatory blood pressure monitoring (ABPM) addresses this by taking a series of 
readings over a 24 hour period, the frequency of which may be up to every 15 minutes 
during the day and 30 minutes at night (Schächinger and Langewitz, 1997). Data may 
be analysed to establish an individual’s normal readings, their range, identify 
variability, overnight dipping and any markers for CVD (Schächinger and Langewitz, 
1997; Grossman, 2013). This has provided more reliable and realistic results, reducing 
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white coat effect and revealing a patient’s underlying readings for an improved 
diagnosis. UK clinical guidelines recommend ABPM in the management of 
hypertension (White and Maraka, 2012).  
Respiration Rate 
Capnography is the standard method of measuring RR in anesthetised, intensive 
care and trauma patients. The exhalatory in-line sensors may be fitted to a ventilator, 
endotrachael tube or mouthpiece and connect to a host monitor to display real-time 
data. Smiths Medical, Nonin, Covidien and Masimo (Masimo Corp., --c) all provide 
hand-held or bedside monitoring systems. A recent innovation (c.2008) is Masimo’s 
acoustic respiration rate sensor (Macknet et al., 2007; Masimo Corp., --a) which sticks 
to the side of the neck of patients and detects respiratory sounds (Figure 1-15). 
 
(Masimo Corp., --a) 
Figure 1-15: Masimo’s acoustic respiration rate sensor (RRa) 
There are few dedicated RR sensors on the market, many choosing to use an 
estimation calculated from HR. The most common of the commercially available 
sensors are thoracic band-based systems for medical use (Thought Technology Ltd., -; 
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Vernier Software & Technology, 2009) and wearable fitness bands that incorporate 
similar technologies (see Zephyr Technology, 2012). 
Blood Oxygen Saturation 
This is measured with a pulse oximeter. These are widely available with in excess of 
450 models (plus accessories) reported on Amazon’s UK website, with examples priced 
from £12.99 (Amazon.co.uk, 2015) and finding use in the home. They are typically 
offered in three main forms: (i) a fingertip model with integrated sensor and display, 
plus (ii) hand-held and (iii) bedside models with separate sensor probes, examples of 
which are presented in Figure 1-16. Leading manufacturers include Nonin, Covidien 
(Nellcor), Smiths Medical and Masimo. 
 
 
(Covidien, 2015) 
Figure 1-16: A range of pulse oximeter sensor probes from Nellcor (Covidien) 
These sensors are frequently incorporated into fitness products such as the wrist-
band devices offered by Withings, Fitbit and others (Withings, 2015a). 
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1.3.2 Multi-Parameter Monitoring Devices 
The majority of vital signs monitors read no more than two parameters (e.g. a blood 
pressure monitor records HR and BP and a pulse oximeter, HR and SpO2), hence 
several different devices may be required if all five vital signs are to be measured. 
Bedside patient monitors found in hospital however are often capable of measuring all 
five of the vital signs (Infinium Medical Inc., -), with some examples providing 
additional physiological data for (ECG-based) cardio (Koninklijke Philips Electronics NV, 
2010) and (capnograph-based) respiratory diagnostics (Covidien, 2013). Probes 
connect to the side or rear of the instrument, which may contain plug-in modules to 
accommodate different sensor types. The probes are attached to the patient for 
continuous monitoring and provide valuable data, although the subject is effectively 
tethered to the bed by the umbilical cables. Therefore these are used primarily with 
bed-bound patients requiring constant monitoring, such those in intensive care.  
An example of a modern bedside monitoring system is shown in Figure 1-17. These 
typically have a large colour LCD display with the key readings (e.g. HR, SpO2, BP, RR 
and temperature etc.) shown prominently in a large font, being clearly visible from 
several feet away, together with signal waveforms (on some models) from ECG, SpO2 
and capnograph sensors. A command button or touch screen user interface allows 
alarm thresholds to be set, diagnostics performed and (on some models) the preferred 
display screen selected. Although normally mains-powered, many systems are capable 
of battery operation to facilitate patient transfers. 
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(Infinium Medical Inc., -) 
Figure 1-17: The Infinium Omni II, an example of a modern bedside patient monitoring 
system  
Systems better suited to ambulatory patients are also becoming available. These 
may be smaller units, with reduced capability, or make use of wireless sensors that 
connect to suitably equipped bedside monitors (Koninklijke Philips Electronics NV, 
2013). Other developments use networked monitoring systems that connect to a 
central server to provide integrated patient care and management capabilities, 
allowing remote access to vital signs readings (Covidien, 2014). 
1.3.3 Vital Signs as an Aid to Diagnostics and Condition Management 
The review presented in sections 1.1 and 1.2 details the vital signs and shows how 
they may be employed in aiding the diagnosis and management of a range of medical 
conditions. Table 1-10 provides a summary of which signs best benefit patient 
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monitoring for those conditions discussed in section 1.2 and for general fitness and 
wellbeing.  
Condition Temp HR BP RR SpO2 Other 
CVD  X X X  Weight Loss 
Cancer    X  Imaging 
COPD and Asthma  X  X X Spirometry 
Pneumonia X X  X X  
Febrile Infection X X  X X Perspiration 
Sepsis X X X X X Delirium 
Fitness and Wellbeing X X X X X  
Table 1-10: The use of vital signs in the diagnosis and management of disease and infection 
as determined from this literature review. 
The findings suggest the following points: 
 Temperature monitoring is best for employed for determining infection and 
wellbeing. 
 HR, and the detection of bradycardia and tachycardia, can be useful for managing 
CVD, respiratory conditions and general fitness, with an increase above normal 
levels aiding in the diagnosis of infection. 
 BP is most effective in CVD management and monitoring general fitness, but can 
be useful in diagnosing sepsis. 
 RR has the widest range of applications in monitoring heart, respiratory conditions 
(including lung cancer), infection and fitness. 
 SpO2 is at its most effective in monitoring respiratory conditions, fitness and 
infection. 
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Of the other signs mentioned only perspiration sensing as a marker for febrile 
infection could realistically be incorporated into a non-invasive VS monitor. This would 
take the form of skin resistance sensing and is reviewed in the following paragraphs. 
Bathroom scales and spirometers (Medical International Research, 2015) are available 
with Bluetooth wireless links, the data from which would complement the 
physiological readings. 
Skin Resistance 
Electrical skin resistance (SR) is a well-known stress marker; this may be due to 
psychological or physiological causes (Strauss et al., 2005), such as infection (see 
section 1.2.2, p36), and is perhaps best recognised as one of the prime measures used 
in lie detectors or polygraph testing. Skin provides evaporative cooling through sweat 
and therefore this mechanism should be apparent with a febrile subject, even though 
the elderly may show a diminished response (Kenney and Munce, 2003). The effects of 
dermal aging in elderly individuals include a thinning epidermis and reductions in 
blood flow, the water-binding capacity of the stratum corneum and sweat gland 
function, all contributing to an increased dryness of the skin (Laube, 2004). 
SR changes according to the level of local skin hydration or sweating and falls as 
hydration increases. Dry skin has a typical resistance in the order of a few hundred 
thousand Ohms, although it is clear that the response can be quite different between 
individuals where a number of factors, including skin type, diet, medication, age, 
hydration level and environmental conditions, may come into play (Hume, 1966). 
Measurement sites display different characteristics; this is largely due to local sweat 
gland density which differs considerably around the body as shown in Table 1-11 
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(Wilke et al., 2007). The key determinants in the electrical evaluation of sweat are 
sweat rate and concentration, the latter of which is inversely proportional to 
resistance (Licht et al., 1957). The specific ratios between the major (ionic) 
constituents of sweat (see Table 1-12) and the rate of sweat production are also likely 
to be measurement site dependent (Patterson et al., 2000). Therefore, in order for 
meaningful comparisons to be made, this should be consistent for any set of tests.  
Region 
Wilke et al,  
2005 
Sato et al,  
1989 
Fiedler et al, 
1968 
IFSCC 
Monograph, 
1999  
Palms 644 600 - 700 620 ± 120 370 
Forearm 134 108 225 ± 25 155 
Abdomen 127 - 190 ± 5 - 
Upper arm 90 108 150 ± 20 - 
Armpit 68 ~100 400 ± 50 90 - 200 
Thigh 57 - 120 ± 10 80 
Face 59 181 360 ± 20 175 
Chest 20 - 175 ± 30 - 
Back - 64 160 ± 30 60 – 100 
(Wilke et al., 2007) 
Table 1-11: Sweat gland density (per cm2) measured by direct (Wilke) and indirect (Fiedler, 
IFSCC) counting  
The design and evaluation of discrete wearable medical devices for vital signs monitoring 
DG Pitts 58 Cranfield University 
Organic Compounds (mEq/L) Inorganic Compounds (mEq/L) 
Sodium 15 - 60 Lactic acid 17 - 330 
Potassium 3 - 8 Urea 3 - 7 
Chloride 15 - 60 Amino acids 0.7 – 1.5 
Calcium 0.1 – 1.0   
Sulphate 0.4 – 1.8   
Trace Elements 
Iron, magnesium, copper, phosphate, iodide, fluoride 
pH 
4.5 – 7.1 
(Licht et al., 1957) 
Table 1-12: The basic composition of sweat from healthy subjects  
1.3.4 Vital Signs Monitoring 
Although there is variation between individuals, the baseline readings for healthy 
adults fall within a broadly similar range. Deviation from an individual’s normal 
baseline values could indicate illness or infection (Harries et al., 2009) while a return to 
normal values may suggest an improving condition or recovery. Readings that may be 
considered normal for the adult population however, can differ from values 
considered normal in the elderly leading to increased patient risk (Wolf, 2007).  
When used as part of the screening process during triage, vital signs monitoring can 
assist in decision making when prioritising critical treatment (Cooper et al., 2002). 
Following initial triaging, monitoring frequency is dependent upon patient condition. 
Emergency hospital admissions or those in critical care may be subject to continuous 
monitoring of at least one parameter in extremis, extending to every 15 to 30 minutes 
if less acute (Evans et al., 2001). For lower risk emergency admissions two-hour 
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intervals are not unusual (especially during busy periods) while inpatients outside of 
intensive care are usually monitored every four hours, within a one-hour window 
(Johnson et al., 2014). Checking for abnormalities in the vital signs prior to discharge 
from a hospital’s emergency department has been shown to result in a reduced risk of 
readmission (Domagala, 2009). 
There are however some practical issues which must be considered if reliable 
measurement is to be achieved:  
1. The frequency and timing of readings are often ultimately determined by 
routine rather than driven by clinical need (Zeitz and McCutcheon, 2006).  
2. With observation-based assessment, inter-observer variability should be 
taken into account as there may be an element of subjectivity in reported 
results (Edmonds et al., 2002). 
3. Once recognised, abnormal VS should be reported promptly allowing for 
timely clinical intervention - delays may be critical for effective patient care 
(Cioffi et al., 2006).. 
These are areas where intelligent electronic monitoring systems with appropriate 
alarm settings may offer a demonstrable advantage.  
1.3.5 Early Warning Scoring Systems 
A measurable deterioration in a patient’s vital signs is frequently apparent six to 
eight hours prior to suffering cardiopulmonary arrest (Schein et al., 1990; Franklin and 
Mathew, 1994; Hillman et al., 2001). All too often, suboptimal care, whether due to 
organisational failure, inexperienced staff, insufficient clinical knowledge, inadequate 
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training or resource issues, has led to avoidable mortality (McQuillan et al., 1998; 
Smith and Poplett, 2002; NCEPOD, 2005; Massey et al., 2008). In particular, there have 
been issues with poor clinical practice where changes in observations and vital signs 
have not been noted, recognised or acted upon (Franklin and Mathew, 1994; NPSA, 
2007).  
Regular observation and monitoring (four hourly or less) should detect deteriorating 
vital signs inside the six to eight hour window for an improved outcome. In an effort to 
ensure best practice and improve outcome a number of innovative practices were 
introduced, including ALERT training and EWS systems. ALERT (Acute Life-threatening 
Early Recognition and Treatment) training was established to provide a one-day course 
for healthcare professionals in the management of critically ill adult patients (Smith et 
al., 2002). In effort to standardise patient monitoring and the response to changes in 
condition, the Early Warning Scoring (EWS) systems were born (Morgan and Wright, 
2007). These aggregate weighted VS readings and observations to provide a score that 
may be used to track changes in patient condition and trigger the appropriate clinical 
response if predetermined thresholds are exceeded.  
EWS systems, in their various forms, have found widespread use. Whilst they may 
vary in the number of parameters scored and their relative weightings, they all employ 
a track and trigger system (TTS). The ViEWS (VitalPAC EWS) system collected readings 
(VS and GCS) on PDAs (personal digital assistants) running VitalPAC software and 
wirelessly linked to a database (Prytherch et al., 2010). The MEWS (Modified EWS) 
system was designed for routine bedside monitoring and uses weighted measures of 
temperature, heart rate, respiratory rate, systolic blood pressure and level of 
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consciousness (Subbe et al., 2001). More recently, the NEWS (National EWS) system 
has been introduced and is being rolled out across the NHS (Royal College of 
Physicians, 2012). 
The NEWS physiological parameters and their weightings are shown in Figure 1-18. 
It is based upon the five vital signs together with level of consciousness, which in this 
case uses an AVPU (alert/verbal/painful/unresponsive) responsiveness score - a 
simplified version of the GCS that tests a patient’s response to verbal and painful 
stimulation (Kelly et al., 2004). Each parameter is scored according to where a reading 
falls in the ranges shown in the table, higher scores exhibiting a greater patient risk. 
These scores are then aggregated for an overall measure of patient condition (Figure 
1-19), with a score of 5 or above, or 3 on a single parameter, being flagged as a 
medium risk and a result of 7 or above as a high risk (Royal College of Physicians, 
2012). 
 
(Royal College of Physicians, 2012) 
Figure 1-18: The NEWS scoring system assessment chart.  
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(Royal College of Physicians, 2012) 
Figure 1-19: The clinical risk thresholds of the aggregated NEWS scores  
 
(Royal College of Physicians, 2012) 
Figure 1-20: The NEWS standardised clinical response, in which monitoring frequency and 
the scale of response track patient risk. 
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Different risk factors trigger an appropriate response depending on the severity of a 
patient’s NEWS score. Figure 1-20 shows the NEWS clinical response chart; it should be 
noted that the observation frequency is proportional to the level of risk (Royal College 
of Physicians, 2012). 
Any EWS system depends on regular and complete sets of patient data; gaps in a 
dataset compromise effectiveness and diminish reliability. Adherence to a 
standardised monitoring protocol is essential if EWS is to be of any clinical value (Day 
and Oldroyd, 2010; Ludikhuize et al., 2012). With appropriate implementation EWS 
systems have consistently demonstrated their value in improving hospital mortality 
figures (Green and Williams, 2006; Moon et al., 2011) and have been reported to be 
superior to clinical judgement alone in detecting critical illness (Fullerton et al., 2012). 
1.4 Telemedicine and Telehealth 
Telemedicine, a term that first appeared in the 1970s, may be considered as the 
“delivery of health services via remote telecommunications” (Moore, 1999). Today, it 
perhaps more accurately describes the application of information and communications 
technology (ICT) to enable the delivery of healthcare services at a distance, rather than 
face-to-face. It encompasses a range of interactive video, audio, imaging and data 
services on a number of platforms (e.g. mobile devices, computers, tele- and 
videoconferencing etc.) to facilitate remote monitoring and consultation, whether 
clinician-clinician or patient-clinician, to aid the diagnosis, treatment and prevention of 
disease or injury. The term lacks a definitive definition, as illustrated by a 2007 study 
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that found no less than 104 in peer-reviewed publications (Sood et al., 2007). The 
WHO definition is widely used and cited (World Health Organization, 2010).  
Telehealth is seen by some as an umbrella term incorporating telemedicine 
together with the remote provision of non-clinical services such as health research and 
education (Cochrane Library, 2010). As with telemedicine, the precise definition is 
unclear, the two terms being frequently confused and used interchangeably and 
synonymously (World Health Organization, 2010). For consistency the telehealth term 
is used throughout this thesis. 
1.4.1 Classification 
There are three main classes of telehealth services, (i) store and forward, (ii) 
interactive and (iii) remote monitoring. Store and forward facilitates the capture and 
sharing of digital medical images and clinical audio, video and observation data. Rather 
than being transmitted in real-time, data is stored and subsequently forwarded to 
clinicians (who may be specialists) for assessment. Interactive telehealth describes real 
time remote audio/video instead of face to face consultation, whether patient to 
clinician or clinician to clinician. Lastly, remote monitoring, as the name suggests, 
involves use of sensors and monitoring devices for the collection of physiological and 
clinical data (Cochrane Library, 2010). This is also known as telemonitoring. 
1.4.2 Telemonitoring 
This was pioneered by NASA following work by Grams et al (Grams and Jin, 1989) 
who in 1980 developed a portable stand-alone medical decision support system for life 
support activities during space missions (Hatcher and Heetebry, 2004). In the years 
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that followed, many researchers proposed, built and reported results from studies on 
wireless ambulatory vital signs monitoring systems. Examples include AMON, a wrist-
worn vital signs monitor (Anliker et al., 2004), MOPET, a sophisticated fitness monitor 
(Buttussi and Chittaro, 2008), SMART, a belt worn vital signs monitoring system (Curtis 
et al., 2008), MUSE, a multi-sensor wireless system for the continuous monitoring of 
congestive heart failure patients (Anand et al., 2011) and Ellingson’s vital signs and 
biomedical monitoring system (Ellingson et al., 2006) shown in Figure 1-21.  
       
(Ellingson et al., 2006) 
Figure 1-21: An example of an ambulatory physiological monitoring system for EEG, HR, 
RR, temperature, bioimpedance and BP.  
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For the most part these were rather unwieldy and not designed with the user in 
mind, which is perhaps understandable, as their intention was to demonstrate proof of 
concept or new sensing techniques. 
With advances in the electronics industry over the last two decades, such as highly 
integrated chips with superior performance, low power chip designs and compact 
component packaging for semiconductors, passives and connectors alike, 
telemonitoring devices, as with commercial ICT and audio/video products, have 
become smaller and more capable. Together with the advent of rapid prototyping 
through the widespread use of CAD for electronic and mechanical design, economic 
fast-turnaround prototype pcb production and assembly and 3D printing, has driven 
down the development time and costs of bringing a device to a pre-clinical trials stage.  
Technological advances have led to numerous new design studies, examples 
including a flexible pcb sensor patch for ECG and temperature measurement (Chang et 
al., 2008); a real-time vital signs monitor for astronauts (Fei et al., 2010); an ear-worn 
cardiac monitor providing an estimation of mean arterial BP (Winokur et al., 2012); the 
AIRBEAT system, a sensor patch for monitoring HR, activity and motion (Li and Kim, 
2012). It has also seen the launch of a number of commercial telemonitoring devices 
such as SensiumVitals®1, a single-use sensor chest patch providing HR, RR and axillary 
temperature (Figure 1-22); Lifetouch2, a similar patch-based device and the EQ02 
                                                 
1 Sensium Healthcare, London, UK 
2 Isansys Lifecare Ltd., Abingdon, Oxfordshire, UK 
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LifeMonitor3, a thoracic belt-mounted device capable of monitoring ECG, HR, RR, SpO2, 
motion and temperature.  
 
(Sensium Healthcare, 2015) 
Figure 1-22: The SensiumVitals sensor patch, a self-adhesive disposable wireless 
monitoring device. 
Interest generated in telemonitoring and personal healthcare has led to the 
announcement of the Qualcomm Tricorder X-Prize in 2014, a “$10 million global 
competition to stimulate innovation and integration of precision diagnostic 
technologies, helping consumers make their own reliable health diagnoses anywhere, 
anytime.” (XPRIZE, 2015). Ten finalists have been announced, the project teams having 
to demonstrate and trial their devices with the winner being announced early in 2016. 
  
                                                 
3 Equivital, Hidalgo Ltd., Cambridge, UK 
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1.5 Conclusions 
The importance of vital signs measurement has long been understood (Stewart, 
2003). In the healthcare sector it is an essential tool in maintaining wellbeing, aiding 
diagnosis and managing morbid conditions (Evans et al., 2001; Ahrens, 2008; Rogers et 
al., 2008). The preceding literature review in this chapter defines the vital signs and 
establishes what they may convey. It then examines common diseases and infections 
to determine where VS monitoring may have the greatest benefit, investigates VS 
monitors and their application in clinic, and finally appraises telemedicine and 
telemonitoring.  
Knowledge of the normal range of readings is a prerequisite if VS measurement is to 
serve any diagnostic purpose. Once established, abnormal readings may be identified 
and their significance deliberated (Harries et al., 2009). As there are a variety of 
confounding factors that may cause temporary changes in VS readings (such as 
circadian effects (Longmore et al., 2009), anxiety, use of medication, smoking and the 
consumption of alcoholic or caffeinated drinks (Pickering et al., 2005; Valentini and 
Parati, 2009)), plus the possibility of atypical patient presentation, careful 
consideration is necessary before judgement is made. Regular monitoring can help 
minimise these problems however, revealing underlying normal levels and aiding 
identification of anomalies. This has great value in general fitness monitoring and 
condition management, where small changes over time may be significant. 
Examination of the etiology, diagnosis and morbidity of common diseases and 
infections helps in understanding how and where VS monitoring may prove beneficial. 
Cancer, cardiovascular and respiratory diseases were identified as the leading causes 
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of death in the UK’s adult population (Office for National Statistics, 2013), with many, 
particularly with elderly individuals, suffering from the added complication of 
comorbid conditions. This group, together with the elderly and immunocompromised, 
where found to be especially vulnerable to infection, the consequences of which are 
more severe with an increased mortality rate (Garibaldi, 1999; Joshi et al., 1999).  
With few exceptions, diagnostic power may be improved by the combined 
assessment of multiple vital signs (Domagala, 2009; Royal College of Physicians, 2012). 
HR and BP monitoring can identify risk factors for cardiovascular disease (tachycardia 
and hypertension), with regular measurement benefitting condition management 
(Pickering et al., 2005). The latter is also true for respiratory disease, where routine 
SpO2 measurement can warn of a worsening condition and hypoxaemia (Decramer et 
al., 2012). For cancer patients, the application for VS monitoring is not disease 
diagnosis itself, but rather that of infection in the immunosuppressed undergoing 
chemotherapy (CDC, 2014). VS monitoring is especially effective in the diagnosis of 
febrile infection, where an elevated temperature (Blatteis, 2003), HR (Kiekkas et al., 
2007) and RR (Marco et al., 1995) may be observed in typical presentations. It is also a 
valuable tool in the diagnosis of atypical presentations of fever (seen in elderly 
patients), sepsis, respiratory infections and pneumonia, where a reduced SpO2 level 
may be observed (High et al., 2009). Infection was identified as an area where regular 
VS monitoring could prove beneficial, especially to vulnerable individuals. 
Outside of hospital VS measurement generally involves the use of multiple devices, 
typically a thermometer for temperature, a BP monitor for BP and HR and a pulse 
oximeter for HR and SpO2. Examples of each are readily available from a number of 
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vendors and manufacturers. Ambulatory heart and BP monitors are also in widespread 
use in specialist secondary care (hospital) for cardiovascular assessment. While RR 
monitoring can yield valuable clinical data, unlike the other VS, readings are not 
routinely taken outside of a hospital setting as there are few commercial sensors 
available (McBride et al., 2005).  
Hospital-based VS measurement may be performed with multiple devices or 
dedicated bedside systems capable of the simultaneous monitoring of multiple or all 
VS. These readings assist in triage and form the basis of Early Warning Scoring (EWS) 
systems, which employ aggregated scoring of routine observations as part of 
standardised patient care. This allows abnormal readings to be rapidly identified and 
reported, enabling a targeted clinical response (Royal College of Physicians, 2012).  
Telemonitoring brings the benefits of ICT to medical devices for remote monitoring 
at the point of care, allowing a subject’s VS to be captured and uploaded for 
assessment and storage. The recent emergence and coalescence of wireless 
technologies, low-power processor chips, lithium batteries and miniature components 
driven by the consumer electronics market has made the design of compact VS 
telemonitoring devices viable. This has seen the development of a number of 
commercial devices, none of which meet the requirements detailed in this chapter’s 
introduction for the routine ‘one-shot’ collection of multiple VS observations in the 
community.  
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In conclusion: 
 Regular and routine VS monitoring facilitates the identification of abnormal 
readings, aids diagnosis, condition management and forms part of standardised 
patient care in hospital. 
 While cardiovascular conditions are well served, VS monitoring as an aid to the 
diagnosis of infection (i.e. temperature, HR, RR and SpO2) was identified as a 
potential application that could be of particular benefit to vulnerable groups. 
 There is a need for non-invasive, discrete and wearable respiratory sensors such 
that a direct measure of respiratory rate may be easily obtained for routine clinical 
assessment. 
 Outside the hospital environment, multiple devices are required in order to obtain 
a full set of VS readings. There is an unmet need for a non-invasive, discrete 
wearable telemonitoring device capable of rapidly and simultaneously acquiring 
routine VS measurements in the community, from where data may be transferred 
to a host platform for display, analysis and storage. 
1.5.1 Aim and Objectives 
Following the conclusions, the aim and objectives of the research are as follows: 
Aim: 
To design, build, test and demonstrate the operation of prototype wearable non-
invasive physiological monitoring devices capable of measuring respiratory rate and 
other vital signs. 
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Objectives: 
 To design a prototype respiratory sensor. 
 To carry out a pilot study of a prototype respiratory device on healthy subjects in 
order to compare the device to reference devices. 
 To design a prototype wireless multisensor device that can simultaneously 
measure VS readings. 
 To carry out a pilot study of a prototype multisensor device on healthy subjects in 
order to compare it to references devices. 
 To test the telemonitoring capability of the multisensory device. 
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2  D e v i c e  S p e c i f i c a t i o n  a n d  S e n s o r  S e l e c t i o n  
2.1 Introduction 
The selection of appropriate physiological sensors is critical to the successful 
operation of the devices outlined in the aim and objectives of this thesis. This chapter 
first defines the specifications and design criteria of the two monitoring devices and 
then determines the optimal sensing options. Each monitoring device’s key features 
are considered; these include measurement range, physical characteristics, how the 
device might be best employed and operational requirements. With these factors in 
mind, the sensors are then reviewed and assessed to facilitate selection for the 
proposed device designs. Here criteria such as transduction method and technologies, 
method of application and usability, resolution and accuracy, ease of interfacing and 
cost are evaluated, scored and aggregated to aid sensor selection. Finally, the sensor 
arrangement and placement of the devices are examined to produce outline designs of 
the prior to device prototyping.  
2.2 Respiratory Sensor 
From section 1.1.4 it is clear that the sensor must measure resting RR at frequencies 
extending beyond the normal physiological range (12 to 20 bpm) to provide any 
diagnostic potential. Therefore the measurement range may be set at 4 to 30 bpm (or 
better), to an accuracy of at least 1 bpm mirroring that of a commercial device 
(Masimo Corp., 2010). The sensor’s response, including averaging effects, should 
ideally not be delayed by more than three or four breaths.  
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Physically, the chosen solution should ideally be small, minimally invasive, 
comfortable to wear and unobtrusive. It should take little power (a few milliwatts), 
require little additional signal conditioning circuitry and have the development 
potential for wireless applications. 
2.3 Multisensor Device 
The simultaneous measurement of a range of physiological parameters in a single 
discrete device would help expedite routine patient monitoring and improve the 
diagnostic power of assessment compared to conventional methods, whether in clinic 
or the community. The proposed multisensor device should incorporate appropriate 
sensors to facilitate these measurements and store or transmit the readings for 
appraisal. It should enable snapshot readings to easily be taken, several times a day (or 
as directed by a physician) rather than being worn for long periods or broadcasting 
real-time data.  
The device should be compact, easy to fit when required and easy to use - 
potentially by the patients themselves. Ideally, it should not encumber the wearer by 
requiring anything to be worn under clothing, be frequently adjusted or place any 
expectation on them to perform any specific exercises in order to acquire readings. 
These should be taken without causing distress or anxiety (eliminating white coat 
effect).  
The unit should be battery powered with sufficient capacity to operate for at least 
30 minutes a day, the batteries being easily changed or recharged as required. This 
would enable a minimum of six readings to be taken daily, allowing around five 
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minutes per reading, in line with typical clinical practice for inpatients (Johnson et al., 
2014). The device should be capable of wireless data transfer to a host PC, tablet or 
smartphone, whether for real-time or archived readings. This should be included in the 
power budget. 
As cardiovascular monitoring is already well served the device may be better 
employed in the detection of infection and disease management. It should therefore 
incorporate as many of the vital signs sensors as practically possible, but in view of the 
proposed application and difficulties of integration, blood pressure monitoring will be 
omitted. Skin resistance (SR) measurement however will be considered.  
2.4 Sensor Specification and Selection 
This section investigates physiological sensing techniques to determine those best 
suited for use with the proposed monitoring devices. Temperature, HR, RR and SR 
sensors are each assessed in turn, compared and scored against a range of measures; 
these include reliability, linearity, ease of interfacing, ease of use and cost. The 
aggregate value for each class of sensor demonstrates the degree of suitability for the 
application. 
2.4.1 Temperature Sensing 
There are many types of temperature sensors, only some of which are in common 
use for medical thermometry. These must be capable of measuring from around 34°C 
(hypothermic) to 42°C (hyperthermic) to an accuracy of ±0.2°C (Braun GmbH., -). 
Ignoring mercury/spirit glass thermometers and liquid crystal adhesive sensors, which 
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must be dismissed as they have no electrical output, the choice is between 
thermocouples, thermistors, semiconductor sensors and infrared pyrometers.  
Thermocouples  
These temperature probes are composed of two dissimilar metals that are joined 
(e.g. welded) at one end; when the junction is heated a thermoelectric voltage is 
produced across the open circuit ends due to the Seebeck effect. The magnitude of 
this voltage produced at a specific temperature depends on the Seebeck coefficients of 
metals used. Connecting thermocouple terminals directly to a monitoring device (via 
metallic conductors) introduces secondary thermocouple junctions that can affect the 
resulting output. If these are maintained at the same temperature however, there is 
no undue output distortion and compensation can be applied to determine the 
temperature at the probe’s junction. The traditional method of achieving this was to 
place secondary junctions in an ice bath to provide “cold junction“ compensation (CJC). 
As this is impractical in most cases, secondary junctions should be thermally matched 
and their temperature monitored using a thermistor to provide CJC; the probe 
temperature being calculated as a product of the thermoelectric output and CJC 
temperature (Horowitz and Hill, 2001. The process is simplified by dedicated chips (e.g. 
Linear Technology’s LTK001 and Analog Devices’ AD595), some with on-board 
temperature compensating sensors, that provide a compensated and linearised 
(mV/°C) output 
Thermistors 
Thermistors come in a variety of forms, but all work on the principle that a change 
in temperature results in a corresponding change in the device’s resistance. They are 
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offered with both positive (PTC) and negative temperature coefficients (NTC) where 
the resistance is respectively proportional or inversely proportional to temperature, 
and either in component form or that of a temperature probe. NTC devices are widely 
used for temperature sensing, including medical applications whereas PTC devices 
employ their inherent self-heating effects to limit current for circuit protection as 
‘resettable’ fuses (Horowitz and Hill, 2001). 
Semiconductor Temperature Sensors 
Semiconductor sensors such as the AD5904 and the LM335A5, are forms of diodes 
that regulate current (1ųA/K) and voltage (10mV/K) respectively, and provide an 
output relative to absolute zero (Horowitz and Hill, 2001. Thus the LM335A has an 
output (its breakdown voltage) of 3.07V (+34°C) to 3.13V (+40°C) at physiological 
temperature ranges. 
IR Pyrometers 
The sensing element in an IR pyrometer is a micro-thermopile that detects radiated 
IR emissions of an object (wavelength ≈ 10µm). The thermopile comprises of an array 
of thermocouples connected in series to produce a thermoelectric voltage which is 
amplified and filtered to give a voltage output, or digitised and processed for a digital 
output. Unlike the other sensors mentioned here, detection relies on radiated heat 
energy rather than heat conduction or convection; hence the sensor may be used for 
non-contact temperature measurement (Wotiz 2012). 
                                                 
4 Analog Devices, Norwood, MA, USA 
5 National Semiconductor, Santa Clara CA, USA 
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Sensor Comparison 
This section compares the attributes of thermocouples, thermistors, semiconductor 
temperature sensors and IR pyrometers for use in medical thermometry. 
Accuracy and Resolution 
Thermocouples tend to have relatively poor accuracy (≥ ±1°C depending on the type 
and whether on standard or special limits (Park, 2005)), due in part to the polynomial 
linearisation used (Texas Instruments Inc., -). Thermistors are amongst the most 
accurate temperature sensors available with highly stable medical-grade devices 
offering ≤±0.1°C accuracy (Measurement Specialties, 2011). For all their convenience 
semiconductor devices have a relatively poor accuracy, e.g. ±0.5°C for the premium-
grade AD590M (Analog Devices Inc., 1997). IR pyrometers, as used in tympanic 
membrane (ear) thermometers, have an accuracy of around 0.5°C (better once 
calibrated) and high resolution (≤ 0.1°C ) (N. V. Melexis SA, 2008). 
Response Time 
The response time of a temperature sensor is related to its thermal mass and 
thermal conductivity of the packaging of the sensing element. The thermopile has little 
thermal mass and provides a faster response from radiated IR rather than heat 
conduction or convection. 
Contact v Non-Contact 
Thermocouples, thermistors and semiconductor sensors require good surface 
contact for reliable and accurate temperature measurement. IR pyrometers are 
designed for non-contact measurement and work very effectively if the target is within 
the focal range and viewing angle of the detector. 
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Linearity 
Thermocouples and thermistors have a non-linear response that may be corrected 
by using a ‘best-fit line’, look-up table or applying the appropriate equation. This is 
likely to produce significant measurement errors unless the approximation is very 
close to the original response. This also affects resolution which will also be non-linear, 
the acceptability of which depending on the relative differences in the V/deg C ratio at 
the points of interest. Semiconductor temperature sensors and IR pyrometers have 
linear outputs across their ranges and are therefore more attractive. 
Interfacing 
Raw thermocouple outputs are in the order of tens of microvolts per degree Celsius 
and require amplification and specific signal conditioning, which includes CJC. 
Thermistors require either a constant current source or a potential divider circuit if 
used with a voltage supply, whereas semiconductor sensors tend to need a single 
resistor. IR pyrometers are available voltage or digital outputs, the latter being either 
pulse width modulated (PWM) to simulate an analogue voltage or two-wire serial bus 
interface. 
Cost 
When representative sensors of a suitable performance, size and accuracy are 
considered, semiconductor sensors6 offer the most cost effective solution. 
Thermistors7 and IR pyrometers8 are next with thermocouples9 proving the most 
expensive option. 
                                                 
6 £0.86 for a LM335A– RS part no. 714-7917 
7 £2.25 for ±0.2˚C accuracy over a 0-70˚C range – RS part no. 629-8708 
8 £8.75 for an MLX90615 – Future Electronics 
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2.4.2 Heart Monitoring 
There are a number of methods currently in use and under development. Some of 
these provide a wealth of data for use in cardio-diagnostics, whilst others produce a 
basic measure of heart rate (HR). They should be capable of measuring rates from 
around 30 bpm extending to a maximal rate of 250 bpm, to an accuracy of ±1 bpm 
(Smiths Medical International Ltd., 2009). The sensors and their sensing methods are 
discussed in the following sections: 
Electrocardiography 
Electrocardiography (ECG or EKG) is a measure of differential (skin) potential over 
time across the body, of the order of a millivolt, as the cardiac muscle expands and 
contracts with each heartbeat (Pocock and Richards, 1999). This is measured at various 
points of the body, typically around the chest, using adhesive electrodes. Fitness 
monitors tend to display heart rate using a simple two electrode system whilst medical 
grade devices, whether bedside monitors or ambulatory systems, utilise multiple 
electrodes (from three to as many as twelve) to provide detailed cardiac data from the 
ECG waveform. This can be used for cardio-diagnostics, where the differential 
potentials from pairs of electrodes can be used to provide detailed electrocardiograms 
characterised by the peaks and troughs of six points, labelled P, Q, R, S, T and U (see 
Figure 2-1), of the cardiac cycle, or for simple HR monitoring based upon beat-to-beat 
(R-R) intervals. 
ECG signal conditioning requires relatively high-gain amplification with good 
common-mode rejection to minimise dc effects and separate the signal from 
                                                                                                                                               
9 £9.89 for a K-type ¼” copper disc probe – RS part no. 621-2287 
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background noise. A range of (analogue) filters are then applied to the amplified 
response to limit the signal bandwidth to 0.05–100 Hz (Alberti, 2008). Further 
processing, perhaps using digital techniques, is required to reject or reduce 
electromagnetic interference (emi), conducted noise from mains electricity (typically 
50 or 60 Hz with higher frequency harmonics), baseline drift due to electrode contact 
noise and motion artefacts prior to digitisation. A key point in ECG interface design is 
patient safety, thus steps must be taken to electrically isolate the electrode 
connections from potentially harmful currents or provide current-limiting protection 
(Company-Bosch and Hartmann, 2003). 
 
(Cheah and Kumar, 2008) 
Figure 2-1: An ECG waveform produced by a normal healthy heartbeat.  
Impedance Cardiography 
This is non-invasive method used in cardiac output monitoring. It employs two or 
more thoracic electrodes to measure changes in bioimpedance due to haemodynamic 
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plethysmography of the heart or surrounding vasculature to provide a measure of 
cardiac output as well as other parameters such as stroke volume. In operation, a high 
frequency ac source (typically in the order of hundreds of microamps to a few 
milliamps) is applied across a pair of excitation electrodes with the resulting voltage 
appearing at a second pair of electrodes being measured; the amplitude of this voltage 
being bioimpedance dependent.  
The development of this sensing technique is based upon Nyboer’s work on 
impedance plethysmography (Nyboer et al., 1950), which followed earlier pioneering 
research first reported by Atzler and Lehmann on the measurement of thoracic 
impedance). After being commissioned by the National Aeronautics and Space 
Administration (NASA) to produce a non-invasive cardiovascular monitor for 
astronauts, Kubicek produced the first true impedance cardiograph (Kubicek et al., 
1966), publishing the comparative results to standard invasive methods. Although this 
measurement method has undergone significant further development it is generally 
considered to have insufficient accuracy, largely due to critical electrode placement 
and a poor signal-to-noise ratio (SNR), for use in clinical practice (Kuper, 2004), though 
studies have demonstrated the potential for this technology (Thangathurai et al., 1997; 
Bour and Kellett, 2008; McFetridge-Durdle et al., 2008).  
Photoplethysmography (PPG) 
This is an optical spectroscopic technique that detects volumetric changes in blood 
flow from which HR, SpO2 and blood perfusion may be measured and is more 
commonly known as pulse oximetry Tissue and haemoglobin absorb different 
wavelengths of visible and near infrared (NIR) light depending on the level of blood 
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oxygenation as depicted in Figure 2-2. The absorption of oxygenated haemoglobin 
(HbO2) is strongest in the infrared (IR) band and reduced haemoglobin (Hb) in red light, 
therefore wavelengths with the greatest departure from the isobestic point (that of 
equal absorption at 800 nm) are chosen for the maximum differential absorption. 
Wavelengths of 660 nm (Hb) and 915 – 940 nm (HbO2) are commonly used with LEDs 
providing the light source (Jalan et al., 2006). 
 
(Nitzan et al., 2014) 
Figure 2-2: The absorption spectra of oxygenated (HbO2) and reduced haemoglobin (Hb) 
Light absorption in perfused tissue follows the Beer-Lambert law in that the 
concentration of an absorbent material may be determined from the intensity of light 
transmitted through it given the light’s intensity, wavelength, path length and the 
absorption characteristics at the emitted wavelength (Sinex, 1999). Light is absorbed in 
the red and IR bands by bone, tissue and venous blood to produce a DC response, the 
magnitude of which is relative to level of absorption. Variations in the absorption of 
arterial blood with the systolic phase of each heartbeat produces a small AC response 
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reflecting pulse frequency (Figure 2-3) which provides an indirect measure of HR; this 
appears in superposition with the larger DC response (Philips Medical Systems, 2003). 
 
(Philips Medical Systems, 2003) 
Figure 2-3: The relative absorption characteristics of perfused tissue 
In operation the two emitters are turned on and off alternately and thus can be 
measured with a single detector. The SpO2 is calculated from the ratio between the 
HbO2 and total haemoglobin measurements and is expressed as a percentage (Moyle, 
2002). As the LEDs can be relatively power hungry, the pulse frequency and duty cycle 
(the relative time that the LED is on or off) may optimised for power saving in portable 
devices. 
Sensor probes are usually clipped on to fingers or toes, although ear lobe sensing is 
sometimes used in cases where subjects have poor circulation in their extremities. 
These are examples of transmissive sensors where the detector measures the amount 
of light transmitted through tissue from parallel-mounted opposed emitters. 
Reflectance oximeters, as the name suggests, measure the amount of light reflected 
from the surface of skin and tissue and are typically applied on the forehead above the 
temporal artery (Fernandez et al., 2007). Some reports suggest that reflectance 
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oximetry is superior and more reliable than fingertip sensing in certain clinical 
environments (Schallom et al., 2007).  
Seismocardiography 
Contact accelerometers have been successfully used for HR measurement by 
detecting cardiac thoracic motion (Phan et al., 2008), a method that has been termed 
seismocardiography (Dinh et al., 2011). Although this method has been successfully 
demonstrated, care must be taken in the separation of the HR signal from the 
respiratory response, motion artefacts and noise sources.  
Other Methods 
Electronic blood pressure (BP) monitors (also known as sphygmomanometers) 
usually use oscillometric methods (Raamat et al., 2010) and are able to record HR over 
the BP measurement period. This is calculated from the period between pulse wave 
oscillations in cuff pressure once the cuff has been inflated. Due to its very nature this 
can only provide periodic snapshot readings and therefore cannot be considered for 
any form of continuous monitoring. 
Sensor Comparison 
This section compares ECG, impedance cardiography, PPG and seismocardiography 
sensing for use in HR monitoring. 
Reliability 
ECG and PPG are in widespread use and offer reliable measurement with the former 
having better performance, being less affected by motion artefacts. Impedance and 
seismocardiography are less developed and prone to a variety of problems such as 
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motion artefacts, accuracy of positioning and high SNR; this makes them less suitable 
for use in the proposed monitoring device.  
Ease of interfacing and data processing 
There is little to choose between the sensing methods in this respect. They all 
require significant signal conditioning, filtering and signal processing to extract a viable 
signal from background noise from which HR can be calculated. 
Ease of use 
PPG is the easiest method to use, especially from the subject’s perspective, as the 
sensor may be clipped on or fixed in place with adhesive material. The other methods 
all necessitate a certain amount of preparation before any data can be collected. ECG 
and cardiothoracic impedance monitoring are both electrode-based (whether single-
use disposable or sprung metallic contacts), requiring clean skin and gel to ensure good 
electrical contact. The accelerometer used in seismocardiography must be securely 
fixed to the thorax (with an adhesive pad). For electrode-based or motion sensing 
there may be problems with the consistency of positioning and adhesive or electrode 
integrity. 
Costs 
The cardiothoracic accelerometer is potentially the most expensive of the sensors 
considered here and requires consumable sticky fixing pads. The electrode-based 
sensing methods may need disposable contacts, but would require conductive gel and 
alcohol wipes. If assembled from discrete LEDs and photodiodes, PPG sensing is 
relatively low cost in parts terms (two LEDs and a photodiode costing approximately £1 
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to £210). The cost of the associated interface circuitry however, though relatively 
inexpensive, must also be considered, together with computational costs. 
2.4.3 Respiratory Monitoring 
There are possibly more sensors and methods for respiratory monitoring than all 
the other vital signs combined. Some have been adopted for clinical use, but there is 
little evidence to suggest the development of monitoring products for the home 
market. Some of the key sensing methods and technologies are discussed in the 
following sections. 
Direct Sensing Methods 
Capnography is perhaps the most common clinical respiratory monitoring 
technique, being used in the observation of anaesthetised patients and in ventilators, 
and is widely considered to be the gold standard. A capnograph measures changes in 
carbon dioxide concentration levels in breath, usually via infrared absorption, to 
provide diagnostic respiratory data. A pneumotachometer (also known as a 
pneumotachograph) may also be used to monitor respiratory flow and breath volume 
(Mandal, 2009).This typically employs a differential gas flow sensor that may be used 
for direct oral measurement or mask-mounted for continuous monitoring. Cranfield 
Health’s Single Metal Oxide Sensor – Gas Analyser system (SMOS-GA), otherwise 
known as the “Breathotron” (Walton et al., 2014) utilises a similar, but simpler (and 
less expensive) monitoring method, in which a mass flow sensor is fitted to the outlet 
                                                 
10 RS Components Ltd, Corby, Northants, UK 
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of a modified respirator mask. Neither of these is particularly discrete, being relatively 
invasive, or suited to continuous ambulatory monitoring. 
Another method employs one or more temperature sensors, typically thermistors, 
mounted in a nasal cannula such that respiratory temperature changes can be 
detected. These devices must have a low thermal mass and sufficient sensitivity such 
that the sensor’s dynamic response can accurately track the convection effects of nasal 
respiratory airflow. Ease of use has led to some clinical adoption although accuracy is a 
concern and the relationship to flow rate only semi-quantitative (Farre et al., 1998); 
nevertheless they have shown some success in the detection of sleep apnoea events 
(Farré et al., 2004) and wireless sensors have been demonstrated (Jovanov et al., 2001. 
A pyroelectric polymer (PEP) based respiratory sensor has been developed and 
validated against standard methods (Brookes et al., 2003) reportedly with notable 
success. Although the device relies on directly sampled breath, it is small enough to 
integrate into a miniaturised system. As of January 2015 there is little evidence to 
suggest the device has been commercialised.  
Thoracic Band-Based Sensing Methods 
There are a number of non-invasive sensing methods that measure physiological 
changes with respiration via a thoracic band. Of the commercial devices, Vernier11 
offer a belt-mounted system (Vernier Software & Technology, 2009) using a pressure 
sensor attached to a pneumatic chest band. There are a number of devices reported 
that utilise a similar mounting, e.g. chest bands featuring piezoelectric tension/strain 
sensors plus chest and back-mounted tri-axial accelerometers (Khoo et al., 2008) and 
                                                 
11 Vernier International Inc., Sarasota, Florida, USA 
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bi-modal ultrasound transducer (Lanatà et al., 2006). Another method which has 
grown in popularity is respiratory inductance plethysmography (RIP); this employs an 
elastic belt containing coiled wire which is energised by an AC current to generate a 
weak magnetic field. Respiratory changes in thoracic cross-sectional area produce 
fluctuations in the magnetic field, causing measurable frequency variations in the 
excitation (Mazeika and Swanson, 2007). Two independent bands are typically used, 
one around the chest and another around the abdomen, giving a measure of normal 
respiration and airway obstruction that is reportedly less prone to spurious signal 
artefacts than impedance measurement methods (Cohen et al., 1994). However 
effective, once again these are relatively cumbersome and not especially discrete. 
One approach to simplify the mounting of a diverse range of sensors is to 
incorporate them into a wearable garment to which a compact monitoring system may 
be attached. One such example uses both an ECG-derived response (EDR) and piezo 
plethysmograph sensors on the thorax and abdomen in to measure respiration in a 
‘bioshirt’ (Nam et al., 2005). This method is, arguably, an improvement over a chest-
band for respiration sensing if multiple physiological parameters are to be monitored. 
Impedance Pneumography 
Electrical impedance pneumography (EIP) uses pairs of conventional ECG electrodes 
placed upon the thorax or abdomen to measure respiratory changes in conductivity 
(Lahtinen et al., 2009). A high-frequency AC current of low amplitude (typically a 
milliamp or less at a frequency above 20 kHz (Baker, 1989) is passed between the 
electrodes, producing a measurable impedance-dependent voltage that rises on 
inhalation and falls on exhalation. The resulting waveform is prone to distortion due to 
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interference from cardiac output and motion artefacts (Wilkinson and Thanawala, 
2009) and sensitive to electrode positioning (Seppä et al., 2007; Lahtinen et al., 2009).  
Estimation from Heart Rate Variability 
ECG-derived respiration monitoring (EDR) employs a range of signal processing 
techniques to provide an estimation of respiratory rate from an ECG waveform. It is 
based upon rhythmic beat-to-beat heart rate variability (HRV) caused by respiratory 
modulation of the heart (Porges and Byrne, 1992). One method analyses an ECG’s R-
wave amplitudes (see Figure 2-4) and extracts the underlying respiratory modulated 
response from the signal envelope to provide a measure of breath frequency 
(Mazzanti et al., 2003; Bailon et al., 2006; O’Brien and Heneghan, 2007; Cysarz et al., 
2008).  
 
(O’Brien and Heneghan, 2007) 
Figure 2-4: An ECG trace showing respiratory-induced amplitude changes in the QRS 
envelope  
Another approach is based upon HRV monitoring, specifically that due to 
respiratory sinus arrhythmia (RSA) (Bernardi et al., 2001). Here, periodic changes in the 
ECG’s R-R interval may be observed as this is shorter during inspiration and longer in 
exhalation. A surrogate respiratory signal with a bandwidth of approximately 0.15 to 
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0.8Hz (Yasuma and Hayano, 2004) may be extracted from the ECG waveform by 
comparing the periods of successive R-waves and applying a range of signal processing 
techniques, an example of which is shown in Figure 2-5 (and reported by Cysarz et al., 
2008; Schäfer and Kratky, 2008; Tiinanen et al., 2010). RSA is most prominent in the 
young and diminishes with both age and fitness, thus it may be less effective in elderly 
individuals (Yasuma and Hayano, 2004). 
 
(Schäfer and Kratky, 2008) 
Figure 2-5: An ECG trace showing R-R intervals (a) plotted as a time interpolated series 
(b)and the extracted respiratory signal (c& d)  
With appropriate filtering and signal processing, respiration may also be 
determined from the photoplethysmograph (PPG) waveform of a pulse oximeter 
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(Leonard et al., 2003; Clifton et al., 2007), although in Vegfors’ fibre-optic IR sensor it is 
suggested that there may be some latency in the response (Vegfors et al., 1993). 
Respiratory Motion Sensing 
Another option is that of directly measuring respiratory thoracic movement with 
single or multi-axis accelerometers. These are electromechanical transducers that are 
sensitive to acceleration forces and thus, motion relative to gravity (1g = 9.81 ms-2) – 
to which they are normally calibrated. Developments in fabrication and the growth of 
micro-electromechanical systems (MEMS) technology have seen a significant reduction 
in the size and cost of devices over the last 10 to 15 years (Walter, 2007) to the point 
that they are becoming ubiquitous. Today, the ubiquitous accelerometer is commonly 
found in vehicles (land, sea and air), hard disk drives, mobile phones, tablet PCs, 
computer gaming controllers and many other products and devices where orientation, 
motion or vibration sensing is required. 
Static measurements can provide a measure of incline where the device’s plane is 
measured relative to gravity. Here, the initial position shown in Figure 2-6 gives an 
output equivalent to +1g – a rotation of 90°= 0g and 180° = -1g. An intermediate angle 
(θ), as shown in the right–hand diagram, may be calculated as follows: 
Equation 2-1: Accelerometer tilt angle calculation 
𝜃 = 𝑠𝑖𝑛−1 (
𝑎𝑐𝑐𝑒𝑙𝑒𝑟𝑜𝑚𝑒𝑡𝑒𝑟 𝑜𝑢𝑡𝑝𝑢𝑡 (𝑔)
𝑔𝑟𝑎𝑣𝑖𝑡𝑦 (𝑔)
) 
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(Fisher, 2010) 
Figure 2-6: Basic gravimetric tilt sensing with a uniaxial accelerometer  
Dynamic measurements can be used to determine the nature of motion that the 
accelerometer is experiencing. Both the magnitude and frequency of the signal are of 
interest, providing amplitude range, angular motion, velocity (acceleration divided by 
time) and, with the application of frequency domain analysis, key frequency 
components (from vibration or motion) from a single signal which may be used to 
characterise a response.  
A study by Reinvuo comparing single-axis accelerometers with HRV-derived 
respiratory measurements from a blood pressure sensor gave passable results 
(Reinvuo et al., 2006). Phan investigated respiratory and cardiac monitoring using a 
biaxial device (two orthogonal axes) (Phan et al., 2008). In their experiments the 
sensor was sited approximately over the heart. Whilst this successfully captures both 
cardiac and respiratory waveforms, they are superimposed and must be separated 
both from each other and from extraneous noise. Hung’s study also uses a biaxial 
device upon the thorax, this time summing the two outputs to give a composite signal; 
a dynamic adaptive filter was then applied to clean the waveform which showed 
correlation to a reference RIP sensor (Hung et al., 2008). 
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Use of a triaxial accelerometer (having three orthogonal axes) would appear to offer 
advantages over uniaxial or biaxial sensing as all three planes may be considered; 
hence a respiratory signal is not dependent upon the orientation of the sensor (Bates 
et al., 2010). Anmin’s work, which employed a triaxial accelerometer as an 
inclinometer upon the diaphragm muscle below the xiphoid, suggests composite 
waveforms may also be considered and that with appropriate signal processing 
interference from non-respiratory motion artefacts may be reduced (Anmin et al., 
2009). 
Acoustic Sensing Methods 
A number of acoustic sensing methods and devices have been reported. Masimo’s12 
Rainbow Acoustic Sensor has recently become commercially available. The sensor is 
incorporated into a self-adhesive neck-worn pad and senses the characteristic 
inspiratory and expiratory sounds from which respiratory frequency is extracted. 
Clinical trials have shown favourable performance when compared to a standard 
capnograph (Macknet et al., 2007; Masimo Corp., --b).  
Corbishley reports on the development of a miniaturised acoustic sensor (Imperial 
College, London) monitoring tracheal sounds; these are caused by turbulent 
respiratory airflow and may be detected as wideband white noise on the skin surface 
(Corbishley and Rodríguez-Villegas, 2008). This reportedly requires relatively high 
sampling rates (11.050 kHz) and a sophisticated algorithm to resolve the respiration 
signal from background noise; speech, swallowing, heartbeat and musculoskeletal 
                                                 
12 Masimo Corp, Irvine, California, USA 
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motion. Proposed future developments included integrating signal processing with the 
sensor assembly, although it would appear that this was not pursued. 
Sensor Comparison 
Although direct aspiratory sensing using flow or temperature sensors would likely 
prove effective, it is relatively invasive and will not be considered here. In the following 
sections thoracic band, thoracic impedance, respiratory motion sensing and estimation 
of RR from HRV are compared. 
Reliability 
With a resting and compliant subject all four monitoring methods should be reliable 
assuming the sensors are fitted correctly and extraneous motion is minimised. All 
should perform satisfactorily with subjects standing, sitting or supine (providing the 
sensors are not disturbed), as demonstrated with a triaxial accelerometer (Chan et al., 
2013). Thoracic bands and estimation from HRV are the most established in clinical 
practice while the other methods are still rooted in research. 
Ease of interfacing and data processing 
Accelerometers used in respiratory motion sensing offer the easiest electrical 
interface, irrespective of whether analogue or digital outputs are available as negligible 
additional signal conditioning is required. Impedance pneumography employs the 
same techniques as those used in seismocardiography (with different electrode 
positioning and excitation parameters) and suffers from motion and cardiac artefacts, 
which must be minimised or removed. Thoracic band interfacing rather depends upon 
the transduction method used, but would nevertheless require analogue signal 
conditioning and digital signal processing to extract respiratory rate. The process of 
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extracting RR readings by estimation from HRV is detailed in section 2.4.3 (page 90) 
and may be achieved algorithmically.  
Ease of use 
Where an HR sensor is already in use, estimation of RR from HRV places the least 
burden on the user as it piggy-backs on an existing sensor. Thoracic band sensing, by 
its very nature, requires that the subject fits one (or two) belts around their torso to 
capture sympathetic respiratory motion; hence there is a reasonable degree of 
preparation prior necessary before measurement can take place, proving unwieldy and 
likely to be unpopular with test subjects. In comparison fitting a respiratory motion 
sensing accelerometer is far more straightforward and is relatively unobtrusive, 
although a degree of preparation is still necessary. A consideration of the issues with 
impedance sensing may be found in section 2.4.2 (page 81).  
Costs 
The thoracic sensing band has the highest associated cost which is essentially the 
one-off cost of the sensor. The respiratory motion sensing accelerometer has the 
second highest one-off cost, but also adds consumables in the necessity for sticky 
adhesive pads. Impedance pneumography would prove cheaper, requiring 
consumables such as disposable contact electrodes, conductive gel and alcohol wipes. 
Estimation of RR from HRV would appear to have no associated impact, aside from 
development, though there is the potential for a small increase in computational cost 
and power budget. 
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2.4.4 Skin Resistance Monitoring 
In its simplest form, skin resistance (SR) can be measured using either of the circuits 
shown in Figure 2-7. Here, resistance is calculated from Ohm’s Law using a simple 
circuit where a constant dc excitation voltage or current is applied across electrodes 
contacting the skin and the resulting circuit current or voltage measured. In either case 
the circuit current should be kept to a maximum safe level of no more than 1 – 2 mA 
and below 1V (Sutherland et al., 2009). It should be noted that in practice potential 
dividers and amplifiers would be employed in additional signal conditioning circuits. 
 
Rskin =  
Vconstant
i
  where: 
Rskin = Skin resistance,  
Vconstant = constant voltage excitation 
i = measured circuit current 
 
 
Rskin =  
V
Iconstant
  where: 
Rskin = Skin resistance,  
Iconstant = constant current excitation 
V = measured circuit voltage 
 
Figure 2-7: Two basic skin resistance measurement circuits using (a) constant voltage and 
(b) constant current techniques, resistance is calculated from the ratio of the constant and 
measured values. 
The simple circuits described should produce a measurable difference between dry 
skin and that moistened by sweat. Both resultants are quoted as a resistance with 
units of Ohms (Ω), but should perhaps more correctly be considered as a conductance 
A 
Rskin 
+ 
- 
Iconstant 
Vconstant 
V 
Rskin 
i 
(a) 
Constant Voltage 
Constant Current 
(b) 
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(G), a reciprocal measure of conductivity (G = I/V from Ohm’s Law) quoted in Siemens 
(S) or Mhos (or Ohm spelt backwards with an inverted Ω symbol) in older literature. 
Strictly speaking, as skin has capacitance and thus reactance or resistance (XC) to an 
alternating voltage or current source, this might be considered when taking 
measurements and reference should be made to impedance rather than resistance. 
Impedance (Z) may be described as the voltage to current ratio in the frequency 
domain and comprises of both resistive and reactive components, the former having 
no frequency dependence and the latter (capacitive reactive component) given by 
XC=1/2пfC (where the variables are capacitance C and frequency f). This has little 
significance at frequencies nearing DC (zero Hz) as the ‘capacitor’ does not conduct, 
reactance tends to infinity and the resistive component dominates. Impedance is often 
quoted as admittance (Y), its reciprocal form, which is also measured in Siemens.  
 
Figure 2-8: A basic equivalent circuit model of skin impedance, with RSC and CSC 
representing the stratum corneum and RS, deeper tissue 
Skin impedance can be modelled by a simple two terminal network as shown in 
Figure 2-8. The stratum corneum may be characterised by a resistor (RSC) and capacitor 
(CSC) in a parallel circuit, which is in series with a resistor (RS) representing deeper 
internal tissue. Typical values quoted range from 104 to 106 Ω cm-2 for RSC, l to 50 nF 
cm-2 for CSC and 100 to 200 Ω cm
-2 for RS (Prausnitz, 1996), to 25 to 500kΩ cm
-2 (RSC) 
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and 10 to 30 nF cm-2 (CSC) (Montagu, 1964). Therefore, at DC and low frequencies RSC 
dominates until the falling reactance of CSC takes over at high frequencies as depicted 
in Figure 2-9. Whatever the measurement frequency may be, as both components are 
area dependent, the intra-electrode spacing is an important factor to consider.  
 
(Prausnitz, 1996) 
Figure 2-9: Ranges of skin impedance shown as a function of frequency  
Irrespective of the parameter of interest, it is electrode properties that are the key 
to successful measurement. The skin-electrode impedance should be minimised, 
particularly at DC and low frequencies, such that it does not compromise 
measurement; thus the electrode material, form and application of conductive 
aqueous gel must all be considered (Rosell et al., 1988). Inter-electrode spacing might 
ideally be of sub-centimetre order, but should be consistent. As skin is far from 
homogenous in terms of measured impedance (Horton and VanRavenswaay, 1935), 
sweat gland density (Wilke et al., 2007) and sweat rate (Licht et al., 1957), the 
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measurement site must be carefully chosen. Those areas prone to interference from 
electro-muscular and cardiorespiratory activity should, where possible, be avoided.  
Sensing Method 
This requires two skin-contacting electrodes, the choice being between wet 
(silver/silver chloride electrodes and hydrogel) or dry (gold) contacts. The other key 
concern is the choice of dc excitation for basic skin conductance measurement or ac 
for true skin impedance/admittance. 
Electrodes 
Whilst silver/silver chloride electrodes and hydrogel undoubtedly give good results, 
as seen with ECG measurements, location and inter-electrode spacing are important 
for reproducibility, and they must be replaced after use. Gold electrodes, whether with 
surface or sprung contacts, may be used dry but are less likely to provide optimal 
results without the use of a gel electrolyte (Neuman, 1999). They may however be 
mounted with fixed spacing in a sensing probe or upon a monitoring device and would 
not require replacement, only cleaning. 
Excitation 
Basic SR measurements using dc excitation are adequate for sweat detection. 
Although impedance measurements with ac excitation would also return viable results 
and provide supplementary data, the additional circuitry and software overhead adds 
significantly to the design burden with little additional benefit. 
2.4.5 Sensor Selection 
Having investigated the sensing methods in each category, these are now discussed 
and scored to determine the preferred option in each case. A relative scoring system is 
The design and evaluation of discrete wearable medical devices for vital signs monitoring 
DG Pitts 101 Cranfield University 
used, in which extremely poor performance is scored at zero and excellent 
performance at ten. 
Temperature Sensing 
In considering the factors discussed in section 2.4.1 (pages 78-80) and their 
influence on sensor selection, the four sensor types were scored by the author based 
upon the evidence presented. The results are shown in Table 2-1. Thermistors and IR 
pyrometers stand out as the best overall options for physiological temperature 
measurement, with the IR device scoring highest due to several clear advantages. As a 
good thermal coupling may not be guaranteed, non-contact thermometry offers 
improved reliability and reproducibility. IR sensors with integral signal conditioning 
also provide a linear response and digital or analogue outputs for ease of interfacing. A 
survey of available IR pyrometers determined that the MLX90615 from Melexis offered 
the optimum solution (chiefly package size and availability) for the proposed 
monitoring device. This has four terminals for a digital (I2C) or pulse width modulated 
output housed in a small 5mm diameter (TO-46) package with the lens aperture 
uppermost and pin contacts below (N. V. Melexis SA, 2008). 
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Resolution at physiological temperatures 6 10 3 9 
Ease of interfacing 4 7 8 9 
Fast response time 8 8 7 9 
Linearity 4 5 8 9 
Non-contact performance 6 6 6 9 
Costs (lower scores indicate higher costs) 4 7 9 5 
Total 32 43 41 50 
 53.3% 71.7% 68.3% 83.3% 
Table 2-1: Temperature sensor scoring 
Heart Rate Monitoring 
Following on from section 2.4.2, the four monitoring methods discussed were 
assessed for use with the proposed monitoring device and scored accordingly (see 
Table 2-2). For reliable monitoring the well-established ECG and PPG methods are the 
preferred options. There is not too much to choose regarding the ease of interfacing 
and data processing as all methods have their own particular issues. From the user’s 
perspective PPG is the easiest to use as there is no preparation required. If integral 
LEDs and detector are assumed, the lowest costs are for PPG; there are also no 
associated consumables.  
The aggregated scores demonstrate that PPG sensing offers the best all round 
solution for HR monitoring, being cheap, easy to use and reliable. It is also 
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advantageous in that it provides the potential for simultaneous SpO2 monitoring if 
suitable algorithms are applied. 
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Reliability 9 6 8 4 
Ease of interfacing and data processing 7 6 6 7 
Ease of use 6 4 9 7 
Costs (lower scores indicate higher costs) 6 6 9 5 
Total 28 22 32 23 
 70.0% 55.0% 80.0% 57.5% 
Table 2-2: Heart rate sensor scoring 
Respiratory Rate Monitoring 
The four monitoring methods discussed in section 2.4.3 were assessed and scored 
accordingly (see Table 2-3). There is little to choose between the sensing methods in 
terms of reliability (see page 95) and ease of interfacing and data processing; here the 
two thoracic methods show a slight advantage. For ease of use and costs, thoracic 
motion sensing and estimation from HRV easily outscore the other methods. The latter 
method in particular is easy to use and without cost if a PPG or ECG signal is already 
available. 
The results show that estimation of respiratory rate from HRV derived from a PPG 
waveform offers the best overall potential sensing method as no additional circuitry is 
required. There are potential problems with the method as discussed (see section 
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2.4.3, page 90); hence the thoracic motion sensor offers a viable option for discrete 
indirect respiratory sensing. 
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Reliability 7 8 7 6 
Ease of interfacing and data processing 5 5 7 5 
Ease of use 9 6 8 5 
Costs (lower scores indicate higher costs) 10 5 7 8 
Total 31 24 28 24 
 77.5% 60.0% 70.0% 60.0% 
Table 2-3: Respiratory rate sensor scoring 
Skin Resistance Sensing 
After consideration the points raised were scored according to perceived values, the 
results being shown in the following tables. Although gold electrode performance is 
likely to prove inferior to silver/silver chloride, this is outweighed by the convenience 
offered by the former in a fixed installation; without the need for disposable parts, 
consumables or constant maintenance. The main drawback of silver/silver chloride 
electrodes however is the use of a water-based electrolyte gel upon the surface of the 
skin; this renders any such measurement of skin water content meaningless. This is 
shown in Table 2-4. 
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Convenience and practicality 3 10 
Contact performance 9 7 
Costs (lower scores indicate higher costs) 3 9 
Total 15 26 
 50.0% 86.6% 
Table 2-4: SR electrode scoring 
 
Property d
c 
ac
 
Performance 9 9 
Benefit 8 9 
Ease of interfacing 8 4 
Total 25 22 
 83.3% 73.3% 
Table 2-5: SR excitation scoring 
Table 2-5 compares dc and ac excitation for SR measurement. Both methods will 
deliver results, but producing a dc output and measuring the resulting response 
considerably reduces circuit complexity. There is no clear benefit to be gained from ac 
excitation and impedance sensing for this application.  
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2.5 Device Placement 
The physical positioning of the devices on the human body can be critical to 
successful and reliable measurement. In considering the sensors, the selected HR 
(PPG) and SR sensors must be in direct skin contact (the former with well perfused 
tissue), while the RR sensing accelerometer must be closely coupled to the body and 
the IR pyrometer in close proximity to a measurement site reflecting core temperature 
or a reliable proxy thereof. Focussing first on temperature, rectal and skin 
measurement can immediately be ruled out on the grounds of inconvenience and 
ineffectiveness respectively, eliminating a wrist-worn solution. Oral measurement may 
also be excluded as though temperature readings would be assured, HR, RR and SR 
would certainly not. Temporal measurement remains a possibility (using a headband 
or hat), but would need to maintain perfect skin contact throughout the measurement 
period which may prove impractical. Having eliminated other temperature 
measurement sites, only the axilla and ear remain as viable options. 
2.5.1 The Axilla Option 
The preferred solution would be a device with multiple integral sensors. In this 
instance this would be unachievable as a wireless or umbilical axillary temperature 
sensor would be necessary – probably in the form of a thermistor. This would however 
allow a multisensor device to be located upon the thorax and attached either to a 
thoracic band or directly via an adhesive backing. A number of extant telemonitoring 
systems, such as those offered by Sensium Healthcare and Hidalgo Ltd. (see section 
1.4.2, p66-67), employ similar wearable sensing solutions. These are effective in a role 
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requiring continuous or longer-term (on demand) monitoring, but do not lend 
themselves to discretely acquiring periodic readings as proposed in this thesis. 
An alternative concept considered employed a small multisensor device attached to 
the clavicle and sited next to the throat (as depicted in Figure 2-10). This featured skin-
contacting reflectance pulse oximetry and SR sensors on the underside, and 
incorporated a tri-axial accelerometer to monitor clavicular respiratory motion. 
Temperature would be measured either in the axilla or, if accurate placement above 
the carotid artery was achievable, via an integral IR pyrometer. Whilst there was some 
merit in this idea, it would be unlikely to provide meaningful temperature readings and 
would be relatively unwieldy in use. This was therefore eliminated for multisensor 
monitoring, but formed the basis for the proposition of a clavicular respiratory sensor. 
 
Figure 2-10: An original design concept for a multisensory monitoring device sited upon the 
clavicle 
2.5.2 The Ear Option 
An ear-based system would appear advantageous for the proposed multisensor 
device. It would provide access for tympanic temperature measurement and a pulse 
oximeter ear clip for HR, SpO2 and estimated RR measurement. SR could prove to be 
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more difficult however unless good skin to electrode contact is achievable. The 
location would certainly facilitate discrete measurement, being easily accessible for 
taking readings and meeting the requirement for periodic monitoring set out in section 
2.3 (p74). As this appeared superior to the clavicular option, the Ear-worn Personal 
Monitoring System (EPMS) was selected for further development. 
2.6 Conclusions 
In this chapter the design specifications for the respiratory and multisensor devices 
were established and the VS sensing options reviewed to aid sensor selection. Finally, 
the optimal placement of the multisensory device was discussed. 
 Both proposed devices would need to be small, consuming little power and 
capable of VS measurement extending beyond the normal ranges.  
 The respiratory monitoring device should be capable of measuring RRs from 4 to 30 
bpm, require minimal signal conditioning and the response not delayed by more 
than three or four breaths.  
 The multisensory device should allow the simultaneous collection of multiple VS 
readings. It should facilitate the recording of ‘snapshot’ measurements taken 
several times a day and wirelessly transmitted to a host device. It should be easy to 
fit and use by non-clinical staff or patients and need only be worn when taking 
readings.  
 Infection monitoring and disease management were identified as potential 
applications. As BP measurement would present difficulties with device integration 
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and was of less diagnostic value, it was dropped from the multisensor device’s list 
of requirements with SR sensing being considered for inclusion. 
 IR pyrometers were chosen for temperature sensing, having good resolution, a fast 
response, linear output, non-contact performance and digital interface. 
 PPG sensing was selected for its clear advantage over other HR sensing methods, 
being reliable, well proven, easy to use and presenting the potential for 
simultaneous SpO2 monitoring if appropriate signal processing was applied. 
 RR estimation from HR variability was the most attractive RR measurement option 
as it extracted readings directly from an HR sensor waveform, albeit with additional 
signal processing load. While this was suitable for the multisensory device, 
respiratory motion sensing accelerometers, the next best option, were chosen for 
development as an independent RR sensor. 
 Measurement sites for the multisensory device were narrowed down to a 
clavicular or ear-worn solution. The ear was chosen as it enabled tympanic 
temperature measurement and HR, SpO2 and RR sensing via a pulse oximeter ear 
probe and satisfied the requirement for accessibility, facilitating discrete periodic 
monitoring. 
 Clavicular sensing was chosen for the wearable RR sensor, where an accelerometer 
would monitor respiratory clavicular motion. 
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3  M a te r i a l s  a n d  M e t h o d s  
This chapter details the materials used and methods applied during the design and 
manufacture of the prototype devices. The former reviews component selection and 
the equipment used over the course of the project, the manufacturers or suppliers 
being listed as footnotes. The materials section describes the design philosophy of the 
electronics and circuit board layouts, the assembly methods employed in circuit 
construction and the design and construction of the system enclosures. 
3.1 Materials 
The materials used in this project are described in the following sections where they 
have been separated into appropriate categories for clarity and convenience. 
3.1.1 Components 
The architecture of the Ear-worn Personal Monitoring System (EPMS) is shown in 
Figure 3-1; this depicts the processor core, the basic functional blocks and connectivity.  
 
Figure 3-1: The general arrangement of the EPMS device 
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As the ear-worn device necessitated a compact design, the preferred power source 
would be a small lithium battery. This offered a nominal terminal voltage of 3.7V which 
would be regulated to provide a +3.3V single-rail voltage supply, thus setting the 
systems’ operating voltage.  
The choice of processor was critical to EPMS performance, especially regarding 
computational resources. Selection of the Atmel and ARM devices was largely 
influenced by computational performance, familiarity with the chip family and access 
to design and debugging tools. Amplifiers used in signal conditioning and drive circuits 
were selected for their analogue performance, namely single supply operation, rail-to-
rail input and output, low noise and minimal input/output offset. For other 
components the criteria for selection were dominated by power budget and board 
space, both of which were at a premium. Preference was given to low-power devices 
in small surface mount packages and chips with integrated functionality. 
A critical factor in component selection was availability, particularly with new or 
recently introduced devices such as those used in the ultimate version of the EPMS 
(v4). The majority of the electronic components were sourced from RS Components13 
and Premier Farnell14. Low capacity lithium polymer (LiPo) batteries were supplied by 
Cool Components Ltd.15 and Proto-PIC.co.uk16. The BQ51050 wireless power 
                                                 
13 RS Components Ltd, Corby, Northants, UK 
14 Premier Farnell plc, Leeds, UK 
15 Cool Components Ltd. London, UK 
16 Relchron Ltd, Kirkcaldy, Fife, Scotland) 
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receiver/LiPo charger and AFE4490 integrated analogue front end pulse oximeter 
chips17 were sourced from Digi-Key18. 
Wireless Modules 
Rather than designing wireless transceivers using one of the many available chipsets 
and discrete components, a decision was made to use commercial off-the-shelf (COTS) 
modules with integral antennae. Using proven technology helped in reducing 
development time and cost, providing a reliable platform and enabling the author to 
concentrate on other aspects of the project.  
Being one of the larger components, size was a key factor in module selection. The 
ATBZ-24-A2 ZigBee modules19 used in EPMS v1 were sourced from Digi-Key, as were 
the RN-41 and RN-42 Bluetooth modules20, used in EPMS v1 and v2 respectively. The 
Bluetooth Low Energy (BLE - also known as Bluetooth v4.0 and Bluetooth Smart) device 
on EPMS v3 was a Bluegiga BLE112 Bluetooth Smart Module21 sourced from Mouser22. 
The final version of the EPMS (v4) used Fujitsu MBH7BLZ02-109004 BLE modules23 (see 
Figure 3-2) from YEG24. 
                                                 
17 Texas Instruments, Dallas, Texas, USA 
18 Digi-Key Corporation, Thief River Falls, MN, USA 
19 Atmel Corporation, San Jose, CA, USA 
20 Roving Networks, Los Gatos, CA, USA 
21 Bluegiga Technologies Oy, Espoo, Finland 
22 Mouser Electronics Inc., High Wycombe, Buckinghamshire, UK 
23 Fujitsu Ltd., Tokyo, Japan 
24 Young Electronics Group, High Wycombe, Buckinghamshire, UK 
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(Mouser Electronics Inc., 2013) 
Figure 3-2: The Fujitsu MBH7BLZ02 Bluetooth low energy (BLE) wireless module. 
3.1.2 Sensors 
Reusable pulse oximeter ear probes and a reference finger probe (part numbers 
3078 and 3044 respectively, both by Smiths Medical25 were obtained from Pulmolink26. 
MLX90615 infrared pyrometers27 were supplied by Future Electronics28. ADXL330 and 
ADXL345 triaxial accelerometers29 were sourced from Premier Farnell. 
3.1.3 CAD and Printed Circuit Boards  
Some initial prototype circuits were constructed on stripboard where they could be 
iteratively tested and modified to achieve the desired performance prior to 
committing the design to a printed circuit board (pcb). 
                                                 
25 Smiths Medical International Ltd., Ashford, Kent, UK 
26 Pulmolink Ltd., Charing, Kent, UK 
27 Melexis Microelectronic Systems, Ieper, Belgium 
28 Future Electronics Ltd., Egham, Surrey, UK 
29 Analog Devices, Norwood, MA, USA 
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The majority of the schematic capture and circuit layout for the designs were 
performed using Easy-PC v1530. The final version of the EPMS (v4) was designed using 
version 8.0 of Pulsonix EDA31, a more sophisticated package from the same software 
stable. In both cases, libraries were created for components, or modified as necessary, 
to facilitate manual assembly as in the author’s experience larger component pad sizes 
are required than those for automated volume production. 
All printed circuit boards were produced by pcb-pool.com32 from uploaded pcb CAD 
design files rather than CAD-generated photoplot and NC (numerically controlled) drill 
files during postprocessing. The majority of the boards were fabricated from standard 
1.6 mm thick FR4 glass-epoxy laminate clad with 35µm copper. All were finished in a 
green soldermask coating with the pads in electroless nickel gold (ENIG) for improved 
surface mount assembly; component legends on both sides of the boards (in white) 
aided component identification. A stainless steel solder paste mask was supplied with 
the EPMS v4 boards and was used during board assembly. 
3.1.4 Equipment 
Most of the board assembly was performed using hand soldering techniques with a 
Weller WP80 soldering iron and WD1000 soldering station33, with a range of tips. 
Soldering was performed with 0.46mm diameter low melting point (179°C - 62% Tin 
                                                 
30 Number One Systems, Tewkesbury, Gloucestershire, UK 
31 Pulsonix, Tewkesbury, Gloucestershire, UK) 
32 trading as Beta LAYOUT Ltd., Shannon, Co. Clare, Eire 
33 Weller Tools GmbH, Besigheim, Germany 
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(Sn), 36% Lead (Pb), 2% Silver (Ag) Alloy) solder wire34, with 0.8mm width desoldering 
braid35 used to clean up surface mount solder joints. A set of SMD tweezers36, 
specifically designed for use with surface mount devices, facilitated the handling and 
manipulation of small components during the assembly process. 
EPMS v4 boards were part-assembled using hot air reflow techniques using a 
Tenma 21-10135 heating plate37 and Duratool D01841 hot air surface mount rework 
station38. Chip Quik SMD4300TF tacky solder flux39 and Multicore SN62RA10BAS86 
solder paste40 were used during board assembly. 
Assembly and rework was greatly aided by the use of a binocular headband 
magnifier with LED illumination41 giving a magnification of x3.5. Inspection was also 
aided by the use of a Duratool BW1008-500X digital USB microscope42. 
Circuitry was powered by a Thandar TS3021S bench power supply43 whilst under 
development. The majority of the testing was performed using Tektronix DMM87044 
                                                 
34 Multicore, Henkel AG & Company, KGaA, Dusseldorf, Germany, (Premier Farnell part number 
419503) 
35 ITW Chemtronics, Kennesaw, GA, USA (Premier Farnell part number 957203) 
36 part number 5-050, BERNSTEIN-Werkzeugfabrik Steinrücke GmbH, Remscheid, Germany; 
supplied by RS Components 
37 Premier Farnell, part number 2064552 
38 Premier Farnell, part number SD01694 
39 Chip Quik Inc., Mashpee, MA, USA (Premier Farnell part number 1850221) 
40 Multicore, Henkel AG & Company (Premier Farnell part number 149968) 
41 RS Components, part number 534-2400 
42 Premier Farnell part number 2319418 
43 Thurlby Thandar Instruments Limited, Huntingdon, Cambridgeshire, UK 
44 Tektronix Inc., Beaverton, OR, USA 
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and Metrix MX24B45 multimeters, a Tektronix TDS 210 digital oscilloscope and 
PicoScope 2105 USB oscilloscope46. A variety of probes and test leads were made using 
2mm and 4mm connectors from laboratory stock to facilitate circuit testing. 
3.1.5 Medical Devices 
A Microplus V002-MS03 digital hand-held spirometer47 with disposable 
mouthpieces was used to collect lung function data for the respiratory sensor pilot 
study (chapter 4).  
A Braun ThermoScan IRT 4520 ear thermometer48 was purchased from Amazon, 
together with a stock of disposable lens filters, for use as a reference in EPMS testing. 
Once placed in the ear and triggered, measurement was completed in around five 
seconds and readings presented on a small display. 
An Oxi-Pulse 20 digital handheld pulse oximeter from Smiths Medical (supplied by 
Pulmolink Ltd.) was used as a reference for the EPMS. This displayed two-digit SpO2 
readings in large numerals with HR below, together with an indication of blood 
perfusion and pulse strength as LED bar graphs (Figure 3-3), and featured “patented 
Serial Autocorrelation” to minimise noise and motion artefacts. A D9 sub-miniature 
connector at the top of the device accepted a range of standard sensor probes. 
                                                 
45 AEMC Instruments, Foxborough, MA, USA 
46 Pico Technology, St. Neots, Cambridgeshire, UK 
47 Cardinal Health, Dublin, OH, USA 
48 Kaz Inc., Southborough, MA, USA 
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Figure 3-3: The Oxi-Pulse 20 digital handheld pulse oximeter – shown here fitted with a 
finger probe.  
3.1.6 Cellular Phones and Tablets 
A variety of mobile handsets were used in this project. Initial work with the EPMS v1 
and v2 designs used the author’s Sony Ericsson W995, running the Symbian operating 
system. As Apple were the only manufacturer initially supporting Bluetooth v4, an 
iPhone 4S was obtained to aid in the development of the EPMS v3. Subsequent 
development of the EPMS v3 and v4 was performed with a Nexus 7 tablet running 
version 4.4.4 of Google’s Android operating system (known as “KitKat”). This had the 
benefit of a larger screen which facilitated testing during trials of the EPMS v4 device. 
3.1.7 Software 
All embedded software for the Atmel AVR and ARM processors and mobile phone 
applications software (Symbian, Apple iOS and Android) used in the ear-worn 
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monitoring devices was kindly written by Paul Knight, a fellow doctoral student and 
professional software engineer. 
3.2 Methods 
This section describes the methods applied in the design and assembly of the 
project’s prototype electronic systems and device enclosures. 
3.2.1 Circuit Design 
Before starting each design or design revision, key components were shortlisted 
and comprehensively reviewed. Having determined and selected the optimum 
component fit, which considered factors such as specification, package type, 
availability and prior experience of a device, component details from manufacturers’ 
datasheets were added to CAD libraries. The schematic design was initially sketched 
out before detail was added and the design expanded across multiple sheets into 
functional blocks for clarity. Careful attention was paid to application notes, 
connectivity details and electrical specifications provided on product datasheets for 
interfacing details, passive component values and circuit connectivity. Decoupling 
capacitors (100nF) were added on a one-per-chip basis with a few more (1 to 10µF) 
around the circuit for power smoothing. Where necessary, prototype circuits were first 
constructed on stripboard to confirm operation before being added to a schematic. 
3.2.2 Circuit Layout 
Both Easy-PC and Pulsonix EDA are integrated packages, thus ensuring direct 
translation of the schematic design to the respective circuit layout utilities whilst 
maintaining complete design integrity. The majority of the pcbs were designed with 
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four electrical layers; the two outer layers for signal tracks (facilitating modification if 
required) and the inner layers providing power and ground connectivity in the form of 
air-gap power planes. This allowed tighter component placement, more room for 
signal routing and had the added benefit of reducing system noise. 
Major components were placed on an oversized outline of the target board outline 
then moved and rotated to give the optimum track routing paths and minimise inter-
layer connecting via holes. The remaining components were then added using both 
sides of the board, again keeping track lengths short wherever possible. The board was 
then manually routed with components being rotated and repositioned as necessary 
to accommodate tracks, via holes and minimise board space. Every effort was made to 
keep analogue signal tracks away from high-speed digital lines, especially clock signals, 
to minimise the possibility of crosstalk. With routing complete, components and tracks 
were carefully ’nudged’ to allow the board outline to be adjusted to its’ minimum size.  
Track widths and clearances (typically ≥0.20 mm) were kept well within the 
limitations of the pcb manufacturer’s guidelines to maximise yield and facilitate 
manual modification if required. It was decided not to use blind or buried inter-layer 
(via) through-holes to keep costs down, reduce design or manufacturing errors and 
simplify testing.  
A critical point of the layout process was to keep the overall board size as small as 
possible without compromising the requirement for hand assembly, which placed 
constraints upon the component packages used as the smallest parts are only 
realistically compatible with automated assembly methods. This ruled out the use of 
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ball grid array (BGA) and other similar chip packages, in which a high-density pad 
matrix is sited on the underside of a chip, and 0402 (1.0mm x 0.5mm) and 0201 
package (0.6mm x 0.3mm) passive parts. On a proven design intended for volume 
production, use of more than four electrical layers, blind and buried via holes and 
smaller components could save valuable board space for a more compact design.  
3.2.3 Hand Assembly of Circuit Boards 
The bulk of the circuit boards used in this project were hand assembled with a 
temperature controlled Weller soldering iron and low melting point solder wire. 
Whereas conventional through-hole component assembly was straightforward, 
assembly of many of the surface mount components proved to be a challenge due to 
their size, pin pitch and packing density. In all cases, the build order was (i) surface 
mount chips, (ii) surface mount passives and (iii) connectors, through-hole 
components and wires.  
Prior to surface mount chip assembly, a single corner pad on each device’s pcb 
footprint was lightly tinned with solder. A chip was then introduced and aligned with 
the pcb pads and the tinned pad carefully reheated to solder the pin flat to the board. 
A second pin diagonally opposite the first was then soldered to stabilise the device on 
the pcb ready for the next step. Where the pin pitch was greater than 1.0mm, the 
chip’s remaining pins could then be soldered individually with a fine soldering bit. 
Devices with a pin pitch less than 1.0mm pin were subjected to drag soldering and 
solder braid clean-up. Here, liquid solder flux was applied to the chip’s pins and the 
wetted (tinned) tip of a soldering iron dragged along one face at a time to create 
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solder joints. As the pins were often bridged with excess solder, this was removed by 
applying solder braid and a tinned iron as required. 
Surface mount passive components, which included resistors and capacitors in 0603 
(1.6mm x 0.8mm), 0805 (2.0mm x 1.25mm) and 1206 (3.2mm x 1.6mm) package 
formats, and small three to five-pin discrete semiconductors, were soldered using a 
similar technique as that used for chip assembly and assembled after the chips had 
been mounted. A single pad in each component footprint on a circuit board was first 
tinned with solder. Components were then offered up to their correct locations with 
SMD tweezers, the value, orientation and alignment checked and the tinned pads 
reflowed flat to the board. Having reflowed a number of components, the remaining 
pads were then soldered. Excess solder or solder bridges were removed with solder 
braid as before. 
Once the surface mount components had been assembled boards were visually 
inspected for solder bridges and bad joints with the binocular headband magnifier and 
USB microscope. Connectors and through-hole components were then fitted, soldered 
and the circuit re-inspected. 
3.2.4 Hot Air Reflow Assembly of Circuit Boards 
The Fujitsu MBH7BLZ02-109004 BLE module and BQ51050, AFE4490 and ADXL345 
chips necessitated a different approach for assembly on to the EPMS v4 boards as each 
had one or more component pads on the underside of the device that were 
inaccessible for hand soldering. As a result, hot air reflow soldering, either by direct 
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(from above with the Duratool rework station) or indirect heating (from below using 
the Tenma hot plate), was the method of choice for prototype board assembly.  
Before attempting to assemble the EPMS v4 board, direct and indirect assembly 
methods were trialled on scrap pcbs using obsolete or surplus components. Indirect 
heating was found to give reasonably consistent results for components with higher 
pin counts and allowed simultaneous soldering of all parts (using solder paste) of one 
side of the board. Direct heating was reasonably effective for soldering larger parts, 
but the air jet tended to disturb smaller parts and blow them off their pads – especially 
where smaller-bore nozzles were used. Reducing the airflow was not a viable option as 
it necessitated a reduction in temperature to prevent the rework station overheating; 
the reduced heat proving insufficient for effective reflow soldering. This experience 
demonstrated that the Duratool device was best used for the targeted reflow of larger 
devices or the removal of specific small components. 
An immediate problem with using the Tenma hot plate was that the EPMS v4 board 
was too small to sit upon the stand above the heating nozzle without a special holder. 
This was fashioned from a thin sheet of brass to which the pcbs were secured with 
twisted loops of tinned copper wire threaded through the board’s four corner 
mounting holes. This enabled boards to be safely positioned over the heating plate’s 
nozzle for effective indirect reflow soldering (Figure 3-4). 
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Figure 3-4: An EPMS v4 pcb wired on to the holder and positioned over the Tenma hot plate 
for reflow soldering. 
A number of approaches were tried including pre-tinning pads and screen printing 
solder paste. As successful mounting of the MBH7BLZ02 BLE module was likely to be 
the most difficult and present the greatest risk this was attempted first. The 
component pads on the board were pre-tinned using a soldering iron and solder wire, 
solder flux applied around the tinned pads and the device was positioned ready for 
soldering. The board was then fixed to the brass holder, arranged on the heating plate 
and reflow soldered using temperature profiles suggested on the device’s datasheet.  
Before any further parts were added, test leads were temporarily attached to the 
board, voltage levels probed and an attempt was made to program the BLE module. 
This proved unsuccessful demonstrating poor connectivity; with no way of adding 
solder paste for reflow and little or no exposed pad area to aid manual soldering, no 
effective remedial action was possible. Thus the board was reflowed on the hot plate 
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and the module removed for inspection which showed a number of contacts had not 
been soldered correctly – most likely due to inconsistent tinning.  
As a result wires were soldered directly to the BLE module’s power pins and SWD 
programming port and a test program uploaded. This output a 1Hz square wave on all 
of the uncommitted general purpose input/output (GPIO) terminals allowing signals to 
be monitored on the circuit board with an oscilloscope to demonstrate connectivity. 
Solder flux was distributed around the tinned pads on the board once more and solder 
paste added to those pads where the solder joints had been of poor quality. After 
reflowing on the heating plate the board was tested once more, this time returning 
square waves signals of the correct voltage threshold on the GPIO pins confirming 
successful assembly. 
With further experimentation it was found that carefully pre-tinning the pads on 
the BLE module with a soldering and “buttering” the pcb pads with solder paste 
produced the most consistent results. With a voltage regulator added for system 
power (U5), programming header and test leads added, boards were programmed 
with the 1Hz GPIO test code and before any other board assembly took place. Here, 
the remaining pads were prepared with solder paste and flux, the components 
carefully positioned and reflow soldered using the holder on the heating plate. The 
boards were then inspected and poor quality joints and solder blobs were reworked 
with the Duratool hot air rework station or manually with a soldering iron and solder 
braid.  
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3.2.5 Enclosure Design and Production 
With the EPMS v1 and v3 designs this was very much an afterthought as the 
circuitry was initially developed for bench testing. As a consequence the enclosures 
were designed around the boards and might be considered less than aesthetically 
pleasing. Conversely, the EPMS v2 and v4 board outlines were designed from the 
outset to fit enclosures arising from design studies. 
EPMS v1 Enclosure Fabrication 
This design consisted of two separate modules communicating over a ZigBee 
wireless network, one worn on the ear and the other carried about a subject’s person. 
After noting board dimensions and making allowances for wiring a design was 
sketched out and then transferred (drawn) onto sheet styrene of various thicknesses49. 
Pieces were cut out using a craft knife and tinsnips and glued together with solvent-
based adhesive (EMA Plastic Weld Cement). Having test fitted the pcbs, the enclosures 
were rubbed down and spray painted with primer, black paint and finished with a coat 
of protective acrylic varnish. A length of heat-formed plastic rod serving as an ear-hook 
and pulse oximeter ear probe clip were then glued to the rear of the ear enclosure 
with two-part epoxy resin adhesive to complete fabrication. 
3D CAD 
The author had hoped to use Autodesk CAD software50 to design enclosures; it soon 
became apparent however that the investment in time to gain sufficient expertise to 
produce the required designs would be prohibitive. Therefore, A fellow doctoral 
                                                 
49 sourced from Squires Model and Craft Tools, Bognor Regis, West Sussex, UK 
50 Autodesk, Inc., San Rafael, CA, USA 
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student and professional 3D CAD user, David Sziroczak, assisted by producing the 3D 
CAD drawings and data files using Catia software51 from the author’s original design 
sketches. 
3D Printing 
This technology has found an application in rapid prototyping and proved its worth 
over the course of this project. Casings were printed on the School of Engineering’s 
Dimension Elite 3D printer52 in white ABS (acrylonitrile butadiene styrene) plastic, the 
printed object being formed by building up successive thin layers of plastic in an 
additive printing process.  
Stereo lithography (.STL) files were generated from the native 3D CAD and uploaded 
to the printer’s host PC where the print settings were adjusted for high resolution 
output (0.254 mm layer thickness) and the cases printed, which took three to six hours 
per unit. Any voids were printed with sacrificial filler material (polylactic acid, a form of 
polyester commonly known as PLA) to support and maintain the ABS parts’ structural 
integrity over the printing process. On completion parts were placed in a tank of hot 
concentrated sodium hydroxide solution for several hours to dissolve the PLA, then 
rinsed with copious water. 
The outer finish on the 3D-printed parts was quite poor, having a pronounced step 
of around 0.2 mm on most curved or angled surfaces. These were rubbed down with 
various grades of wet and dry paper to achieve a smoother and more pleasing finish.  
                                                 
51 Dassault Systèmes, Vélizy-Villacoublay, France 
52 Stratasys Ltd., Eden Prairie, MN, USA 
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Assembly 
Holes in cases (e.g. for pulse oximeter sensor cables and USB connector access) 
were made using a range of small drill bits held in a pin vice, needle files and scalpels. 
IR pyrometers were glued into ear probes with a PVA adhesive (for ease of removal) 
and tested prior to the probe being glued to the case. Solvent-based (EMA Plastic 
Weld, sourced from a local model supplies shop) and two-part epoxy adhesives were 
used to glue parts together.  
3.3 Conclusions 
 The component selection criteria, design philosophies and assembly techniques 
employed successfully delivered a series of prototype systems. 
  The circuit design and layout methods employed resulted in the production of 
good quality pcbs with very few errors and proved to be extremely reliable. 
 Assembly of the BLE module and smaller surface mount devices on EPMS v4 
proved to be especially challenging. This required significant experimentation and 
effort to achieve a good yield with quality solder joints and suggests that 
subcontract manufacture may have been a better option.  
 3D printing proved to be ideal for EPMS case manufacture as this allowed the rapid 
prototyping of complex shapes that would have been too costly or inefficient using 
conventional methods. 
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4  C l a v i c u l a r  Re s p i ra to r y  S e n s o r  
4.1 Introduction 
Respiratory rate is one of the key vital signs with a wide diagnostic potential 
(Cretikos et al., 2008). Unlike temperature, HR, BP or SpO2 however, there are few 
dedicated sensing devices available and accepted for medical use. Outside of the 
hospital environment it is underutilised, largely due to a dearth of reliable automatic 
monitoring equipment (McBride et al., 2005).  
This chapter reports the use of accelerometers to monitor respiratory motion. 
Whereas thoracic sensing has been the subject of a number of studies (including 
Reinvuo et al., 2006; Phan et al., 2008; Bates et al., 2010; Hung et al., 2008), clavicular 
respiratory motion sensing is described here for the first time. The findings of a pilot 
study comparing RR readings derived from clavicular and thoracic motion with those 
from an expiratory breath flow reference sensor are presented and discussed. This 
work was reported in the journal Physiological Measurement (Pitts et al., 2013) 
4.2 Materials and Methods 
This section documents the materials used in the construction, design and 
calibration of the sensors and the protocols and analytical methods employed in this 
pilot study. 
4.2.1 Respiratory sensors  
A sensor circuit board (18 x 15 x 3mm) was designed around the ADXL330 
accelerometer53 (Analog Devices Inc., 2007), a tri-axial device which benefits from 
                                                 
53 Analog Devices Inc., Norwood, MA, USA 
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nano-scale MEMS (Micro Electro Mechanical System) technology to produce a small 
4mm x 4mm monolithic package (Figure 4-1). A number of boards were assembled; 
each attached to a 2.5m four-core screened connecting cable and wrapped in non-
allergenic surgical tape to provide insulation and protection. For data validation, a 
mask-mounted AWM720 mass flow sensor54 was used to measure exhalatory breath 
flow (as reported in Walton et al., 2014).  
 
Figure 4-1: The tri-axial accelerometer boards designed for and used in the respiratory 
monitoring study.  
Filters and Interfacing 
Working with the RR specified in section 2.2 of 4 to 30 bpm, this equated to a 
frequency range of 0.067 to 0.5Hz. A feedback capacitor value of 470nF was chosen to 
limit the 3db signal bandwidth to approximately 10Hz on each axis, requiring a sample 
rate of at least 20 Hz to meet the Nyquist rate. A 10Hz cut off was chosen as this would 
attenuate high frequency transients and mains electricity-derived electromagnetic 
interference (emi), which is prevalent at frequencies of 50/60Hz and its higher 
harmonics, leaving lower frequencies unaffected. At this experimental stage it was 
                                                 
54 Honeywell Sensing and Control, Golden Valley, MN, USA 
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considered more practical to use software filters during post-processing; the hardware 
filters being optimised as part of future sensor development. 
With reference to Figure 4-2, capacitors C4, C5 and C6 combine with internal 32kΩ 
resistors to form bandwidth-limiting low-pass filters for each output. The 3db point of 
the filter (i.e. half power) is given as: 
Equation 4-1: Accelerometer low-pass filter formula 
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With a Cf value of 470nF (instead of the 220nF shown in Figure 4-2), this gives us: 
Equation 4-2: Accelerometer low-pass filter calculation 
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Figure 4-2: A schematic of the triaxial accelerometer circuit showing filter capacitors C4-C6. 
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A basic interface board providing power distribution for the sensors (+3.3V for 
accelerometers and +10V for the mass flow sensor), and connectivity to a data logger 
was designed and assembled. No additional signal conditioning or amplification was 
applied. Data acquisition was provided by a Cranfield CardCorder system55; 12-bit data 
was acquired using 0-5V (accelerometers) and 0-10V input ranges (AWM720) at 100 
samples per second, well above the Nyquist rate, on each signal channel. 
4.2.2 Calibration 
Accelerometers are normally calibrated with reference to gravity, therefore 1g 
equates to an acceleration of a nominal 9.81 ms-2. Output signals from the ADXL330 
are ratiometric and therefore proportional to the supply voltage. For the 3.3V supply 
voltage, sensitivity is an effective 330mV/g with a full scale output of ±990mV at ±3g. 
The output swings about a centre of zero g, which is specified at half the supply, 1.65V 
in this instance. This gives a full scale output span of 0.66V to 2.64V.  
                                                 
55 formerly produced by Cranfield Impact Centre Ltd., Cranfield, Bedford, UK 
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(Analog Devices Inc., 2007) 
Figure 4-3: The gravimetric response of the ADXL330 in all three axes.  
The static gravimetric output responses for all three accelerometer axes are shown 
in Figure 4-3. A two-point calibration was applied to the accelerometers by rotating 
each axis in turn with respect to gravity upon a true horizontal surface (confirmed by 
spirit level) with the aid of an engineer’s square. This provided voltage readings 
corresponding to positive and negative gravity (± 1g) which were entered and stored in 
the logger’s setup software for each respective input.  
Reference Sensor 
The AWM720 mass flow sensor data was recorded as a pure voltage for translation 
into standardised litres per minute (SLPM) in post-processing. Because of the non-
linear relationship, a calibration curve was produced (Figure 4-4) from the data (Table 
4-1) provided on the manufacturer’s product datasheet (Honeywell International Inc., 
2008) and an equation derived to give an estimation in SLPM. 
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Equation 4-3: Honeywell AWM720 flow sensor linearisation 
𝐵𝑟𝑒𝑎𝑡ℎ 𝑆𝐿𝑃𝑀 =  𝑒(𝐵𝑟𝑒𝑎𝑡ℎ 𝑚𝑉−886.89)/776.93 
Flow (SLPM) Output (mV) 
1 1000 
25 2990 
50 3820 
75 4300 
100 4580 
150 4860 
200 5000 
Table 4-1: The AWM720 flow sensor voltage output for different levels of flow in 
standardised litres per minute (SLPM) 
 
 
Figure 4-4: A plot of the AWM720 sensor’s calibration table data showing curve fitting 
y = 776.93ln(x) + 866.89 
R² = 0.983 
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4.2.3 Study Participants and Assay Description 
After ethical approval (from Cranfield University Health Research Ethics Committee 
– CUHREC) and full consent had been obtained (see for Appendix E for details), eight 
healthy volunteers aged 24 to 55 years old (i.e. non-smokers, free from any respiratory 
condition or infection and not taking any medication in the days prior to or during the 
study period) were recruited for the study. Five were male (volunteers 01, 02, 04, 07 
and 12) and three female (volunteers 06, 08 and 11). Each was asked to attach two 
motion sensing accelerometers with non-allergenic surgical tape – one to the left 
clavicle, the other, over the sternum along the sagittal plane along the line of the fifth 
rib (see Figure 4-5); the latter to provide reference data to determine how clavicular 
measurement might compare with the form of thoracic sensing used in other studies 
(including those by Phan et al., 2008; Bates et al., 2010).  
 
Figure 4-5: Diagram showing the locations of the motion sensors and their orientation on 
the body with respect to gravity 
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Both sensors were positioned with the same basic orientation (facilitating cable 
routing), giving a nominal resting output of x (lateral) =0g, y (vertical) =-1g and z 
(longitudinal) =+1g on the sensors’ axes with respect to gravity with a standing 
volunteer; the offsets being removed during offline data processing. Volunteers were 
then fitted with a breath monitoring mask, the headstall being adjusted to provide a 
secure yet comfortable fit. Several minutes were allowed for acclimatisation prior to 
initiating each experiment. 
Tests commenced with the volunteers standing and breathing normally. After two 
minutes of normal breathing, volunteers were asked to vary their breathing patterns, 
taking random short, long, shallow and deep breaths for a further 90 seconds, 
following which, they were asked to provide a full and deep outbreath and resume 
normal breathing for the last 30 seconds of the experiment. This provided a four-
minute recording of a range of breathing patterns allowing direct comparison between 
the sensors. Participants were asked not to speak over this period and refrain from 
excessive movement, remaining as still as reasonably possible.  
Data was uploaded serially (RS232) immediately after each test in an ASCII text CSV 
file format and backed up on a network drive provided by the University. 
4.2.4 Spirometry 
As the sensing methods in the study were based upon thoracic and clavicular 
motion, reference spirometry readings were taken to establish whether there was any 
relationship with motion data. Each participant was asked to take a deep breath and 
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blow into a hand-held spirometer56 with full expiratory effort for three comparative 
readings from which the means were calculated. Four parameters, FVC, REV1, FER and 
PEF (see Table 4-2 for details), were recorded for six of the eight volunteers. 
Parameter Meaning / Units Description 
FVC Forced Vital Capacity (L) Full forced expiratory volume 
FEV1 
Forced Expiratory Volume in 
one second (L) 
Volume measured in the first second of full 
forced expiration  
FER Forced Expiratory Ratio (%) 
FEV1/FVC, the percentage of FVC exhaled in 
the first second 
PEF Peak Expiratory Flow (Ls-1) Peak flow rate at full forced expiration 
Table 4-2: A glossary of the spirometry terms used and parameters measured in the study 
4.2.5 Data analysis 
MATLAB software57 was used for data processing, analysis and visualisation. A 
series of scripts were written to automate data importation and signal processing 
tasks. 
The raw accelerometer data was essentially sinusoidal with a DC offset (from static 
gravitational forces) and exhibited significant signal noise (Figure 4-6). The DC offset 
was first removed by applying a DC blocking filter; a 5-pole low-pass Butterworth filter 
(Butterworth, 1930) was then applied to remove signal noise. This was selected for its 
flat response in the pass band rather than the additional ripple and sharper cut-off 
transition of a Chebyshev or the flat phase response of a Bessal filter (Horowitz and 
Hill, 2001). A cut-off frequency (-3dB point) of 0.5 Hz, equivalent to a RR of 30 bpm, 
                                                 
56 Microplus V002-MS03, Cardinal Health, Dublin, OH, USA 
57 Mathworks Ltd., Natick, Massachusetts, USA 
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was found experimentally to provide a sufficiently clean signal for effective peak 
detection, whilst preserving waveform shape. 
 
Figure 4-6: An example of raw clavicular accelerometer data (study participant 012) 
Signal processing of the reference data was limited to unit conversion (to SLPM) and 
the removal of signal noise with a 5-pole low-pass Butterworth filter once again. A 
higher cut-off frequency of 2.5Hz was selected as this was found to preserve the shape 
of the waveform, in which each breath displayed a fast rise time with a slower decay 
(Figure 4-7). Ideally, both the accelerometer and reference flow sensor data would 
have the same cut-off frequency to minimise any phase shift or time delay issues. With 
the cut-off frequencies closely matched however, any phase issues were considered 
negligible compared to the flow sensor peak rounding had both sensors been filtered 
at the lower frequency or accelerometer signal noise at the higher frequency. 
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Figure 4-7: An example of raw flow sensor data (study participant 012) 
Scripts for peak detection used MATLAB’s ‘findpeaks’ function with threshold filters 
for magnitude (relative to the waveform mean) and periodic time (±150 samples) to 
eliminate false peaks. Breath periods were then extracted and exported to MS Excel 
for plotting and statistical analyses. 
An estimation of the mean minute volume, a standard measure of exhalatory 
breath in a one minute period, was calculated for each participant from the flow 
sensor signal in MATLAB to provide an indication of ventilatory condition. This was 
achieved by summing the areas of each outbreath over the study period (using the 
trapezium rule) and dividing the resultant by four for the mean minute reading. 
To assess the agreement between the CRS and TRS median respiratory rates 
regression and Bland-Altman (difference) plots were computed. The Bland-Altman plot 
is a method of data plotting used in analysing agreement between two different 
techniques of measurement, one of which may be a reference method or gold 
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standard, by calculating the mean difference between the two methods of 
measurement (the bias) and 95% limits of agreement as the mean difference (1.96 SD) 
(Altman and Bland, 1983). It is expected that the 95% limits include 95% of differences 
between the two techniques of measurement. 
4.3 Results 
This section presents the results from the pilot study and includes comparative 
sensor data, plots and statistical analyses. 
4.3.1 Comparison of Clavicular and Thoracic Motion Responses 
An example of an individual’s resting breath-by-breath clavicular respiratory 
responses are shown in Figure 4-8. The dominance of the amplitude response in the 
longitudinal (Clav fZ) and lateral (Clav fX) axes was clearly defined with a regular phase 
relationship between all axes, albeit that the lateral axis was inverted.  
 
Figure 4-8: Tri-axial clavicular sensor motion following the application of a DC block and 
low-pass Butterworth filter 
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On inhalation and following thoracic expansion, this translated to three-dimensional 
clavicular motion that showed slight upward (vertical) displacement accompanied by 
pronounced forward (longitudinal) and outward (lateral) movement, with a reversal on 
exhalation as the chest contracted. 
The thoracic sensor demonstrated a similar three dimensional motion as it tracked 
chest expansion. Again the dominant signals were in the longitudinal (Thor fZ) and 
lateral (Thor fX) axes (Figure 4-9), but their magnitude was less than the corresponding 
clavicular axes (0.075 ms-2 versus 0.2 ms-2 peak to peak) and comparable with the 
weak vertical (Clav fY) response. In addition a slight irregularity in relative phase was 
observed between the three thoracic axes on most datasets. Analysis of data from the 
two motion sensors demonstrated that clavicular respiratory sensing (CRS) was 
superior to thoracic sensing (TRS) in terms of signal amplitude (typically double), phase 
relationship and consistency. 
 
Figure 4-9: Tri-axial thoracic sensor motion following the application of a DC block and low-
pass Butterworth filter 
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4.3.2 Comparison of Motion and Reference Waveforms 
A series of time-history graphs were plotted of volunteer’s respiratory responses to 
establish the temporal alignment of the respiratory motion signal peaks with the 
reference. It was found that the clavicular sensor’s longitudinal (Z) axis produced the 
best overall agreement. An example of this may be seen in Figure 4-10 where the 
alignment (between clavicular peaks and the rising edge of the reference) of individual 
breaths, inhalation and exhalation phases and inter-breath periods are shown.  
 
Figure 4-10: Respiratory periods measured by clavicular motion and exhalatory breath flow 
showing alignment of the two traces. 
An example of the breath-by-breath differences observed during the mixed-
breathing phase is shown in Figure 4-11. Here, the relative depth of two consecutive 
breaths can clearly be seen and may be characterised from the duration, area and 
amplitude of each breath pulse, all of which are shown to be proportional to breath 
volume. 
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Figure 4-11: Respiratory depth measured via clavicular motion and exhalatory breath flow; 
differences in magnitude and area may be observed between the two breaths 
 
Figure 4-12: Occasional double-peaks observed in the data from one volunteer, the reasons 
for which were unclear 
Figure 4-12 shows the occasional double-peaks observed in a single breath in the 
data from one volunteer. Whilst the clinical significance of this is unknown and has not 
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been investigated as part of this research project, it is nevertheless interesting as the 
effect is undoubtedly real, being evident in motion and exhalatory flow traces. It does 
however pose a problem for peak detection if the magnitudes of the secondary pulses 
are above those of the cut-off threshold and approximate shallow breaths. The double 
peak may result in the detection of two breaths rather than one. 
4.3.3 Spirometry 
Spirometry readings are presented in Table 4-3 with the exception of the results for 
two volunteers, which were not recorded. All FER values are of the normal range of 
approximately 80% (Pearce, 2011).  
Volunteer FEV1 FVC FER PEF 
Minute 
Volume (L) 
Tidal Volume 
(mL) 
001 - - - - 8.73 598 
002 3.64 4.56 79.33 629.00 6.67 569 
004 4.20 5.15 81.00 710.33 6.39 573 
006 2.46 3.05 80.67 345.67 4.04 212 
007 - - - - 6.33 727 
008 2.65 2.99 88.00 263.67 2.92 288 
011 2.84 3.57 79.00 344.00 7.03 892 
012 4.51 5.66 79.67 679.33 11.90 797 
Table 4-3: The means of three replicate measures of study participant’s spirometry 
readings shown with their calculated minute and mean tidal volumes  
Minute Volumes 
With typical resting values in the range of 6 to 10 L (US Navy, 2005), five of the 
volunteers fall within the normal range. However, the results from volunteers 006 and 
008 (4.04 and 2.92 L respectively) appear lower and 012 (11.9 L) slightly higher than 
the norm. Mean tidal (single breath) volumes were calculated by dividing the minute 
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volumes by the mean median RRs from exhalatory flow (see Table 4-4) for each 
volunteer. This is normally given as 6 – 12 mL\kg of body mass (Grossbach et al., 2011) 
giving a median figure of around 600 mL for a mass of 70kg (Walpole et al., 2012). 
Although weights were not taken in the study, the estimated volumes for subjects 006 
and 008 appear unusually low which may be indicative of poor mask sealing. 
4.3.4 Respiratory rate analysis 
The peak-to-peak periods were extracted from each respective dataset and entered 
into an MS Excel spreadsheet. These were converted to instantaneous RRs (60 
seconds/breath-periods) and the resulting data plotted to show raw and processed 
readings over the study period. The relationship between breath periods and RR is 
shown in Figure 4-13. It can be seen that small changes or measurement errors in 
breath periods have a significant effect on RRs at normal physiological ranges. 
 
Figure 4-13: The relationship between breath periods and breaths per minute (bpm) over 
the typical physiological range 
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Instantaneous Respiratory Rates 
These were calculated for each tabulated breath period and plotted as a series of 
graphs, one for each of the participants, as shown in Figure 4-14. Each graph shows the 
reference expiratory flow RR (Ref), CRS x- and z-axes RRs (CRS_X and CRS_Z) and TRS z-
axis RR (TRS_Z) plotted against consecutive breath numbers over the study period.  
Some discrepancies in the agreement between and the total number of peaks in the 
reference and accelerometer responses were observed. Occasional small extraneous 
peaks in breath flow were almost certainly due to volunteers talking as noted during 
study sessions; one peak was removed from a dataset where the time correlation was 
clear. Instances of missing peaks following a full outbreath may be explained by 
imperfect mask sealing on some volunteers. 
Median Filtered Respiratory Rates 
Displaying instantaneous RRs could be considered impractical for real-world use due 
to “jitter” from normal inter-breath variation, thus additional processing was applied 
to moderate breath frequency. Here the median value of a sample window of five 
ordered consecutive breaths was used; this method was chosen as intermittent high or 
low readings have a reduced influence on results, but rate changes that occur over a 
number of (>3) readings are preserved. Graphs showing the results of a five-sample 
median filter for each study participant are presented in Figure 4-15. 
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Figure 4-14: A comparative plot of instantaneous breath-by-breath RRs for each of the 
eight study participants 
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Figure 4-15: A comparative plot of ordered five-sample median filtered RRs for each of the 
eight study participants 
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Study Mean Respiratory Rates  
Table 4-4 shows the mean instantaneous and mean median RRs for each study 
participant giving the respective figures for the reference, CRS x and z axes and TRS z-
axis. It can be seen that the results for subject 001 are quite closely matched 
throughout while the others show clear discrepancies. Results for the z-axis clavicle 
sensor appear the closest to the reference. 
Volunteer 
No. 
Reference 
RR 
CRS-X 
RR 
CRS-Z 
RR 
TRS-Z 
RR 
Median 
Reference 
RR 
Median 
CRS-X 
RR 
Median 
CRS-Z 
RR 
Median 
TRS-Z 
RR 
001 14.84 14.54 14.57 14.50 14.59 14.46 14.34 14.24 
002 12.45 11.31 11.25 15.13 11.72 11.20 10.80 15.35 
004 11.63 12.70 11.42 11.05 11.14 12.66 11.29 10.68 
006 19.31 17.47 17.42 16.92 19.05 17.90 17.32 17.12 
007 8.84 8.65 9.13 10.94 8.71 8.96 9.11 10.45 
008 10.35 10.38 10.29 14.95 10.14 10.00 9.93 14.06 
011 8.90 11.11 8.71 13.82 7.88 10.89 8.08 12.54 
012 14.72 15.38 14.89 16.27 14.93 15.07 14.86 16.32 
Table 4-4: The means of breath-by-breath and five-breath median RRs from the study for 
each participant 
Statistical Analysis 
The mean median RR data from Table 4-4 was used to prepare regression and 
Bland-Altman plots of the CRS x and z and TRS z-axis against the reference, showing 
relative performance. 
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Figure 4-16: Regression of the means of the CRS X-axis median RRs against the reference 
(a) and Bland-Altman plots of the means and difference of the paired readings (b). 
Figure 4-16 shows comparative plots of the CRS x-axis and the reference. The 
regression plot shows a relatively tight grouping around the trend line giving a 
coefficient of determination (R2) of 0.896 (p <0.001). The Bland-Altman plot shows a 
small mean bias (-0.37) with four outliers outside of the limits of agreement. The 
largest errors point to underestimation in the lower ranges, but with a general 
tendency to overestimate 
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Figure 4-17: Regression of the means of the CRS Z-axis median RRs against the reference 
(a) and Bland-Altman plots of the means and difference of the paired readings (b). 
Comparative plots of the CRS z-axis and the reference are shown in Figure 4-17. The 
tight grouping around the trend line in the regression plot gives an R2 value of 0.981 (p 
<0.001). The Bland-Altman plot shows a smaller mean bias (0.30) than the CRS x-axis 
with a single outlier and, with most of the points below the mean bias line, a 
propensity for underestimation.  
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Figure 4-18: Regression of the means of the TRS Z-axis median RRs against the reference 
(a) and Bland-Altman plots of the means and difference of the paired readings (b). 
Figure 4-18 shows comparative plots of the TRS z-axis and the reference. The 
regression plot shows a relatively loose grouping around the trend line with R2 = 0.603 
(p <0.023). The Bland-Altman plot shows the greatest mean bias (-1.58) of the three 
plots presented here. The limits of agreement too are the highest of the set (2.23) with 
three outliers. There is noticeable greater scatter and as with the CRS x-axis plot, the 
largest errors point to underestimation in the lower ranges and overestimation at 
higher frequencies. 
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4.4 Discussion 
The pilot study reported here produced encouraging results and has successfully 
demonstrated that CRS can ably track resting RRs. Clavicle sensor signals were of 
superior amplitude and signal to noise ratio than those from the thoracic device, giving 
notably superior RR readings using relatively basic signal processing techniques with 
the longitudinal (Z) axis providing the best results.  
Precise sensor positioning upon the clavicle was not found to be particularly critical, 
a feature that should reduce user error and facilitate use by non-clinical staff and in 
home monitoring. Optimal operation would require compliant subjects, which should 
not present any more of a problem than with other vital sign measurements of resting 
patients. Any non-respiratory motion-induced artefacts could be minimised by 
considering composite or angular waveforms (Anmin et al., 2009), an activity 
monitoring algorithm (Mathie et al., 2004) applied to qualify the respiratory data or 
the sample window size increased, whether for signal averaging or a median filter as 
used here. Alternatively the types of algorithms employed in more sophisticated pulse 
oximeters to suppress motion artefacts (Moyle, 2002) could be adopted.  
Additional and missing peaks were observed in the study datasets, some of which 
were caused or masked by non-respiratory motion. With good sensor to clavicle 
coupling, CRS RRs compared well with the reference. Two volunteers experienced 
problems with poor sensor adhesion, a key factor for optimal performance, causing 
inadequate coupling, which was reflected in the data. This was generally more of a 
problem with male participants due to body hair; this may be easily addressed by local 
hair removal, use of alcohol wipes and more resilient surgical tape. The estimated 
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minute and tidal volumes suggest that mask sealing was an issue for two volunteers, 
the masks (medium and large sizes) being incorrectly sized and causing leakages. 
The signal processing techniques employed were relatively simple and 
straightforward compared to those in many medical devices. Rather than having to 
process analogue and acquire waveforms in a host device this would allow the use of 
small, relatively basic and low-cost microprocessors for on-board data processing. This 
would offer embedded algorithms and digital output, practical devices being available 
in wired USB-powered or wireless (battery powered) formats. Power requirements 
would be very low, so many hours of wireless operation would be possible with a small 
battery unless continuous real-time wireless monitoring was required.  
4.4.1 Comparison with Other Methods 
Clavicular respiratory sensing is less intrusive than direct monitoring methods, such 
as capnography and nasal thermometry, that measure exhalatory flow and more 
convenient and discrete than thoracic band-based measurement. Being motion-based, 
it does not suffer from the contact resistance, electrical noise and interference, 
arrhythmia-induced or treatment-related problems seen with ECG or impedance 
respiratory sensing methods employing electrodes to capture thoracic electrical 
activity (Malik, 2004). The estimation of RR via EDR or RSA from ECG or PPG signals 
does not offer the accuracy or range suggested by the CRS in this study. Whereas the 
CRS was sampled at 100 Hz, a rate that could be increased for improved temporal 
resolution, as the accuracy of the EDR and RSA methods are dependent upon the ratio 
between HR and RR; as this narrows accuracy suffers. A study by Wu estimating RRs 
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derived from ECG and PPG waveforms gave mean errors of 0.85 ±0.53 bpm and 1.46 
±1.12 bpm respectively (Wu et al., 2010), both significantly inferior to the CRS figures 
(0.30 ±0.70 bpm). When compared with Cysarz’s findings (Cysarz et al., 2008), 
clavicular respiratory sensing appears superior at lower RRs (<10 bpm) and has better 
potential for accurately detecting higher RRs (>20 bpm).  
4.4.2 Respiratory Depth 
The study shows that the magnitude of the accelerometer waveform is proportional 
to that of respiratory motion. This is of clinical interest as it offers a potential means of 
monitoring respiratory effort and has seen interest by researchers investigating 
respiratory flow in sleep apnea (Dehkordi et al., 2012). Shallow breathing, where 
minimal thoracic movement may be observed, could indicate orthopnoea in a 
recumbent patient (Haldane et al., 1919). Changes in breath depth, where this 
becomes shallower over time for example, could be of value for monitoring 
progressive dyspnoea (Longmore et al., 2009). It also facilitates the detection of 
Cheyne-Stokes respiration and apneas and may assist in the early detection of acute 
exacerbations of COPD and asthma (Maitre et al., 1995).  
4.4.3 Study Limitations 
A few limitations were apparent in this pilot study, the greatest being the number 
of participants. A larger study group would address this, having greater statistical 
power, and could include the investigation of postural influences upon RR readings. It 
would also help to determine the device’s accuracy and bias across a wider range of 
frequencies. A more thorough assessment of ventilatory condition involving 
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spirometry, body mass index (BMI) and thoracic measurements would help build an 
understanding of the relationship between respiratory depth and signal magnitude. 
This would provide calibration data for the estimation of tidal and minute volumes.  
4.4.4 Applications 
This pilot study demonstrates that clavicular respiratory motion sensing is superior 
to thoracic sensing and offers a viable and convenient method for the non-invasive 
monitoring of respiratory rate. Whilst this in itself is of value, especially outside of 
clinical settings, the possibility of simultaneous measurement of respiratory depth 
significantly enhances the devices’ potential as a practical diagnostic or monitoring 
device (Folke et al., 2003). Use of such a discrete respiratory monitor could benefit 
dyspnoea sufferers as it could help promote patient compliance for breathing 
exercises by offering valuable feedback and encouragement (Gavish, 2010). For home-
based patients, whether elderly or suffering from long-term conditions such as COPD, 
the regular monitoring of RR depth and breathing patterns with a device such as the 
CRS, could be of great clinical value. When combined with pulse oximetry and other 
vital signs in a telemonitoring system, it could provide an early warning of acute 
exacerbations, a worsening condition or the onset of severe respiratory infection. 
These enhancements, together with further waveform and multi-parameter analysis, 
may yield useful data in characterising respiratory patterns as an aid to diagnosis 
(Tobin et al., 1983; Dellweg et al., 2008). 
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4.5 Conclusions 
The work reported in this study meets two of this thesis’ stated objectives: 
 A novel prototype respiratory sensor (CRS) was designed and produced. 
 A pilot study of the prototype respiratory device on healthy subjects was 
completed in order to allow comparison with a reference device. 
 
Results from the study demonstrate the following points: 
 When compared with the reference, the longitudinal (z) axis gave the most 
consistent results in both the clavicular and thoracic sensors. 
 The mean study results demonstrate that clavicular sensing (R2 = 0.981, p <0.001, 
mean bias = 0.30, limits of agreement = 0.96) was superior to thoracic 
measurement (R2 = 0.603, p <0.023, mean bias = -1.58, limits of agreement = 2.23) 
when compared with the reference, with which it had an excellent agreement. 
 The CRS (z-axis) study data gave a mean error of 0.30 ±0.70 bpm, meeting the 
desired 1 bpm accuracy. 
 It was observed that the magnitude of the accelerometer response was 
proportional to respiratory depth, offering the potential for further study into the 
viability of the method for the estimation of tidal volume. 
 Clavicular respiratory sensing has demonstrated its potential for development as a 
discrete wearable RR sensor. 
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5  D e v e l o p m e n t  o f  a n  E a r - w o r n  P e rs o n a l  
M o n i to r i n g  Sys te m  ( E P M S )  
5.1 Introduction  
Having established that ear thermometry was the best proxy for core body 
temperature it was apparent that this was the preferred temperature measurement 
site. With pulse oximetry selected as the preferred HR monitoring method and the 
availability and acceptance of ear probes for sensing, by logical progression the 
optimal arrangement for simultaneous multiple-sensor vital signs monitoring was an 
ear-worn device. In choosing the ear as a monitoring site this facilitated access for 
periodic monitoring and saved users from having to undress to fit the sensing device. 
Over the course of the project there were four major design iterations; these are 
referred to here as EPMS v1 to v4, with EPMS v4 being the final incarnation of the 
design. 
This chapter describes the engineering of the prototype EPMS designs. The four 
main sections cover the sensor design and installation, electronic systems and initial 
tests, concluding with a discussion. Details of the key aspects of the sensor and system 
designs are reported, these include schematics of sub-circuits, control system 
flowcharts, the specifics of circuit operation, CAD images of the board designs, the 
particulars of sensor installations and system enclosures. The results of initial testing 
are then presented, providing an indication of sensor and system performance. The 
differences between evolutions of the device design are also highlighted and 
discussed. 
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5.2 The Sensors 
This section reports the development of the sensors for the EPMS device, with the 
temperature, pulse oximeter, accelerometer and SR sensing each covered in turn. The 
pulse oximeter design is covered in particular detail, showing the basic design criteria 
and the theory of operation. 
5.2.1 Temperature Sensing 
The Melexis MLX90615 was housed remotely in an in-ear probe such that the 
sensor lens was aimed at a subject’s inner ear. In the EPMS v1 this was encapsulated 
(epoxy resin) inside a modified audio earpiece whereas a 3D-printed hollow conical 
probe was used in the other designs. The design of the latter was modelled on that of 
a Braun Thermoscan ear thermometer, having similar overall dimensions with the 
exception of probe length – this was shortened slightly to minimise the potential for 
injury or discomfort. In all cases the sensor was connected to a +3.3V power supply 
and the host circuits’ I2C serial bus, the connections being made directly to a pcb by 
short wires (40 to 60mm long). 
Sensor calibration was not required, the quoted resolution being 0.02°C with an 
accuracy of ±0.5°C over the physiological temperature range. The emissivity was left at 
the factory setting of 1.0 - equivalent to that of a perfect black body. Emissivity of 
human skin is typically quoted as 0.96 to 0.98 (Boylan et al., 1992); as this is close to 
the pre-set value there was little to be gained by changing the setting.  
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5.2.2 Pulse Oximeter 
This consists of the sensor probe (described in the next paragraph) and 
accompanying circuitry. The circuitry itself may be broken down into two distinct 
sections, drive control and signal conditioning, which are necessarily interdependent 
and described in the sections on pages 160 and 161 respectively. The control systems 
employed in the prototype devices are described in the section from pages 162-165. 
Ear Clip Probe 
All designs used a standard off-the-shelf Smith’s Medical reusable pulse oximeter 
ear clip probe (part number 3078), which was worn on the ear lobe. As delivered, 
cables were terminated with a D9 sub-miniature male connector. These used a 
standard pinout employed by Nellcor58, Masimo59, Nonin60, Smiths Medical and other 
leading device manufacturers (see Table 5-1).  
9 pin D-Sub male 
connector 
Function Details 
2 LED A LED Drive input 
3 LED B LED Drive input 
5 Photodiode Anode Sensor output 
7 Ground Sensor/cable shield 
9 Photodiode Cathode Sensor output 
(Markandey, 2010) 
Table 5-1: Standardised pulse oximeter probe pin connections, as used by Nellcor (Covidien) 
and many other leading manufacturers  
                                                 
58 Covidien plc, Dublin, Ireland 
59 Masimo Corporation, Irvine, CA, USA 
60 Nonin Medical, Inc., Plymouth, MN, USA 
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In this configuration the two (red and infrared) LEDs were connected in an inverse 
parallel configuration requiring two connections to a drive circuit which alternately 
switches polarity to illuminate the LEDs, e.g. an H-bridge. The remaining connections 
accommodate the photodiode (more correctly a PIN diode) connections and a shield 
for the sensor cable and pcb which must be grounded. For installation into the 
prototype devices, cables were significantly shortened (to less than 100mm), the 
braided screens pigtailed with a ground wire and the individual wires soldered directly 
to the circuit boards. With the EPMS v1 the clip was glued to the ear module 
enclosure; as fitting the device to the ear was found to be rather difficult, the clip was 
left free on subsequent designs where it could be easily clipped onto the earlobe.  
Smith’s Medical were contacted on several occasions regarding technical and 
calibration data for the ear probe, but unfortunately this was not forthcoming. 
Drive Control Overview 
The drive control sets the illumination intensity of the probes LEDs and the pulse 
repetition frequency. Instantaneous drive current could exceed 100mA per LED (with 
this equal to [drive voltage - LED forward voltage] / LED series resistance and assuming 
typical values of [3.3V – 1.5V] / 15Ω), though the mean ac current was considerably 
less. Thus components with appropriate power ratings were used. This allowed a range 
of tissue thicknesses and skin tones to be accommodated with transmissive sensing.  
An H-bridge LED driver circuit, a common feature of pulse oximeter designs 
employing inverse parallel LEDs (Markandey, 2010; Texas Instruments Inc., 2010; Texas 
Instruments Inc., 2013), was used in all of the EPMS variants. In the case of EPMS v1 to 
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v3 this used discrete components whereas in EPMS v4 it was on-chip in a dedicated 
integrated device. This allowed control of both LED drive (via digital-to-analogue 
converters - DACs) and switching. Once enabled, the LEDs were cycled at the chosen 
pulse frequency – IR ON, both OFF, red ON, both OFF – such that only one LED was 
illuminated at any time, the OFF periods providing reference ambient light levels 
(Figure 5-1). The clock frequency of the LED drive for the EPMS v1 to v3 was 500 Hz 
and 1000 Hz for EPMS v4; the sampling rate for the four quartiles being 125 Hz and 
250 Hz respectively. 
 
 
 
 
Figure 5-1: Pulse Oximeter LED switching timing diagram shown with equal switching 
periods (T1 – T4) 
Signal Conditioning Overview 
Signal conditioning for the photodiode employed a transimpedance amplifier to 
convert the diode’s small photocurrent to a voltage, and rail-to-rail input and output 
op-amps to filter and amplify the signal prior to analogue to digital conversion. The 
circuit designs used in EPMS v1 to v3 were based around discrete components under 
digital control while the EPMS v4 used integrated analogue and digital circuits in a 
dedicated chip for essentially similar signal conditioning provision. 
Red 
Infrared 
ON 
ON 
T1 T2 T3 T4 
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Control System 
This is a critical part of any pulse oximeter design and encompasses control of the 
LED drive and signal conditioning using feedback to control dynamic system behaviour, 
and signal demultiplexing.  
As the LEDs may have different adsorption characteristics, independent adjustment 
of their light intensity is required. In addition, as the power budget is limited, it is 
important that LED light intensity is optimised, balancing the signal response and LED 
drive. Another key feature is to turn off or reduce intensity of one or both LEDs when 
no viable target (i.e. tissue) is present to save energy.  
Feedback from the digitised photodiode response allows dynamic adjustment of 
LED drive under software control to achieve the desired results. A flowchart of the 
control system is shown in Figure 5-2. In an initial “standby mode”, the red LED alone is 
pulsed at low frequency and moderate intensity, with test readings taken. With the ear 
clip not in use there would be no apparent absorption whereas a change in adsorption 
could indicate tissue is present. In this case the red and IR LEDs are turned on, 
monitored and adjusted for optimum performance such that data sampling can begin 
if viable. If the adsorption levels during sampling suggest the clip has been removed 
(i.e. minimal absorption) the system enters standby once more, whereas, if the signal 
levels exceed predetermined boundaries (e.g. poor perfusion, sensor fitting or motion 
artefacts) the LEDs are “retuned”. 
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Figure 5-2: A flowchart showing pulse oximeter LED drive control and adjustment 
As there are two LEDs and a single photosensor, this presents a composite output of 
red, IR and ambient (reference) signals. These must be demultiplexed (separated) 
before anything useful can be achieved. This may be performed in software, hardware 
or a mixture of both techniques; however, the critical point in all cases is that the 
timing of the LED switching and sample acquisition are in lockstep. While this alone 
may suffice for software methods, it should be noted that the host microprocessor or 
microcontroller must also simultaneously process the signals, acquire data from other 
The design and evaluation of discrete wearable medical devices for vital signs monitoring 
DG Pitts 164 Cranfield University 
sensors and manage system-level functions. Performance is therefore dependent upon 
the micro’s computational power and specification. A hardware solution, which is 
relatively straightforward, takes the burden away from the embedded software, but 
adds to the component count and circuit space requirements. For lower performance 
micros, a compromise between both methods employing software-controlled 
analogue switching could present the best option. 
 
Figure 5-3: A flowchart showing the relationship between pulse oximeter LED control and 
sample acquisition 
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Figure 5-3 shows the basic sampling algorithm with the sample intervals sequenced 
with the LED control timing (see also Figure 5-1). A reference sample, taken with both 
LEDs turned off, gives an indication of the ambient light levels and provides a useful 
baseline indicator. 
Filtering and Signal Processing 
The demultiplexed signals have both a dc and ac component - and a degree of noise 
in superposition. These must be separated to produce clean PPG waveforms for HR 
and SpO2 calculation. A resting HR of 60 bpm equates to a frequency of 1Hz and an 
HRmax of 240bpm to 4Hz, thus a form of filter is required with a pass band ranging 
from around 0.5Hz to 4Hz. 
The question of the method of choice is the same as that for signal demultiplexing. 
Digital filtering, using the onboard processor, requires a relatively high performance 
device and may not be sensible or even possible on lower specification micros. At 
higher sample rates, such as the 250 Hz used in the ultimate prototype here, the 
computation required places a high demand on the processor. If this is to be 
performed in real-time, the computational requirements necessary may demand the 
use of dedicated digital signal processing (DSP) chips.  
Analogue (hardware) filters, especially in multipole form, are very efficient at 
attenuating higher frequencies, but not so effective at frequencies approaching dc. The 
preferred option here therefore is to combine the techniques giving the best of both 
without placing undue load on the embedded processor. 
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Figure 5-4: A diagram of the filter and digital signal processing chain 
The basic outline of the filter chain is shown in Figure 5-4. A low-pass (active or 
passive) analogue filter was first employed to remove higher frequencies (e.g. >5Hz) 
before a final stage of digital filtering using an infinite impulse-response (IIR) was 
applied to clean the final signal. The EPMS v4, with an ARM (Cortex-M0) processor and 
dedicated signal conditioning chip, employed a 5Hz IIR low-pass multipole digital filter. 
Heart Rate 
HR may be calculated from either the filtered red or IR waveforms, or both, giving a 
self-checking option. A peak detection algorithm first determines the waveform’s 
peaks, then either counts the number of inter-peak samples, multiplying this by the 
sample period or measuring the inter-peak interval to give an instantaneous measure 
of HR (60 \ peak-to-peak period) in bpm. As the instantaneous reading is unstable due 
to HRV and RSA additional processing is necessary to return a stable indication of HR. 
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There are a number of methods of achieving this. Although the methods and 
algorithms used in commercial devices are not published, being commercially sensitive 
and closely guarded, available details suggest the use of moving averages and in some 
instances, look-up tables of historic data to counter motion artefacts (Moyle, 2002).  
Regarding moving averages, there is a question of the size of the sampling window 
and the effect this has upon the processed data – too short and the result may be 
unduly affected by transients, too long and a time delay is introduced. A median filter 
provides the best of both narrow and wide sample windows without the need for 
sample weighting. This takes a number of samples which are then ordered, the result 
being the middle value in the ordered list. Most transients tend to fall above or below 
the middle value and do not influence results unless reflected in several consecutive 
readings (suggesting they may be real), whereas an average value would be affected. It 
also offers a rapid response as the sample window may be relatively short (Bernholt et 
al., 2006). A 5-sample moving median filter was used initially, however this was 
extended to 9 samples to reduce jitter. 
Blood Oxygen Saturation 
This may be calculated from well-perfused tissue’s relative absorption of red and IR 
light, where oxyhaemoglobin (HbO) has a greater absorption in IR than in red light and 
deoxyhaemoglobin (Hb) a greater absorption in red light than IR. This may be 
expressed in terms of an absorption ratio (R) as shown in Equation 5-1: 
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Equation 5-1: Absorption ratio equation for the calculation of blood oxygen saturation 
𝐴𝑏𝑠𝑜𝑟𝑝𝑡𝑖𝑜𝑛 𝑅𝑎𝑡𝑖𝑜 (𝑅) =
(𝑅𝑒𝑑 𝐴𝐶)/(𝑅𝑒𝑑 𝐷𝐶)
(𝐼𝑅 𝐴𝐶)/(𝐼𝑅 𝐷𝐶)
 
 
Where Red AC and IR AC are the amplitudes of the AC signal components and Red 
DC and IR DC the amplitudes of the DC component in the respective waveforms (Rusch 
et al., 1996; Moyle, 2002). Absorption ratios are referenced to a look up table to 
produce corrected SpO2 values, the data for which was derived from real clinical 
measurements of healthy subjects. Here absorption ratios or SpO2 readings (perhaps 
involving multiple probes) are referenced to SaO2 measurements from a blood gas 
analyser while study volunteers breathe a hypoxic (nitrogen-oxygen) gas mixture. The 
mixture’s ratio is adjusted to provide an SaO2 range of around 70 to 100% in subjects 
under close medical supervision. Regression and Bland Altman plots determine the 
relationship for each probe against the reference and provide calibration data (Smiths 
Medical PM, 2006). 
A plot showing the relationship between the absorption ratio (R) and SaO2 values is 
presented in Figure 5-5; this is based on empirical data (Webster, 1997; Reddy et al., 
2008). The graph shows a calibration curve that is almost linear for saturation levels of 
75% to 100%, but non-linear below this threshold. As the linear portion approximates 
the physiological range of clinical interest a linear approximation may be used. This is 
shown overlaid in Figure 5-5 with Equation 5-2 giving the derived formula: 
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(Reddy et al., 2008) 
Figure 5-5: Empirically-derived and calculated SaO2 for a range of R values, with those of 
normal clinical interest (70% to 100%) highlighted 
 
Equation 5-2: A linear approximation equation for the estimation of blood oxygen 
saturation values for a given absorption ratio, R. 
𝑆𝑝𝑂2 = 110 − 25𝑅  
(Rusch et al., 1996) 
5.2.3 Accelerometer 
A low-power triaxial accelerometer was used on all design variants, an ADXL330 on 
EPMS v1 and an ADXL345 (both from Analog Devices) on subsequent devices. The 
ADXL330 chip has a measurement range of ±3g and a sensitivity of a nominal 330 mV/g 
(being dependent on the supply voltage and thus ratiometric) on each of its three 
analogue voltage outputs, swinging around a centre (zero g) voltage of 1.65V (Analog 
Devices Inc., 2007). The ADXL345 provided a digital interface to an I2C serial bus and 
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offered a programmable 10-bit measurement range of ±2, 4, 8 or 16g. Other features 
included activity/inactivity monitoring and single/double tap detection; the former was 
in EPMS v4 as part of the power management system to awaken the processor from 
sleep mode after a period of inactivity (Analog Devices Inc., 2008).  
5.2.4 Skin Resistance 
The skin resistance sensing circuit consisted of tinned copper or gold contact 
electrodes connected to the basic potential divider and amplifier circuit shown in 
Figure 5-6. This connected to the potential divider formed by resistors Rh, Rl and Rn; 
high values were chosen for Rl and Rn (680kΩ) while Rh (10kΩ) provided a resistance 
path between the negative electrode and ground, offering shock protection from 
external sources. The probes themselves were connected in parallel with Rl, thus the 
resultant was a product of the two resistances. This minimised skin current flow to a 
maximum of 4.8ųA with shorted probes (with a terminal voltage of 47mV). Clamping 
diodes on EPMS v4 offered additional protection to overvoltage conditions.  
 
Figure 5-6: A drawing of the skin resistance sensing circuit from the EPMS (v4) schematic. 
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Equation 5-3: Skin current calculation 
𝐼𝑠𝑘𝑖𝑛 =
𝑉𝑐𝑐
𝑅𝑛 + 𝑅ℎ (
𝑅𝑙 + 𝑅𝑠𝑘𝑖𝑛
𝑅𝑙. 𝑅𝑠𝑘𝑖𝑛
⁄ )
 
 
Where Vcc = 3.3V, Rl and Rn = 680kΩ and Rh = 10kΩ 
 
Equation 5-4: Skin terminal voltage 
𝑉𝑠𝑘𝑖𝑛 =
𝑉𝑐𝑐. (𝑅ℎ + (
𝑅𝑙 + 𝑅𝑠𝑘𝑖𝑛
𝑅𝑙. 𝑅𝑠𝑘𝑖𝑛
⁄ ))
𝑅𝑛 + 𝑅ℎ (
𝑅𝑙 + 𝑅𝑠𝑘𝑖𝑛
𝑅𝑙. 𝑅𝑠𝑘𝑖𝑛
⁄ )
 
The output from the potential divider connected to the non-inverting input of an 
op-amp configured in non-inverting mode. Here the voltage gain (AV) was set by the 
ratio of resistors Ro and Rp (each 39 kΩ). The resulting amplifier output voltage was 
proportional to SR. 
Equation 5-5: SR amplifier voltage gain 
𝐴𝑉 = 1 +
𝑅𝑜
𝑅𝑝
= 1 +
39𝑘𝛺 
39𝑘𝛺
= 2 
SR sensing was tested on EPMS v1 using thin wires glued to the pulse oximeter clip 
which gave mixed results due to poor skin contact and adhesion to the clip. The circuit 
was included on all other variants, but not connected to skin electrodes.  
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5.3 System Designs 
The design details of the four iterations of the evolving EPMS device are described 
here, with both circuit and system operation being reported (with reference to the full 
circuit schematics presented in appendices A to D).  
5.3.1 EPMS v1 
Initial investigations suggested that ZigBee technology (ZigBee Alliance, 2009), with 
its mesh networking capability, would provide an ideal platform for connecting a range 
of physiological and environmental sensors to form a personal network. The design 
used two separate modules communicating over a ZigBee wireless data link, one worn 
on the ear acquiring physiological signals and the other carried by the subject acting as 
a Bluetooth gateway (Figure 5-7). 
 
Figure 5-7: The arrangement of the EPMS v1 wireless communications 
ATBZ-24-A2 Zigbee modules were chosen as a basis for the design. These are 
compact low-power 2.4GHz ZigBee wireless (IEEE 802.15.4) modules with integrated 
antennae incorporating a programmable Atmel ATmega1281V microcontroller and 
associated support circuitry (Atmel Corporation, 2009). The micro’s control and 
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input/output (I/O) pins were accessible via terminals around three of the device’s 
sides; these were used to connect power and peripheral devices to the ear (see 
Appendix A-1) and auxiliary module (Appendix A-3).  
The ear and auxiliary modules comprised two pcbs, one hosting the ZigBee module 
(Appendices A-1 and A-3, Figure 5-10a, b and Figure 5-11a, b) and the other the 
analogue and interface circuitry (Appendices A-2 and A-4, Figure 5-10c, e and Figure 
5-11c, e). The system circuit boards are shown in Figure 5-8, with the ear unit in its 
intended application in Figure 5-9. 
 
Figure 5-8: The EPMS v1 system showing the Auxiliary Unit on the left (with the RN-41 
Bluetooth module nearest) and the Ear Unit, thermometer probe and enclosure to the right 
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Figure 5-9: The ear-worn component of the initial EPMS v1 prototype device 
Ear and auxiliary module digital circuit description 
As many of the usual microcontroller support components (e.g. crystals, power rail 
decoupling etc.) were on-board the module, this helped simplify circuit design. The SPI 
serial bus was used as a high-speed interface to an FM25H20ds 2Mbit flash memory 
chip61 for local data storage and the I2C bus to connect a DS1337 real time clock62 and 
the MLX90615 IR pyrometer. The serial busses and I/O pins were connected to sockets 
S1 to S5 and S7 to S12 respectively, to provide breakout for the accompanying 
interface board. The JTAG (Joint Test Action Group) programming port was brought 
out to another socket (JT1) to facilitate programming and in-system debugging. A 
status LED was added (GPIO8), together with decoupling capacitors and pull-up 
resistors to the I2C bus and reset pin. The pcb layout used surface mount components 
on both sides of the board which had a cutaway beneath the ZigBee antenna to 
minimise wireless signal attenuation. 
                                                 
61 Cypress Semiconductor Corporation, San Jose, CA, USA 
62 Maxim Integrated, San Jose, CA, USA 
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Figure 5-10: EPMS v1 CAD of the pcbs’ top layer showing the (a) ear unit processor, (b) 
auxiliary processor, (c) ear unit interface, (d) adapter/charger and (e) auxiliary interface 
 
Figure 5-11: EPMS v1 CAD of the pcbs’ bottom layer showing the (a) ear unit processor, (b) 
auxiliary processor, (c) ear unit interface, (d) adapter/charger and (e) auxiliary interface 
(a) (b) 
(c) 
(d) 
(e) 
(a) (b) 
(c) 
(d) 
(e) 
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Ear module interface circuit description 
The interface (Appendix A-2) contained the power supply and signal conditioning for 
the pulse oximeter and SR sensor. The board was provided with mating headers (P1 to 
P5) connecting to the I/O pins from the ATBZ-24-A2 Zigbee module on the digital 
board.  
The pulse oximeter LED drive was provided by a pair of PBSS2515YPN NPN/PNP dual 
transistors63 in an H-bridge arrangement, the maximum current being set by resistors 
(10 - 20Ω) on the NPN emitters. The bases of the NPN transistors were connected to 
the outputs of an MCP4822 dual-channel SPI 12-bit DAC64, providing independent 
control of LED light intensity. The PNP bases were connected via header P4 to pulse 
outputs on GPIO3 and GPIO4 on the ZigBee module for LED switching. 
The pulse oximeter probes photodiode output was connected to one half of a dual 
op-amp (U7a) configured as a transimpedance amplifier, thus converting the output 
current to a voltage. The output (DACoff) was fed via header P6 to an ADC input (ADC 
in1) to give a reading of the DC offset voltage, and to the other half of the op-amp 
(U7b) where the signal was filtered and amplified with the output passing to the ADC 
(ADC in2). The composite signal was demultiplexed in software to give separate signals 
for the red and IR LEDs from which HR and SpO2 were derived. 
The unit was powered from a small lithium polymer (LiPo) 3.7V battery which fed a 
TPS73233 low dropout voltage regulator65, giving a 3.3V output to power the system. 
                                                 
63 NXP Semiconductors Netherlands N.V., Eindhoven, The Netherlands 
64 Microchip Technology Inc., Chandler, AZ, USA 
65 Texas Instruments, Dallas, TX, USA 
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The regulator itself was controlled by a simple logic circuit combining a push-button 
switch and two GPIO lines (Power_Hold and Power_Cntl) with a 74AHC1G00 two-input 
NAND gate66. Both NAND inputs were normally held high by pull-up resistors (to the 
battery voltage) holding the output low and disabling the regulator output; either 
input going low sent the output high and turned power on. The push button and 
Power_Cntl, an input to the microcontroller, shared one input while Power_Hold, an 
output, occupied the other. Pressing and holding the switch caused the output logic to 
change state, turning on the regulator and powering the rest of the circuitry. With the 
power on the processor booted up, read the Power_Cntl pin and pulled Power_Hold 
low, holding power on, irrespective of the state of the other NAND input. Pressing and 
holding the switch with power on initiated a safe shutdown. 
A simple battery monitor was added by feeding the output of a potential divider 
connected between the battery’s positive terminal and ground into an ADC input  
(ADC in0). This gave a half-scale output such that a fully charged battery 
(approximately 4.2V) would read 2.1V and around 1.8V when discharged. This enabled 
the unit to be automatically turned off should the battery voltage reach levels  
(i.e. <3.0V) where it would suffer damage or degradation of performance. 
In addition to JTAG for debugging, the TTL-level TxD (transmit data) and RxD 
(receive data) of the ATBZ-24-A2’s UART (Universal Asynchronous Receiver 
Transmitter) were taken to a mini-USB socket. This was connected to the Programming 
                                                 
66 NXP Semiconductors, Nijmegen, Netherlands N.V. 
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Adapter/Charger board (Appendix A-5), featuring an on-board serial to USB converter 
and USB-powered LiPo charger. 
Auxiliary module interface circuit description 
This (Appendix A-4) shared features such as the system power supply and control 
logic and battery monitor with the ear module interface, but included a number of 
additional circuit blocks which are described next: 
An ADXL330 tri-axial accelerometer’s voltage outputs connected through header 
P12 to the ATBZ-24-A2’s ADC inputs (ADC in1 to 3) for activity or gravimetric 
orientation monitoring. 
The TxD and RxD lines from the microcontroller’s UART were taken to a 6-pin 
header for jumper selectable wired (via a serial to USB converter and mini-USB socket) 
or wireless Bluetooth communication. The FT232BL integrated serial to USB 
transceiver chip67 converted the (3.3V) TTL-level serial data to USB 1.1 and 2.0 
compliant standards, facilitating communication with a host PC for test and 
development. Alternatively, the RN-41 Bluetooth module68 converted the serial data to 
a Bluetooth v2.1 compliant radio signal for wireless communication. As this was 
relatively power hungry the module was powered by its own switchable TPS73233 
voltage regulator and enabled under software control. 
A charger circuit for the unit’s LiPo battery was also included. This was based 
around a MAX1555 single-cell charger chip69 which managed battery charging 
                                                 
67 Future Technology Devices International Limited, Glasgow, UK 
68 Roving Networks, Los Gatos, CA, USA 
69 Maxim Integrated, San Jose, CA, USA 
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according to discharge level, limiting charge current to 100mA. The circuit was 
powered from by the +5V USB supply when connected. 
Adapter/charger circuit description 
This combined the serial to USB converter and LiPo battery charger circuit blocks 
with a USB type-A connector producing an external USB communications adapter 
(using another FT232BL chip) and battery charger (MAX1555) for the ear module 
(Appendix A-5). This may be seen in the board layouts in Figure 5-10d and Figure 5-11d 
and the photograph in Figure 5-12. The adapter plugged directly into a PC USB port 
with a mini-USB lead hard-wired to four contacts on the pcb. The USB data link saw 
limited use during system testing. However, with the USB cable replaced by a battery 
connector, the adapter was used as a convenient means of charging numerous small 
LiPo cells over the course of the project. 
 
Figure 5-12: The USB adapter/LiPo charger, shown here with a wired battery charger lead 
Enclosure Fabrication 
This was essentially an afterthought to facilitate handling, testing and system 
demonstration, the boards being designed for evaluation of the electronic systems 
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without regard for packaging. As no suitable off-the-shelf enclosures were available, 
these were fabricated by hand from sheet polystyrene (see section 3.2.5, page 125 for 
details) to produce cases for the ear (48 mm x 34 mm x 23 mm, plus the ear hook and 
pulse oximeter clip) and auxiliary modules (53 mm x 48 mm x 24 mm). 
5.3.2 EPMS v2 
It became apparent that despite increasing interest and use of ZigBee, its 
application in portable medical monitoring devices would be compromised by poor 
market penetration and low uptake by mobile device (smartphone and tablet) 
manufacturers - notwithstanding the mesh network capability had many advantages. 
Bluetooth technology meanwhile was becoming a standard feature. It was thus 
decided to dispense with ZigBee and redesign the EPMS circuitry for a Bluetooth-
enabled single-box solution incorporating a number of improvements over EPMS v1.  
Circuit schematics may be found in Appendices B-1 to B-4 while a 3D CAD 
representation of the pcbs (Figure 5-13) and photographs showing the system’s 
general arrangement (Figure 5-14) and the system in its casing (Figure 5-18) follow: 
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Figure 5-13: 3D CAD representation of the EPMS v2 digital (left) and interface boards 
(right) 
 
Figure 5-14: The EPMSv2 digital (left) and interface boards (right) that form the top and 
bottom of a two-board stack (shown separated), with the Bluetooth board below. 
EPMS v2 digital board description 
A dedicated ATmega1284P microcontroller70 was chosen for the design (Appendix 
B-1), offering superior performance to the Atmel-powered ZigBee module due to lack 
                                                 
70 Atmel Corporation, San Jose, CA, USA 
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of software overhead reserved for wireless control. As this was from the same 
processor family this offered continuity for the embedded code.  
The microcontroller’s I2C bus accommodated both the MLX90615 temperature 
sensor and an ADXL345 tri-axial accelerometer, from which an alarm output was 
connected a microcontroller I/O pin. As with the EPMS v1 the SPI bus was connected 
to an FM25H20ds 2Mbit flash memory chip and MCP4822 dual-channel 12-bit DAC, 
and also, together with Reset, to a 6-pin ISP (In-System Programming) header, which 
facilitated device programming and served as a debugging aid.  
Additional features included a 32.768 kHz crystal which was connected to the 
micro’s PC6 and PC7 terminals as a reference for the micro’s on-board real time clock 
and for power saving low frequency operation in standby. Two 10-pin headers, J1 and 
J2, connected power and I/O to the mating interface board. Two pairs of serial I/O lines 
from the micro’s UART provided serial communication links to the outside world - 
RxD0/TxD0 connecting to a mini USB socket for connection to the adapter/charger 
board and RxD1/TxD1 (via wires to the Jio solder pads) to the Bluetooth board. 
With this design the pulse oximeter’s LED drive circuitry (Appendix B-2) was 
relocated to the digital board (Figure 5-15 and Figure 5-16), largely to provide more 
space for components and track routing on the interface board. It employed the same 
H-bridge transistors as EPMS v1, but with an op-amp buffer (U4a and b) on each DAC 
output and a 2N3904 NPN transistor buffering the two TTL pulse outputs for improved 
drive characteristics. 
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Figure 5-15: CAD layout of the top of the EPMS v2 digital (left) and analogue board (right). 
 
Figure 5-16: CAD layout of the bottom of the EPMS v2 digital (right) and analogue board 
(left) shown mirrored. 
EPMS v2 interface board description 
The design of the interface board (Appendices B-2 and B-3) built on the experience 
gained with EPMS v1 and included the pulse oximeter signal conditioning, power 
supply and the SR sensing circuits used previously. 
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Pulse oximeter signal conditioning differed substantially from that in EPMS v1 in 
that it used hardware demultiplexing to split the composite signal into its separate 
components. One of the amplifiers in a quad op-amp package (U10a) formed a 
transimpedance amplifier, converting the photodiode current to a voltage; this was 
then buffered by another op-amp stage from the same quad package (U10d). The 
output then split into two, connecting to a pair of 74LVC1G66 single-pole analogue 
switches71 configured as sample and hold circuits (U9 and U12). These were 
synchronously and alternately switched (i.e. the respective enable pins cycled) by the 
microcontroller in lockstep with the pulse oximeter LEDs to produce independent red 
and IR signals, which were fed to separate buffer amps (U10b and U10c). These 
outputs were AC coupled and a fixed offset, Vref, (derived from the voltage divider 
network on op-amp U8b) introduced (+1.65V) before the signals passed to a final gain 
stage (op-amps U8a and U8d) and the ATmega1284P’s 10-bit ADC for digitisation. 
EPMS v2 Bluetooth board description 
This comprised of the RN-42 Bluetooth module and a few basic components 
(Appendix B-4 and Figure 5-17), which were all assembled on the same side of the pcb. 
A pull-up resistor on the RN-41’s PIO7 pin set the baud rate at 9600 while PIO5 
connected a status LED via a series resistor. Connections to the digital board for power, 
RxD1, TxD1 and Reset were made using a short length of 1.27mm pitch ribbon cable. 
                                                 
71 NXP Semiconductors, Nijmegen, Netherlands N.V. 
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Figure 5-17: CAD layout of the EPMS v2 Bluetooth board (bottom shown mirrored on the 
right) 
Enclosure Design 
This was based upon a conceptual design study by Cranfield MDes students for a 
3D-printable casing for an ear-worn monitoring device incorporating an in-ear 
temperature sensing probe (Umeh et al., 2011). The 3D-CAD of the original version had 
a number of issues, not the least of which was holes in the 3D mesh and inadequate 
wall thickness, rendering it was unprintable. These problems were corrected and the 
design modified by an experienced 3D-CAD operator, David Sziroczak, a fellow doctoral 
student, to better accommodate the system’s pcbs and battery. With a diameter of 50 
mm and thickness of 20 mm (less the ear probe) the printed case proved to be a tight 
fit for the boards and wiring (Figure 5-18).  
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Figure 5-18: The EPMS v2 with its 3D-printed enclosure 
5.3.3 EPMS v3 
Building on EPMS v2, this introduced new ideas and components in a two-board 
solution and was intended primarily as a technology demonstrator. However, over the 
course of the debugging phase it was decided that an enclosure was required. This was 
quickly developed using 3D printing to rapidly produce a prototype enclosure to 
facilitate system demonstration. 
A key element of the design was the adoption of the Bluetooth Low Energy (BLE) 
(also known as Bluetooth v4 or Bluetooth Smart) in place of Bluetooth v2.1 for wireless 
communication. This offered significant savings in power (see Table 5-2) and board 
space over the older RN-42. A Bluegiga BLE112 Module72 was chosen as it was one of 
the most compact devices available at the time of purchase (late 2012).  
                                                 
72
 Bluegiga Technologies Oy, Espoo, Finland 
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The circuit schematics may be found in Appendices C-1 to C-4. A 3D CAD 
representation of the main boards (Figure 5-19) and a photograph showing the 
system’s circuit boards and enclosure (Figure 5-22) follow: 
 
Figure 5-19: 3D CAD representation of the top sides of the EPMS v3 Processor / BLE (left) 
and analogue interface boards (right) 
EPMS v3 digital board description 
This was broadly similar to the EPMS v2 design, the key difference being the 
Bluegiga BLE-112 module in place of the Roving Networks RN-42 for Bluetooth v4 
compliant wireless communication. The cut-out beneath the BLE-112’s antenna and 
ground-linked via holes around the board edge (see pcb layouts in Figure 5-20 and 
Figure 5-21) follow the pcb layout guidelines in the manufacturer’s datasheet (Bluegiga 
Technologies Oy, 2011). 
The ATmega1284P microcontroller’s I2C bus connected to the IR pyrometer and 
ADXL345 triaxial accelerometer, from which an alarm output was connected to a 
microcontroller I/O pin. The SPI bus connected to a flash memory chip and dual 12-bit 
DAC, and also, together with Reset once more, to a 6-pin ISP header (ISP) for device 
programming and debugging.  
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Two 10-pin headers, J1 and J2, connected power and I/O to the mating interface 
board. The two UART channels provided serial I/O for communication links. Here, 
RxD0/TxD0 were tracked to pads on the PCB (labelled A and B respectively) to which 
the USB adapter/charger board (described previously) could be connected. RxD1, 
TxD1, CTS1 and RTS1 were linked to the BLE-112 module (Appendix C-4), the additional 
lines providing hardware “handshaking” to improve data throughput. 
 
Figure 5-20: CAD layout of the top of the EPMS v3 digital (left) and analogue interface 
boards (right). 
 
Figure 5-21: CAD layout of the bottom of the EPMS v3 digital (left) and analogue interface 
boards (right) shown mirrored. 
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EPMS v3 interface board description 
Much of the circuitry will be familiar from the EPMS v2 design, although there were 
some significant detailed differences with the power supply in particular. 
The pulse oximeter’s LED drive circuitry (Appendix C-2) was moved to the interface 
board, but was otherwise the same as that used in EPMS v2. Signal conditioning 
followed that in the previous design, the only specific differences being the capacitors 
in the filter network before the final gain stage (Cl, Cm, Cu and Cv) which were of a 
polyphenylene sulphide (PPS) rather than multilayer ceramic (MLCC) construction for 
improved signal filtering. 
Instead of a single voltage regulator for the system, the design employed multiple 
devices independently enabled under software control (Appendices C-3 and C-4) as 
part of a power management system. The microcontroller drew its power (Vcc on the 
schematic) from a ZMR330FTA +3.3V linear voltage regulator73 which was always “on”, 
the microcontroller entering a sleep mode when the system was inactive, running from 
the 32 kHz crystal clock. Three TPS73233 regulators provided power for the digital 
(Vdd), analogue (+3V3) and BLE module (Vdd Blue) and were enabled by the 
microcontroller as required. 
Another addition to the board was the potential for wireless battery charging, the 
technology relying on inductive coupling for power transfer between a compatible 
target (receiver) and host (transmitter). This was based around the bq51050B single-
chip Qi-compliant wireless power charger (WPC) receiver (Texas Instruments) which 
only required a few additional passive components and a special charging coil 
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optimised for the application74. The design was based upon specified criteria and 
application notes in the product datasheet (Texas Instruments Inc., 2012a) and 
evaluation module documentation (Texas Instruments Inc., 2012b). As low capacity 
batteries were being used (110 to 165 mA/h) the maximum charge current was set to 
100 mA to keep the charge rate below the 1C threshold. A provision for battery 
temperature monitoring was afforded by the inclusion of a thermistor to be mounted 
next to the battery. 
Enclosure Design 
As originally conceived, the circuit boards were intended as a proof of concept 
design to evaluate the BLE-112 and wireless charging on the test bench. Apart from 
this and an effort to generally minimise board space, the size and shape of the boards 
had not been considered important. It was however subsequently decided that 
encasing the boards would allow more realistic evaluation of the core sensing 
technology whilst communicating over a BLE wireless data link.  
The key criteria determining the enclosures internal dimensions were the pcbs (48 
mm x 25 mm x 13 mm overall when stacked), battery (30 mm x 18 mm x 4 mm), 
wireless charging coil (38 mm x 38 mm x 2 mm), plus accommodation for the bulky 
pulse oximeter ear probe cable and other wiring. A series of design sketches were 
made to ascertain the maximal internal dimensions of the casing (approximately 52 
mm x 39 mm x 14 mm) which were passed to an experienced 3D CAD designer (David 
Sziroczak) to produce the design drawings. The resulting design was larger than 
                                                 
74 Wurth Elektronik, Niedernhall, Germany 
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anticipated so the charging coil was omitted in an effort to slim down the design, the 
battery being charged externally with the USB adapter/charger.  
The final enclosure design consisted of a 3D-printed box and lid with internal mating 
flanges (see Figure 5-22), the lid having an integral ear probe for the temperature 
sensor as per the EPMS v2 and pulse oximeter cable entering through a small hole in 
the base. A box-mounted pivoting hook fabricated from 1/8” copper tubing covered in 
heat-shrink tubing was used to hold the unit in place on a subject’s ear. This proved 
adequate for the task.  
 
Figure 5-22: The EPMS v3 circuit boards and enclosure with ear hook. 
5.3.4 EPMS v4 
This was a departure from earlier variants being based around early examples of 
newly announced devices (mid 2013), namely the MBH7BLZ02 BLE wireless module75 
and AFE4490 single-chip integrated Analogue Front-End (AFE) for pulse oximeters76. 
                                                 
75 Fujitsu Component Ltd., Tokyo, Japan 
76 Texas Instruments, Dallas, Texas, USA 
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These components allowed the bulk of the design to be fitted onto a single double-
sided circuit board measuring 30 x 30 mm and promised a reduced power budget. A 
second single-sided board provided an onboard battery charging capability, with USB 
and wireless charging options being designed.  
The circuit schematics may be found in Appendices D-1 and D-2, while a 3D CAD 
representation of the main boards (Figure 5-23) and a photograph showing the 
system’s circuit boards and enclosure (Figure 5-24) follow: 
 
Figure 5-23: 3D CAD representation of the top of the EPMS v4 core circuitry (left) and 
battery charging boards (right) with the USB LiPo battery charger uppermost. 
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Figure 5-24: EPMS v4 prototype showing (a) the lid with ear probe, (b) the enclosure base, 
battery and charger board, and (c) main board showing the BLE module on the left and 
central AFE4490 pulse oximeter chip 
EPMS v4 board description 
The MBH7BLZ02 BLE wireless module, at 15.7 x 9.8 x 2.0 mm, is the smallest of all 
those used over the course of this project. It is based around an nRF51822 chip77, 
which incorporates a 32-bit ARM Cortex-M0 processor with onboard RAM (16kB), flash 
(256 kB), flexible I/O and BLE wireless, the module adding an integrated antenna and 
ancillary support components. As this provided superior computational power to the 
Atmel ATmega1284P microcontroller, the MBH7BLZ02 assumed the dual roles of 
processor and wireless data link. The module was positioned along a board edge with 
the antenna overhanging as suggested in the manufacturers’ design guidelines (Fujitsu 
Component Limited, 2014). This may be seen in Figure 5-23 through to Figure 5-26. 
                                                 
77 Nordic Semiconductor ASA, Oslo, Norway 
(a) (b) (c) 
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Figure 5-25: CAD layout of the top of the EPMS v4 core circuit (left), USB charger (top right) 
and wireless charger boards (bottom right) 
 
Figure 5-26: CAD layout of the bottom of the EPMS v4 core circuit (right), USB charger (top 
left) and wireless charger boards (bottom left) 
As the MBH7BLZ02’s I/O pins were software configurable, these were first 
designated for general I/O or serial bus connectivity. As before the IR pyrometer and 
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ADXL345 triaxial accelerometer were connected via I2C (GPIO28 and 29) while the 
higher speed SPI bus (GPIO17 – 19) connected the flash memory and the AFE4490 
pulse oximeter chip. TTL-level serial I/O was provided (GPIO9 and 11) as a debugging 
aid, the data lines being tracked to pads on the pcb. A dedicated Serial Wire Debug 
(SWD) port (PL1 header), a feature of ARM Cortex processors, was used for in system 
programming and debugging.  
The AFE4490 incorporates all the features required for pulse oximetry sensing, 
combining on-chip LED drivers, programmable signal conditioning, a 22-bit ADC and 
software configurable registers in an integrated “front-end” for connection to a host 
microsystem. This saved two quad and one dual op-amp, three sample and hold 
circuits, a dual-channel DAC, H-bridge transistors and numerous passive components 
when compared with the EPMS v3 design - only a handful of capacitors being required 
for filtering and decoupling purposes. In addition to the SPI bus, connections were 
made to system Reset, three control lines (AFE_Enb, AFE_Rdy and AFE_Diag) and two 
alarm outputs (PD_Alm and LED_Alm). An external 8 Mhz crystal ensured synchronous 
operation. 
The power supply was arranged similarly to that in the EPMS v3 design. Three 
TPS73233 were used, one (U5) was permanently enabled and powered the 
MBH7BLZ02 and accelerometer (Vcc), with the others enabled under digital control. 
One of these (U6) powered the digital circuitry (Vdd) and the other (U7) the analogue 
circuitry and the oximeter LED drive of the AFE4490 (+3V3). The power management 
was arranged such that the system would power off the Vdd and +3V3 supplies after a 
period of inactivity and enter sleep mode (consuming approximately 50 µA), from 
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which it could be awoken via accelerometer motion sensing by a signal on the 
MBH7BLZ02’s GPIO5 interrupt pin. 
On-board Battery Charger 
The design included options for on-board wireless (bq51050B chip) or USB charging 
(MAX1555). These were produced on separate pcbs with identical footprints and fixing 
centres, the USB charger acting as insurance in case of problems with the wireless 
option. The wireless charger design was almost identical to that used in EPMS v3, 
having only minor detail differences. The USB charger was essentially the same as that 
employed in the charging adapter (see section 5.3.1, page 179), but included a micro 
USB socket to connect to an external USB power source. 
Enclosure Design 
The main electronic systems were laid out on a single pcb with minimal dimensions, 
offering more flexibility in the enclosure design. The internal dimensions of the casing 
had to be at least 38.5 mm for the wireless charging coil, being ample for the systems 
board (29 mm x 29 mm x 7 mm, with the BLE antenna extending 6 mm from one face), 
battery charger board (35 mm x 16 mm x 6 mm – the latter being the height of the USB 
version) and battery (approximately 30 mm x 17 mm x 4 mm). Thus the case was 
designed around the charging coil with a solid area at the top and bottom for fixing 
screws resulting in the design shown in Figure 5-24. The casing’s lid accommodated the 
in-ear temperature probe which was engineered with multiple parts facilitating the 
optimisation of the sensor’s position and incorporated a ‘snap on’ mounting point for 
attaching off the shelf ear hooks for Bluetooth earpieces. The probe itself was 
modelled on that used in the v2 device, being around a millimetre longer and having a 
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reduced diameter (0.5 mm) over its length. The pulse oximeter cable entered the case 
via a small hole in the base of the case’s bottom section, passing close to one of the 
fastening screws. 
The final design measured 50 mm x 41 mm x 18 mm, less the ear probe, being the 
most compact of the four design studies. As with EPMS v2 and v3, the CAD was 
prepared by David Sziroczak and 3D-printed using the University’s facilities.  
5.4 Results 
This section reports the results of initial system testing and examines both sensor 
and system-level operation, comparing the relative performance of the four EPMS 
designs. 
5.4.1 Temperature 
The EPMS v1 typically reported temperatures of around 31°C, up to 6.5°C below 
normal core body temperature when tested on a healthy individual. Mounted on a 
short length of cable and by no means uncomfortable, this proved difficult to fit with 
any consistency and had a tendency of quickly becoming dislodged after a few minutes 
use. The v2 design employed a conical ear probe in which the sensor’s lens was located 
in the tip, the aperture giving an unobstructed field of view. This proved to be a more 
reliable fit than the v1 model and could be worn for up to 30 minutes without 
becoming dislodged or causing discomfort. Typical readings however were in the range 
of 32°C to 34.5°C. Readings from the EPMS v3 device were no better than its 
predecessor (32.5°C to 34.5°C) and although the probe was a snug fit, it was not 
comfortable.  
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The final design (v4) showed a marked improvement in performance in showing test 
readings ranging from 34.5°C to 36.5°C, much closer to those of normal core body 
temperature. The fit of the probe (see Figure 5-27), being slightly slimmer than the 
preceding versions, was good although it display a propensity to disengage from the 
ear canal after some minutes of continuous use. 
 
Figure 5-27: A photograph showing the lens of the IR thermometer mounted in the 
aperture of the EPMS v4 sensor probe 
There was a notable increase in recorded temperatures with each evolution of the 
EPMS design, with v4 approaching nominal body temperature. The reason for the 
discrepancies was unclear; test readings of skin temperatures, though understandably 
lower than the body norm, appeared more consistent and comparable than those 
from the ear. Although the EPMS had only been trialled by the author at this stage, this 
suggested that the probe design may be responsible for the measurement errors. 
5.4.2 Pulse Oximeter 
The first design demonstrated that it was possible to acquire HR readings from the 
PPG signals, though not reliably. Processor performance proved insufficient for the 
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effective real-time control of data acquisition and signal processing tasks required in 
obtaining robust and stable signal waveforms, making SpO2 measurement impossible. 
The EPMS v2 and v3 pulse oximeter circuits were essentially the same in both 
execution and performance. The combination of a higher performance 
microcontroller, buffered H-bridge control and a redesigned signal chain with sample 
and hold (S&H) circuits providing a more robust PPG signal. The addition of S&H 
circuits helped in reducing processor load, which in turn allowed the application of 
more sophisticated digital signal processing techniques for improved signal integrity. 
This made for better peak detection for the determination of beat-to-beat periods for 
HR calculation. Although much improved compared to EPMS v1 the variations in DC 
offset of the red and IR waveforms meant that realistic SpO2 calculations were not 
viable.  
The introduction of the AFE4490 chip and ARM processor in the final EPMS v4 
design gave superior results to those achieved with the previous designs. Figure 5-28 
shows exemplar raw (unfiltered) red and IR waveforms, displaying the degree and 
nature of the superimposed noise. The post-filtered waveforms are presented in 
Figure 5-29 and demonstrate the effectiveness of the filtering techniques in presenting 
clean pulsatile signals, the IR response being characteristically larger than that red 
waveform. This facilitated peak detection and extraction of the beat-to-beat periods 
from the IR response used in HR calculation. 
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Figure 5-28: Raw SpO2 red and IR signal waveforms with a close up of a single peak inset. 
 
Figure 5-29: SpO2 red and IR signal waveforms post filtering showing wide DC separation. 
Although the filtering of the AC component of the PPG signals was successful 
significant DC drift was routinely observed, an example of which is presented in Figure 
5-30. The main causes of this were found to be motion artefact and changes in 
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ambient light levels, the latter being a particular problem with ear probes which do not 
incorporate a light shield, unlike finger probes. In addition to the relatively slow drift, 
rapid changes in the DC response were also frequently observed (see Figure 5-31). 
While the 22-bit ADC values of the AC component ranged from 2000 to 12000 that of 
the DC drift could range from 10,000 to 200,000 (over time). With EPMS v1-3 poor 
signal stability in the DC response prevented any meaningful calculation of SpO2 
values. Although this was much improved in EPMS v4, extraction of robust SpO2 data 
proved extremely challenging with R values from 0.97 to 1.02 being returned from 
differential absorption (Equation 5-1) during bench tests. R values of 0.6 to 0.4 would 
typically be expected for SpO2 readings of 95% to 100%; those recorded equated to 
SpO2 levels of around 85%. At this time it was unclear whether this was due to 
systematic errors or incorrect calibration. 
 
Figure 5-30: Filtered PPG signals showing DC drift over a 40 second period (EPMS v4), the 
drift being of greater magnitude than the AC response. 
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Figure 5-31: Rate of change of DC drift observed in the PPG signals (EPMS v4), the two 
signals are almost superimposed. 
5.4.3 Accelerometer 
On all variants the static gravimetric readings proved reliable in all axes; this was 
confirmed using a flat surface (confirmed in two planes with a spirit level) and 
engineers square. With the first three variants the outputs were combined (taking the 
square root of the sum of the squares) to give a measure of relative activity. In 
addition to this function the EPMS v4 successfully employed the accelerometer’s 
threshold-triggered alarm output to wake the system from a low-power sleep mode 
(initiated after 30 seconds of inactivity). 
5.4.4 EPMS System Level Performance 
This section considers the system level performance of the four EPMS designs and 
examines power consumption, battery charging and wireless communications 
performance. 
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Power Consumption 
In all cases, the wireless system and pulse oximeter were responsible for drawing 
the majority of circuit current in the EPMS systems. That used by the remaining 
circuitry (where low power operation was a key design criterion) differed between 
designs, but nevertheless may be considered as relatively insignificant. The power 
budget for the pulse oximeter circuitry, though essentially similar in the first three 
versions and using a dedicated chip in EPMS v4, was dependent upon the LED drive 
current, pulse frequency and duty cycle and therefore nominally the same for a given 
level of tissue illumination. Therefore, it can be seen that system power consumption 
is directly related to the properties of the respective wireless devices.  
As EPMSv1 and v2 use Bluetooth v2 modules, one may anticipate that these would 
be expected to be less energy efficient than the BLE examples used in the EPMSv3 and 
v4 designs. This is borne out in the module manufacturers’ published current 
consumption data which was used to calculate the power consumption figures (while 
operating with a +3.3V supply) shown in Table 5-2.  
EPMS Module 
Standby/Sleep 
(mW) 
Connected 
(mW) 
Receive 
(mW) 
Transmit 
(mW) 
v1 RN-41 0.825 - 8.25 26.4 – 99.0 116 – 198 99 - 330 
v2 RN-42 0.086 39.6 – 82.5 132 - 165 132 - 165 
v3 BLE-112 0.71 – 2.97 - 83 92 - 119 
v4 MBH7BLZ02 0.017 - 54 - 79 29 - 76 
Table 5-2: Manufacturer’s quoted power consumption for the Bluetooth modules used in 
this project when running from a +3.3V power supply. 
The operating power for the EPMS devices operating from a +3.7V bench power 
supply (simulating a LiPo battery) are given in Table 5-3 . This shows power 
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consumption in sleep mode, whilst in standby and whilst attempting to pair with 
Bluetooth devices and whilst operational, using the pulse oximeter and broadcasting 
Bluetooth data.  
The figures for EPMS v1 reflect the simultaneous use of ZigBee and Bluetooth radios 
and combine the readings of the two system components. As a proof of concept 
demonstrator little effort was made to establish sleep mode operation (as indeed was 
the case with EPMS v2 and v3). The power figures are therefore understandably high. 
The EPMS v2 benefits from ZigBee omission and an improved Bluetooth v2 module 
(RN-42) to show substantial power savings, but is still considerably down on the BLE-
equipped EPMS v3 and v4 units. The main difference between these devices is the 
level of power efficiency offered by the more recent MBH7BLZ02 BLE module. 
EPMS 
Sleep Mode 
(mW) 
Standby/Pairing  
(mW) 
Operating Mode 
(mW) 
v1 - 218 275 
v2 - 89 155 
v3 - 33 70 
v4 < 1 11 52 
Table 5-3 : Typical EPMS power consumption when powered from +3.7V bench power 
supply. 
Battery Charging 
A dedicated USB-powered LiPo battery charger (see section 5.3.1, page 179) was 
designed to externally charge system batteries. These were connected to a mating 
polarised connector (as wired to the pcbs) attached via a length of cable to the USB 
charger. This successfully charged a range of different LiPo batteries, with capacities 
from 30 to 360 mA/h, the charge rate and time being capacity and charge status 
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dependent. The unit was used throughout the development program and specifically 
with EPMS v1 to v3. 
EPMS v3 included a prototype design for a wireless battery charger using Texas 
Instrument’s bq51050B chip. Difficulties in the assembly of the device prevented 
testing which was abandoned in favour of progressing the design and development of 
EPMS v4. This included options for on-board wireless or USB charging - a prudent 
decision as it transpired. During the design phase the wireless charging circuit was 
reviewed and minor modifications made. It then became apparent that many of the 
key details listed in the manufacturer’s reference designs (Texas Instruments Inc., 
2012a; Texas Instruments Inc., 2012b) were in direct contradiction. Although sample 
boards were assembled, seemingly successfully this time, testing was postponed in 
light of the aforementioned findings to focus on other aspects of the project. Thus the 
USB charger was used with the intent of revisiting the wireless charger as time 
permitted. 
Wireless Systems 
Aside from differences in their respective power budgets, the pairing or connection 
times and ranges of the wireless systems must be considered. The time for a host (e.g. 
a smartphone or tablet) to connect to an active EPMS device was found to shorter with 
the BLE-equipped EPMS v3 and v4 (typically 1 – 2 seconds), though no connectivity 
problems were experienced with either wireless system. The operating range of the 
Bluetooth systems exceeded 10m whereas BLE was limited to around 10m, both more 
than adequate for the intended application. Initial ranging problems experienced with 
the initial EPMS v4 prototype (limited to 2m) were found to be due to the loss of two 
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small passive components necessary for tuning the BLE module’s integral antenna. It 
became clear that this had occurred during pcb assembly and rework and thus 
additional care was taken when assembling other boards. 
5.5 Discussion 
From an initial proof of concept demonstrator, the iterative design of the EPMS 
culminated in the fourth and final version of the device, an evolution which offered a 
marked improvement in performance together with a reduction in size. This was made 
possible by a combination of the availability of newer highly-integrated chips and the 
experience gained in designing, building and testing successive devices. 
5.5.1 EPMS Devices 
The initial EPMS v1 acted as an initial demonstrator to prove the concept of a multi-
sensor ear-worn monitoring device. It was clear from the outset that a two-box 
solution was not ideal and thus would require extensive optimisation. The decision to 
use ZigBee was based upon the requirement for a compact ear-worn unit powered by 
a single small LiPo battery, ZigBee offering low power operation (compared to 
Bluetooth) and the provision for the development of local wireless mesh networks for 
further physiological sensors. Although this initially appeared to be a good solution, 
the ear unit needed to connect to a host mobile device to manage the acquisition and 
display of sensor readings; this posed a problem as there were no ZigBee-equipped 
mobile devices on the market. This necessitated the use of a second body-worn unit 
acting as a ZigBee hub that also included Bluetooth to communicate with a host mobile 
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device. Here, case size was less of an issue allowing the use of a larger battery to 
power the two wireless systems. 
Sensor performance was not as good as had been hoped, but established the 
feasibility of the application. The potential of the ear temperature sensor was clear 
despite the poor probe design. Pulse oximeter performance was impeded by that of 
the processor, which was lacking the computational power required to both control 
signal acquisition and perform digital signal processing on real-time signals. The degree 
of variability in the PPG waveforms prevented SpO2 calculation, though verifiable HR 
readings were achieved - albeit without any degree of consistency. 
Lessons learned with the design of EPMS v1 strongly influenced the design of the 
next development, EPMS v2. This eliminated ZigBee and was based around a standard 
Atmel ATmega microcontroller offering improved performance. The use of a new 
lower-power Bluetooth module (RN-42) allowed the design to fit onto two stacked 
pcbs and a Bluetooth daughter board with relatively small footprints. The design also 
introduced 3D printing to produce the case which featured an integral ear probe to 
house the ear temperature sensor. 
EPMS v2 performance was superior to its predecessor at sensor and system level. 
Temperature readings were closer to the 37°C norm, but still around four degrees 
short. HR readings were encouragingly more consistent and seemingly accurate 
(compared to a reference pulse oximeter) although once again the SpO2 readings were 
not obtainable, the excessive variability in DC levels making reliable calculations 
impossible. The unit did however deliver substantial power savings allowing extended 
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operation. The case design, with its integral ear probe, was more compact, 
comfortable to wear and aesthetically pleasing than the hand-crafted system 
enclosures fabricated for EPMS v1. 
EPMS v3 was conceived as a technology demonstrator, introducing BLE and wireless 
charging to an EPMS v2 based design. The 3D-printed case could not be considered 
small or attractive, but nonetheless was functional if somewhat uncomfortable to 
wear. Sensor performance was (unsurprisingly) comparable to EPMS v2, but with an 
operating power just less than half of that of the previous design.  
EPMS v4 saw a number of new developments incorporated, with a BLE module 
featuring an ARM processor and dedicated pulse oximeter signal conditioning chip. The 
revised designed saved a number of chips which led to a considerable reduction in 
overall board space on the main system pcb. The case was designed around a compact 
wireless charging coil to accommodate the main system and battery charger pcbs, a 
LiPo battery and system wiring and had a reduced wall thickness compared to previous 
designs. This proved to be the smallest of the EPMS devices and demonstrated 
superior sensor and system performance. 
Temperature readings were by far the closest to a 37°C norm, being around 1.5°C 
below the mark, while the probe afforded a good degree of comfort for the user. HR 
readings were a good match to a reference pulse oximeter and though the SpO2 results 
were the best yet attained, the R values obtained gave an estimated SpO2 reading of 
around 85% using the standard method of calculation. A larger sample size would be 
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required to ascertain whether the problem with readings was a functional or 
arithmetic error, or a calibration issue. 
5.5.2 Practical Issues 
Efforts to reduce device size led to problems and delays with board assembly and 
testing, which required a significant level of manual dexterity in handling, soldering 
and checking the small components employed. A range of assembly techniques were 
evaluated before being used on the prototype pcbs as, at least initially, surface mount 
assembly tools were not available, pcb assembly having previously been sent out to 
sub-contract manufacturers. As this couldn’t provide the level of flexibility required for 
device development, some basic surface mount assembly equipment was purchased 
allowing assembly in the laboratory. Whilst this helped improve yield, it was an 
imperfect solution as discovered during testing where many solder joints had to be 
carefully reflowed, prolonging board and system testing. It became clear that only 
professional-level equipment could provide the reliability and quality required when 
working with the latest chip technology and packaging. 
5.6 Conclusions 
The work reported in this chapter meets one of this thesis’ stated objectives: 
 A novel prototype wireless multisensor device that can simultaneously measure VS 
readings was designed and produced. 
 
In addition, the following conclusions may be made: 
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 The project saw the evolution of four iterative designs for the EPMS device; each 
demonstrated an improved performance and, with the exception of EPMS v3, a 
reduction in size. 
 All EPMS devices were able to measure HR, the reliability and suggested accuracy 
improving with each evolution of the device’s design. 
 SpO2 measurement was not viable with EPMS v1 -3, the signal waveform being 
insufficiently robust and the computational load for signal processing too high. 
Improved signal conditioning and processor performance in EPMS v4 provided 
readings, which were lower than expected. This was caused by DC drift in both red 
and IR signals, whether from ambient light effects, motion artefacts or other 
sources, which affected the differential absorption calculations. 
 Temperature readings were consistently lower than body temperature. These 
ranged from 31°C (EPMS v1) to 34.5 - 36.5°C (EPMS v4). 
 The use of 3-D printing was found to be an efficient and cost-effective solution for 
case production, proving superior to traditional methods. 
 The maximum system power consumption, with active wireless transmission and 
pulse oximeter drive, showed a dramatic improvement from EPMS v1 (275 mW) to 
EPMS v4 (52 mW). 
  Wireless communication proved successful on all design variants and gave an 
operating range of ≥ 10m from a host mobile device. Connection times (around 1 – 
2 seconds) were noticeably shorter with the BLE-equipped EPMS v4 and v4.  
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6  E P M S  Tr i a l s  o n  H e a l t hy  I n d i v i d u a l s  
6.1 Introduction 
Data captured by the EPMS during bench testing and during device demonstrations 
gave an insight into system performance, but was limited to use by one individual - the 
author – and insufficient replicate measures or rigour. It was therefore important to 
trial the device on a wider population to determine how readings compared with 
reference measurements, gain calibration data and capture feedback on usability.  
This chapter reports the methods and findings resulting from a pilot study using the 
EPMS (v4) and reference devices to monitor the vital signs of a number of healthy 
subjects. It describes the devices used in the study and the study methods, detailing 
the study protocol, the study participants, inclusion criteria and the data analysis 
techniques employed. The results are grouped by VS parameter (HR, SpO2 and 
temperature) and presented as both individual readings and mean datasets. These are 
shown in tabular form and as time history, linear regression, Bland-Altman and 
frequency distribution plots. Observations and feedback on the usability of the EPMS 
are also included before a final discussion where the results are analysed and the 
device’s overall performance is considered. 
6.2 Materials and Methods 
This section reports the materials and methods employed in the execution of the 
trials performed with EPMS v4 on healthy subjects. 
The design and evaluation of discrete wearable medical devices for vital signs monitoring 
DG Pitts 212 Cranfield University 
6.2.1 Materials 
Details of the devices used in the study are shown in this section. These include the 
EPMS, mobile devices, reference medical devices and a description of the EPMS 
support ‘app’. 
EPMS device 
Two EPMS v4 devices were produced for the study, labelled ‘3’ and ‘4’, each 
identifiable via a unique Bluetooth MAC (media access control) address transmitted 
with each dataset. Ultimately all experiments were conducted with device ‘3’. The ear 
probe, enclosure and oximeter clip were thoroughly cleaned with antiseptic medical 
wipes prior to use to minimise any hygiene risks to study participants and ensure a 
clean optical sensor path for optimal performance. 
Mobile Devices 
Second generation Google Nexus 7 tablets and a Motorola Moto G smartphone, all 
running version 4.4.4 of the Android operating system (also known as “KitKat”) for BLE 
compatibility, were used to interface with the EPMS device. All study sessions were 
conducted with the same Nexus 7 tablet. 
EPMS Support Software 
This app was provided by Paul Knight and developed with the assistance of the 
author to facilitate both the execution of the EPMS study and to provide a 
demonstration platform for the device.  
On starting the app the user was invited to connect to an EPMS v4 device, an 
operation that typically took around a second to complete. Once connected, the main 
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display screen was launched; this displayed real-time vital signs readings from the 
EPMS and controlled device and data connectivity. A connection to the University’s 
wireless network was confirmed prior to the commencement of a study session. 
The display screen (see Figure 6-1) presented real-time EPMS data in numeric and 
graphical formats, this being updated every second. HR (bpm), SpO2 (%), temperature 
(°C) and battery status (ADC units) were displayed numerically; the latter as raw 
hexadecimal ADC values where 540H represented a low battery (3.7V) and indicated 
that the EPMS should be recharged. A further data field to display blood pressure data 
from third-party BLE monitors was reserved for use in Paul Knight’s PhD project.  
A ten-minute parameter-selectable time history window allowed readings of HR, 
SpO2, temperature and activity level to be displayed graphically. All traces were 
overlaid on a common display, each ascribed a different colour to aid identification 
and scaled relative to normal ranges - the Y axes scales and labels not being shown for 
clarity and to avoid a cluttered and confusing display. By default all four traces were 
displayed, but could be selected or deselected by tapping on the appropriate tick box. 
A separate bar chart displayed instantaneous activity level. 
A test ID field allowed each test to be logged against a unique identifier, simplifying 
data management. Once connected wirelessly to the internet, the ‘Send Email’ button 
sent the last 60 seconds of acquired data to the author’s university email account. 
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Figure 6-1: The main display page of EPMS support software running on a Nexus 7 tablet 
showing time history and instantaneous numeric data 
Reference Devices 
A Smiths Medical Oxi-Pulse 20 digital handheld pulse oximeter (and 3078 ear probe) 
provided reference readings of HR and SpO2. The manufacturer’s data for the former 
(Smiths Medical International Ltd., 2009) specified an HR measurement range of 30 – 
254 bpm with an accuracy of ±1 bpm (for a finger probe assuming minimal motion and 
good blood perfusion) and a range of 70 – 100% for SpO2 (to ±2.5 %). It should be 
noted that although a capability to measure an oxygen saturation of 100% was 
claimed, in actuality the reading displayed was limited to 99% as only two significant 
figures are displayed.  
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A Braun ThermoScan IRT 4520 ear thermometer was used to take reference 
temperature readings (see section 3.1.5). The ear thermometer’s user manual (Braun 
GmbH., - quoted an overall measurement range of 34 – 42.2°C with an accuracy of 
±0.2°C between 35.5–42°C and ±0.3°C outside this range. Repeatability was quoted as 
±0.14°C.  
Both reference units were fitted with new batteries prior to the commencement of 
the study; these were checked and replaced as necessary before each trial. 
6.2.2 Methods 
This section documents the methods employed in this study. It provides details of 
the study participants, the study protocol, data handling and the analysis methods 
employed. 
Ethics 
This study was subject to approval from Cranfield University Health Research Ethics 
Committee (CUHREC), which was applied for and granted (reference no. 02/12, 
17/09/2014). All participants gave fully informed written consent prior to joining this 
study. For the patient information sheet, study consent form and CUHREC approval, 
please see Appendix F. 
Study Participants  
After ethical approval (from CUHREC) and full consent had been obtained, 8 
volunteers (6 male and 2 female) aged 18 to 65 years old were recruited for the study. 
The inclusion criterion was for individuals who would consider themselves to be in 
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good health and were not taking medication in the days prior to the study period. A 
test schedule was agreed with each participant prior to commencing the study.  
Each subject was assigned a test identifier (see Table 6-1) which was used 
throughout the study. The study was conducted over a two-month period with up to 
five datasets being collected from each participant, though it can be seen that only 
subjects H and S provided a full dataset and subject G only one. Wherever possible 
data from individual subjects was sampled over the course of a week (subjects F, H and 
S), though this proved inconvenient in some cases (subjects N and R). Two participants 
(subjects E and O) were able to provide sample readings over a single day.  
Subject ID Gender Age Datasets Notes 
E Male 40-50 4 Data collected over a single day 
F Male 50+ 4 - 
G Male 20-30 1 - 
H Female 50+ 5 Reference pulse oximeter finger probe used 
N Male 30-40 3 - 
O Female 30-40 2 Data collected over a single day 
R Male 20-30 2 - 
S Male 40-50 5 - 
Table 6-1: Details of the EPMS study participants (n=8) showing their age range, gender, 
the number of datasets collected and study notes. 
Assay Description 
On joining the study consent forms were collected and subjects were asked to 
choose (and retain) an anonymising test identifier (A to Z) using a ‘lucky dip’ method. 
To aid study data management a unique test identifier was used to reference readings 
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and observations recorded in the author’s laboratory notebook and entered in the 
EPMS App’s Test ID field before each test. This took the form: 
Exp_[Subject ID] [Day Number] [Session Number]; 
e.g. Exp_A11 
 
Where the Subject ID was the anonymised subject identifier (A-Z), the Day Number 
indicated which of the subject’s five test days were being reported (1-5) and the 
Session Number, which of the four daily test sessions the data related to. 
The study was conducted in (private) offices or conference rooms to minimise 
participant anxiety and prevent observation by third parties in accordance with 
CUHREC guidelines. Room temperature in all cases was a comfortable 20-23°C. On 
arrival and having completed any formalities, subjects were invited to sit down and 
place the EPMS in their right ear and reference pulse oximeter ear clip on their left ear 
such that several minutes of resting readings could be taken concurrently. As the 
reference oximeter did not have a recording facility, four HR and SpO2 readings were 
noted at 15 second intervals in the author’s laboratory notebook. Upon completion, 
the last 60 seconds of EPMS data was sent to the author’s University email account. A 
stopwatch app on the author’s mobile phone was used to synchronise the oximeter 
readings with the EPMS such that they fell upon the mid-quartile points of the 
recorded dataset. Participants were then asked to remove the EPMS and reference 
oximeter probe and take three replicate ear temperature measurements (in the same 
ear as the EPMS) with the reference ear thermometer, which were once more noted in 
the author’s laboratory notebook.  
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Readings were only viewed by the author. Study participants were not shown their 
readings and they were not discussed; this was to reduce bias and ‘white coat’ effect 
and to satisfy the requirements of the Ethics Committee. 
Data Analysis 
All noted data was anonymised and entered in a spreadsheet held electronically on 
a secure University server. Anonymised EPMS data was emailed to the author’s 
university email account in an embedded comma separated variable (CSV) format. The 
header contained the Test ID, a time and date stamp, the device’s unique BLE identifier 
and battery status, with the column headings and data shown in Figure 6-2. Each EPMS 
dataset comprised of 60 seconds of readings collected at one second intervals, each 
line of data featuring HR (bpm), SpO2 (expressed as the R value x 25000), ear 
temperature (°C) and activity level (a dimensionless value). This was imported into MS 
Excel with the resultant files being held on the same secure server. 
The design and evaluation of discrete wearable medical devices for vital signs monitoring 
DG Pitts 219 Cranfield University 
 
Figure 6-2: An example EPMS data email (exp_H11: subject H, dataset 1) showing the test 
and device (BLE) identifiers, battery status and physiological study data in CSV format 
Separate files were created for each study subject’s data with each EPMS dataset 
having its own worksheet with others being used for reference and statistical data. 
Tabulated HR, temperature and activity level readings required no conversion, 
whereas SpO2 readings were converted into R values and estimated SpO2 readings (see 
Equation 5-2). All calculations, statistical analyses and graphs were produced in MS 
Excel78. Descriptive statistical data (minima, maxima and mean values) and 
comparative plots of EPMS and reference data were produced for each of the study 
datasets and for each of the three studied parameters. Regression and Bland-Altman 
plots (Altman and Bland, 1983) were then prepared from the paired mean reference 
and EPMS readings from each test session to establish the degree of correlation and 
                                                 
78 MS Office Professional Plus 2010, Microsoft Corp., Redmond, WA, USA 
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bias. Histograms showing the frequency distribution of the differences in paired 
readings were also produced for each of the three vital signs monitored.  
6.3 Results 
These are ordered and presented by vital signs. They compare readings from 
individual EPMS and reference datasets and their means to establish the correlation, 
bias and validity of the measurements, and thus the performance of EPMS. With 
reference to Table 6-1, it should be noted that different numbers of datasets were 
collected from volunteers, reflecting their availability and willingness in participation. 
6.3.1 Heart Rate 
Subject HR data is presented in Table 6-2. This shows the minimum and maximum 
recorded readings (and thus the ranges) for each test subject across their respective 
datasets with both the EPMS and reference pulse oximeter. It can be seen that the 
EPMS has the same range of readings as the reference (53 – 87 bpm v. 54 – 87 bpm), 
spanning the nominal healthy range of 60 – 90 bpm. The overall means (67.235 v. 
67.869 bpm) are also very closely matched. Figure 6-3 displays the subject dataset’s HR 
characteristics graphically.  
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Subject Datasets 
EPMS HR (bpm) Reference HR (bpm) 
Min Max Mean Min Max Mean 
E 4 53 66 58.750 54 66 59.563 
F 4 61 79 66.942 62 74 67.313 
G 1 58 75 64.817 60 71 65.250 
H 5 58 76 66.180 57 74 67.300 
N 3 62 87 76.100 63 84 75.750 
O 2 68 87 76.567 70 87 77.500 
R 2 57 70 63.625 62 68 64.875 
S 5 58 76 64.903 59 73 65.400 
Overall 26 53 87 67.235 54 87 67.869 
Table 6-2: Study subject heart rate (HR) data showing the minima, maxima and means for 
EPMS and reference data collected from each participant 
 
Figure 6-3: A plot showing the paired range and means of EPMS and reference HR readings 
of subject datasets 
Analysis of HR Data 
Plots were prepared from each set of subject data. These comprised of 60 seconds 
of continuous time history EPMS data with reference data superimposed at the four 
mid-quartile points; the means of the EPMS data in each quartile (labelled Q1 to Q4) 
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were also added to provide a direct comparison with the reference data and to assist 
in identifying trends. The scaling on the Y-axes was fixed for all plots according to the 
established recorded minimal and maximal limits (50 – 90 bpm) to facilitate 
comparison. The complete set of plots from the study may be found in Appendix G. 
Subject’s HR plots may be classified by the degree of deviation observed in the 
respective responses, having minimal, moderate or significant variation. This is 
illustrated in the following example figures: 
 
Figure 6-4: A comparative plot of EPMS and reference HR data showing minimal deviation 
(subject N, dataset exp_N11). 
Figure 6-4 illustrates an example of minimal deviation as observed in 5 of the 26 
datasets (19.23%). Here there is little variation in the EPMS data, which closely tracks 
the reference in all four quartiles.  
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Figure 6-5: A comparative plot of EPMS and reference HR data showing moderate 
deviation (subject F, dataset exp_F31). 
Figure 6-5 shows moderate deviation. In this instance there is some variation in the 
EPMS response, but it nevertheless tracks the reference quite closely in most quartiles. 
This trend was observed in 16 of the datasets (61.53%), which was by far the most 
common pattern. 
Figure 6-6 illustrates an example of significant deviation as observed in 5 of the 
datasets (19.23%), matching the number observed with minimal deviation. Here there 
is variation in both the EPMS data and the reference, which does not track the EPMS as 
well. There is a suggestion of a time lag (approximately 10 seconds) between the two 
traces, something that was also observed on other plots and by the author over the 
course of the study. The mean EPMS quartiles in this example show a relatively ‘flat’ 
response due to the nature of the distribution of the original EPMS data. 
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Figure 6-6: A comparative plot of EPMS and reference HR data showing significant 
deviation (subject H, dataset exp_H41). 
In order to explore the nature of the relationship between the EPMS and reference 
pulse oximeter further, HR data was collected for a full five minutes from subject S – 
the EPMS providing continuous readings and with reference readings taken every 10 
seconds. The results are presented in Figure 6-7 which shows the EPMS and reference 
readings plotted on common axes together with a measure of the activity level (using a 
second Y-axis on the right of the graph). The latter was plotted to help determine 
whether there was any change in either HR response that may be due to motion 
artefact. 
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Figure 6-7: A comparative time history plot (subject S) showing five minutes of continuous 
EPMS  and reference pulse oximeter HR data (taken every 10 seconds). 
The EPMS and reference traces show a close relationship, but provide further 
evidence for an apparent ‘phase lag’ between the two devices. Figure 6-7 shows the 
EPMS peaking several seconds before the reference at 65, 125 and 245 seconds. The 
range of the readings however is extremely close (EPMS = 61 – 69 bpm, reference = 61 
– 68 bpm) with a difference of only 0.164 bpm between the means of the two datasets 
(EPMS mean = 64.003 bpm, reference mean = 63.839 bpm).  
Regarding motion artefact, a change in the EPMS reading of 1 bpm may be 
observed coincident with activity peaks at 40, 100, 160 and 190 seconds and in the 
reference at 160 and 190 seconds. Conversely however, there is no change in the 
EPMS response following the activity peaks at 220 seconds and 290 seconds. 
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Analysis of the Mean HR Datasets 
The mean HR readings in each of the study datasets are shown in Table 6-3. The 
means of the EPMS and reference readings provide the data for the correlation plot in 
Figure 6-8, while the means and differences (EPMS minus the reference) of the paired 
data were used to produce the Bland-Altman plot in Figure 6-9.  
Dataset EPMS Ref Mean Diff 
E11 55.567 55.750 55.658 -0.183 
E12 64.567 65.250 64.908 -0.683 
E13 56.767 58.000 57.383 -1.233 
E14 58.100 59.250 58.675 -1.150 
F11 68.800 67.000 67.900 1.800 
F21 65.867 67.500 66.683 -1.633 
F31 69.233 69.500 69.367 -0.267 
F41 63.867 65.250 64.558 -1.383 
G11 64.817 65.250 65.033 -0.433 
H11 64.333 66.750 65.542 -2.417 
H21 70.517 70.750 70.633 -0.233 
H31 68.000 68.000 68.000 0.000 
H41 63.467 65.000 64.233 -1.533 
H51 64.583 66.000 65.292 -1.417 
N11 63.867 64.250 64.058 -0.383 
N21 81.300 81.750 81.525 -0.450 
N22 83.133 81.250 82.192 1.883 
O11 70.900 71.000 70.950 -0.100 
O12 82.233 84.000 83.117 -1.767 
R11 63.350 63.750 63.550 -0.400 
R21 63.900 66.000 64.950 -2.100 
S11 65.450 65.500 65.475 -0.050 
S21 63.200 63.750 63.475 -0.550 
S31 59.333 60.750 60.042 -1.417 
S41 64.400 65.000 64.700 -0.600 
S51 72.133 71.500 71.817 0.633 
Means 67.235 67.869 67.552 -0.633 
Table 6-3: The study HR EPMS and reference readings means and differences (bpm).  
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A linear regression plot of the paired means of the EPMS and reference readings 
was prepared to establish the degree of correlation between the two sets of data. This 
is presented in Figure 6-8 and shows an almost linear relationship with the data points 
distributed fairly evenly about the trend line, to give a coefficient of determination (R2) 
value of 0.980 (P <0.001). This indicates a strong correlation. 
 
Figure 6-8: A linear regression plot of the 26 paired mean EPMS and reference HR readings 
for each dataset showing correlation. 
Figure 6-9 shows a Bland-Altman plot comparing the means and differences in the 
paired data to highlight any bias. The mean bias (difference) is close to zero and 
relatively small (-0.633), with half of the data points falling close to the mean bias line. 
The distribution suggests a general tendency for the EPMS to underestimate at heart 
rates below 67 bpm and overestimate slightly at thresholds above and beyond this, 
giving a small proportional error. All but two of the data points (F11 and N22) fall 
within the limits of agreement (±1.96 x the standard deviation of the differences 
between the datasets). 
y = 1.0371x - 3.1151 
R² = 0.9798 
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Figure 6-9: A Bland-Altman plot of the means and differences of the paired mean EPMS 
and reference HR readings. 
Figure 6-10 provides a frequency distribution plot of the differences in the datasets. 
It can be seen that 13 of the datasets (50%) fall within 0.5 bpm of the reference while 
all fall with a range of ±2.5 bpm. 
 
Figure 6-10: A distribution plot of the mean differences in HR readings between the study 
datasets. 
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6.3.2 Blood Oxygen Saturation 
Subject SpO2 data is presented in Table 6-4. This shows the minimum and maximum 
recorded readings (and thus the ranges) of EPMS R values and estimated SpO2 readings 
together with reference readings for each test subject across their respective datasets. 
The R values were calculated by dividing raw EPMS readings by 25000, while an 
estimated SpO2 value was calculated using the empirically derived formula described in 
Equation 5-2. 
Subject Datasets 
EPMS R values EPMS SpO2 (%) Reference SpO2 (%) 
Min Max Mean Min Max Mean Min Max Mean 
E 4 0.958 1.025 0.994 84.378 86.040 85.156 96 98 97.125 
F 4 0.985 1.019 0.996 84.535 85.363 85.056 95 98 96.625 
G 1 0.979 1.050 1.018 86.036 88.533 86.884 99 99 99.000 
H 5 0.950 1.070 1.006 83.262 86.261 84.860 96 98 97.000 
N 3 0.943 1.046 0.984 83.852 86.417 85.398 95 99 97.083 
O 2 0.964 1.068 1.018 83.289 85.912 84.547 98 99 98.500 
R 2 0.979 1.092 1.034 82.700 85.537 84.138 95 99 97.500 
S 5 0.928 1.040 0.996 84.012 86.799 85.099 96 99 97.600 
Overall 26 0.928 1.092 1.006 82.700 88.533 85.142 95 99 97.554 
Table 6-4: Study SpO2 data showing the minima, maxima and means for EPMS calculated R 
values, estimated SpO2 values and reference readings. 
It is immediately apparent that the estimated EPMS SpO2 values fall some way short 
of the reference pulse oximeter readings, though the ranges between the minima and 
maxima are broadly similar. All reference measurements were within the healthy 
range (>95%) whereas as those from the EPMS were less than <90%. 
The design and evaluation of discrete wearable medical devices for vital signs monitoring 
DG Pitts 230 Cranfield University 
Analysis of SpO2 Data 
This follows the same approach as that employed with HR analysis in section 6.3.1. 
It compares continuous EPMS time history data with reference at the four mid-quartile 
points. Again, the means of the EPMS data in each quartile (Q1 to Q4) were also added 
to provide a direct comparison with the reference. The scaling on the Y-axes was fixed 
for all plots according to the established recorded minimal and maximal limits (80 – 
100%) to facilitate comparison.  
Subject’s SpO2 plots were classified by the degree of deviation observed in the 
reference, as illustrated in the following example figures: 
 
Figure 6-11: A comparative plot of EPMS and reference HR data showing no deviation in 
the reference (subject S, dataset exp_S31). 
Figure 6-11 shows an example SpO2 plot, the most noticeable thing in which initially 
is the difference in the scale of the readings between the EPMS and the reference. The 
other thing of note however is the unwavering reference reading. It might therefore be 
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expected that there is little variation in the accompanying EPMS trace. This was 
observed in 21 of the 26 datasets (80.77%). 
 
Figure 6-12: A comparative plot of EPMS and reference HR data showing slight deviation in 
the reference (subject N, dataset exp_N11). 
Figure 6-12 shows an example of an SpO2 plot where there is variation in the 
reference reading, something that should be echoed in the corresponding EPMS data 
and was indeed observed in 5 of the datasets. Here there is greater variation than in 
the previous example although there is a suggestion it may be inversely proportional.  
Analysis of the Mean SpO2 Datasets 
The mean HR readings in each of the study datasets are shown in Table 6-5. The 
means of the EPMS and reference readings provide the data for the regression plot in 
Figure 6-13, while the means and difference of the paired data were used to produce 
the Bland-Altman plot in Figure 6-14. 
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Dataset EPMS Ref Mean Diff 
E11 84.970 97.000 90.985 -12.030 
E12 85.029 97.000 91.015 -11.971 
E13 85.634 96.500 91.067 -10.866 
E14 84.989 98.000 91.495 -13.011 
F11 85.065 95.500 90.283 -10.435 
F21 84.983 98.000 91.491 -13.017 
F31 85.227 98.000 91.614 -12.773 
F41 84.951 95.000 89.975 -10.050 
G11 86.880 99.000 92.940 -12.120 
H11 84.426 97.250 90.838 -12.824 
H21 85.041 97.750 91.395 -12.709 
H31 84.883 96.000 90.442 -11.117 
H41 85.005 97.000 91.003 -11.995 
H51 84.946 97.000 90.973 -12.054 
N11 85.090 95.500 90.295 -10.410 
N21 85.791 98.750 92.271 -12.959 
N22 85.313 97.000 91.157 -11.687 
O11 84.846 99.000 91.923 -14.155 
O12 84.249 98.000 91.125 -13.751 
R11 84.548 99.000 91.774 -14.452 
R21 83.728 96.000 89.864 -12.272 
S11 85.126 98.000 91.563 -12.874 
S21 84.803 99.000 91.901 -14.197 
S31 84.388 98.000 91.194 -13.612 
S41 85.523 96.000 90.761 -10.477 
S51 85.654 97.000 91.327 -11.346 
Means 85.142 97.554 91.348 -12.412 
Table 6-5: The study SpO2 EPMS and reference readings means and differences (%).  
A linear regression plot of the paired means of the EPMS and reference SpO2 
readings is presented in Figure 6-13 and shows the data points distributed evenly 
about the trend line, but very poor correlation with an R2 value of 0.020 (P = 0.489).  
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Figure 6-13: A linear regression plot of the 26 paired means EPMS and reference SpO2 
readings for each dataset showing correlation. 
 
Figure 6-14: A Bland-Altman plot of the means and differences of the paired mean EPMS 
and reference SpO2 readings. 
Figure 6-14 shows a Bland-Altman plot comparing the means and differences in the 
paired data. The mean bias is large (-12.412), reflecting the discrepancies in the 
magnitudes of the readings. All of the data points fall within the limits of agreement 
y = 0.0705x + 78.178 
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with the distribution suggesting the error to be inversely proportional to the means of 
the readings.  
 
Figure 6-15: A distribution plot of the SpO2 mean differences in the study datasets. 
Figure 6-15 shows a histogram displaying the frequency distribution of the 
differences in the datasets; this clearly highlights that the EPMS SpO2 under reads by  
-12% in the majority of the datasets.  
6.3.3 Temperature 
This section first investigates the repeatability of the replicate readings taken with 
the reference tympanic thermometer and then compares these with the EPMS. 
Reference Temperature Data 
Table 6-6 shows the replicate reference temperature readings from the study 
cohort together with the range and means from each of the study sessions. The first 
replicate gave the highest reading on 23 occasions (88.5%) with readings equal to or 
above 37°C being observed in all three replicates on only four occasions (O12, S31, S41 
and S51). Mean temperatures of this mark were only recorded consistently by subjects 
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O and S (O11, O12, S31, S41 and S51), while the mean readings for subject R (< 36.0°C) 
were significantly cooler than the established norm. The mean temperature 
measurement was 36.707°C with a mean variation of 0.238°C. The widest range 
observed was 0.7°C (Subject R, dataset R21). 
Subject Datasets 
Replicate Readings (°C) Range and Means (°C) 
1 2 3 Range Mean 
E 
E11 37.1 36.9 36.9 0.2 36.967 
E12 37.1 37.0 37.0 0.1 37.033 
E13 36.8 36.8 36.7 0.1 36.767 
E14 36.7 36.7 36.8 0.1 36.733 
F 
F11 37.1 36.8 36.8 0.3 36.900 
F21 37.2 37.0 36.8 0.4 37.000 
F31 37.1 36.9 36.9 0.2 36.967 
F41 36.9 36.7 36.7 0.2 36.767 
G G11 36.4 36.4 36.4 0.0 36.400 
H 
H11 37.0 36.8 36.7 0.3 36.833 
H21 36.7 36.6 36.4 0.3 36.567 
H31 36.4 36.4 36.5 0.1 36.433 
H41 36.8 36.5 36.4 0.4 36.567 
H51 36.7 36.5 36.2 0.5 36.467 
N 
N11 36.8 36.7 36.6 0.2 36.700 
N21 37.0 36.8 36.8 0.2 36.800 
N22 37.1 36.8 36.8 0.3 36.900 
O 
O11 37.1 36.9 37.0 0.2 37.000 
O12 37.4 37.1 37.1 0.3 37.200 
R 
R11 36.1 36.0 35.8 0.3 35.967 
R21 36.1 35.9 35.4 0.7 35.800 
S 
S11 36.9 36.7 36.7 0.2 36.767 
S21 36.9 36.9 36.8 0.1 36.867 
S31 37.3 37.2 37.1 0.2 37.200 
S41 37.5 37.4 37.4 0.1 37.433 
S51 37.4 37.3 37.2 0.2 37.300 
Overall 34.6 36.7 Means 0.238 36.707 
Table 6-6: Replicate study temperatures (°C) showing the range and means of the reference 
ear thermometer readings. High readings are shown in bold.  
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A Comparison of Temperature Data 
Subject HR data is presented in Table 6-8. This shows the minimum and maximum 
recorded readings for each test subject across their respective datasets with both the 
EPMS and reference ear thermometer. Random instances were observed of zeroes 
being recorded by the EPMS, no more than two instances in any given dataset. These 
were manually replaced in affected spreadsheets by the means of the two surrounding 
values. 
Subject Datasets 
EPMS Temperature (°C) Reference Temperature (°C) 
Min Max Mean Min Max Mean 
E 4 35.5 36.3 35.822 36.7 37.1 36.875 
F 4 35.7 36.3 35.898 36.7 37.2 36.908 
G 1 35.5 36.0 35.545 36.4 36.4 36.400 
H 5 34.7 35.9 35.431 36.2 37 36.574 
N 3 35.6 36.0 35.769 36.6 37.1 36.800 
O 2 36.5 36.7 36.592 36.9 37.4 37.100 
R 2 35.0 35.2 35.122 35.4 36.1 35.883 
S 5 34.6 36.4 35.718 36.7 37.5 37.113 
Overall 26 34.6 36.7 35.737 35.4 37.5 36.707 
Table 6-7: Study subject temperature data showing the minima, maxima and means for 
EPMS and reference data collected from each participant 
The EPMS readings were noticeably lower than the reference (overall means 
showing 35.737 versus 36.707°C) although the overall spans were the same (2.1°C). 
The mean variation was 0.214°C, proving better than the reference (the lowest subject 
mean variation being N and O at 0.1°C and G the highest with 0.5°C). Results followed 
the same general trend as the reference with subject O recording the highest mean 
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temperature and subject R the lowest. Differences may be noted in the mid-rankings 
however. 
 
Figure 6-16: A plot showing the range and means of readings of the study subject’s 
temperature datasets. 
Figure 6-16 displays the subject dataset’s temperature profiles graphically. This 
demonstrates there was no overlap between the measurement methods on an 
individual dataset whereas there was substantial overlap between the dataset means. 
Analysis of Temperature Data 
Plots were prepared from each set of subject data. These comprised of 60 seconds 
of continuous time history EPMS data with the means of the three replicate reference 
readings (complete with error bars) superimposed. The scaling on the Y-axes was fixed 
for all plots according to the established recorded minimal and maximal limits (34 – 
38°C) to facilitate comparison.  
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Figure 6-17: A comparative plot of EPMS and reference temperature data (subject H, 
dataset exp_H51). 
Figure 6-17 shows a typical example of the recorded temperature data. It can be 
seen that there is little variation in the EPMS temperature reading over the 
measurement period (0.3°C), which closely compares with the range of the reference 
observations (0.5°C in this example). Though stable, there is however a marked 
difference in the recorded temperatures in all datasets with the EPMS consistently 
under-reading. 
Analysis of the Mean Temperature Datasets 
Table 6-8 shows the means of the EPMS and reference readings for each dataset 
and the means and differences of the paired readings used in the following regression 
(Figure 6-18) and Bland-Altman plots (Figure 6-19). 
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Dataset EPMS Ref Mean Diff 
F11 35.800 36.900 36.350 -1.100 
F21 36.203 37.000 36.602 -0.797 
F31 35.792 36.967 36.379 -1.175 
F41 35.797 36.767 36.282 -0.970 
G11 35.545 36.400 35.973 -0.855 
H11 35.790 36.833 36.312 -1.043 
H21 34.900 36.567 35.733 -1.667 
H31 35.380 36.433 35.907 -1.053 
H41 35.490 36.567 36.028 -1.077 
H51 35.593 36.470 36.032 -0.877 
N11 35.600 36.700 36.150 -1.100 
N21 35.931 36.800 36.365 -0.869 
N22 35.777 36.900 36.338 -1.123 
O11 36.557 37.000 36.778 -0.443 
O12 36.627 37.200 36.913 -0.573 
R11 35.123 35.967 35.545 -0.843 
R21 35.120 35.800 35.460 -0.680 
S11 35.490 36.767 36.128 -1.277 
S21 34.643 36.867 35.755 -2.223 
S31 35.913 37.200 36.557 -1.287 
S41 36.200 37.433 36.817 -1.233 
S51 36.343 37.300 36.821 -0.957 
Means 35.727 36.782 36.255 -1.055 
Table 6-8: The means and differences of study EPMS and reference temperature readings 
(°C).  
A linear regression plot of the paired means of the EPMS and reference SpO2 
readings was prepared to establish the degree of correlation between the two sets of 
data. This is presented in Figure 6-18 and shows the most of the data points 
distributed evenly about the trend line, but with two significant outliers (H21 and S21) 
which reduce R2 to 0.448 (P < 0.001).  
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Figure 6-18: A linear regression plot of the 26 paired mean EPMS and reference 
temperature readings for each dataset showing correlation. 
 
Figure 6-19: A Bland-Altman plot of the means and differences of the paired mean EPMS 
and reference temperature readings. 
Figure 6-19 shows a Bland-Altman plot comparing the paired means and differences 
of the temperature data. The mean bias is small and close to zero (-0.970), with most 
y = 0.8642x + 3.9413 
R² = 0.4479 
34.0
35.0
36.0
37.0
38.0
34.0 35.0 36.0 37.0 38.0
M
e
an
 E
P
M
S 
Te
m
p
 /
 d
e
gs
 C
 
Mean Ref Temp / degs C 
-2.5
-2.0
-1.5
-1.0
-0.5
0.0
0.5
1.0
1.5
2.0
2.5
35.0 35.5 36.0 36.5 37.0
Te
m
p
e
ra
tu
re
 D
if
fe
re
n
ce
 /
 d
e
gs
 C
 
Mean Temperature / degs C 
+1.96SD = -0.269 
-1.96SD = -1.670 
Mean Difference = -0.970 
95% Limits of Agreement = ±0.701 
The design and evaluation of discrete wearable medical devices for vital signs monitoring 
DG Pitts 241 Cranfield University 
of the data points falling close to the mean bias line. With the exception of an outlier 
(S21) all data points fall within the limits of agreement, though one is on the line of the 
lower limit (H21) and another (O11) quite close to the upper limit. The even 
distribution of the data suggests minimal bias. 
 
Figure 6-20: A distribution plot of the mean differences in temperature readings of the trial 
datasets. 
Calibration 
Figure 6-20 shows a histogram displaying the frequency distribution of the 
temperature differences in the datasets. This shows that an EPMS error of -0.8°C was 
most common with H21 (-1.667 °C) and S21 (-2.223 °C) skewing the mean error. With 
these points removed the mean error falls from -0.970 to -0.890°C. If this is added to 
the EPMS readings as a compensation factor, the resulting regression (Figure 6-21) and 
Bland-Altman plots (Figure 6-22) show a notable improvement. The revised R2 value 
increases to 0.659, confirming improved correlation, while the modified mean bias is 
effectively zero (-0.091°C) with all points evenly distributed along the mean bias line 
and, with a single exception, constrained within tighter limits of agreement (±0.470°C). 
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Figure 6-21: A linear regression plot of the paired mean EPMS and reference temperature 
readings with H21 and S21 removed and an EPMS compensation factor of +0.890°C added. 
 
Figure 6-22: A Bland-Altman plot of the means and differences of the paired mean EPMS 
and reference temperature readings post-compensation. 
The frequency distribution plot presented in Figure 6-23 demonstrates the effect of 
the temperature compensation. The removal of the two outliers and addition of the 
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+0.89°C offset results in a reduced range of readings spanning from -0.547 to +0.447°C 
centred around zero. 
 
Figure 6-23: A distribution plot of the mean differences in compensated temperature 
readings from the trial datasets. 
6.3.4 Usability 
The EPMS and software performed well throughout the trials with no technical 
issues to report. None of the participants reported discomfort when wearing the 
device although two experienced some problems with the fit of the ear probe. Most 
experienced initial problems in fitting and securing the device’s pulse oximeter clip on 
their ear lobes without dislodging the ear probe. 
Something immediately apparent was the difference in equilibration times between 
the EPMS and the reference pulse oximeter, an observed throughout the study. The 
EPMS was significantly more responsive, being faster in acquiring readings and 
reacting to changes, thus appearing slightly less stable. Acquisition time from attaching 
the ear clip was consistently less than five seconds with up to a further 10 seconds for 
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readings to stabilise. The reference took between 10 and 20 seconds to initially acquire 
readings from its ear probe (which it sometimes failed to do) with a stabilisation time 
of around 10 seconds. This caused issues with the reference device, frequently 
requiring the probe to be re-sited or the unit power cycled to reinitialise sample 
acquisition. These difficulties led to a finger probe being used with subjects H (all 
datasets) and F (dataset F41) which offered improved reliability over the ear probe. 
6.4 Discussion 
Analysis of the study results show mixed success in that the EPMS provides 
excellent HR, promising temperature and poor SpO2 data. These will be discussed in 
turn in sections 6.4.1 to 6.4.3.  
6.4.1 Heart Rate 
The results demonstrate excellent correlation between the EPMS v4 design and 
reference as seen in individual datasets and the mean data. This is borne out by the 
difference in the means of the datasets (-0.633 bpm), which is well within the quoted 
accuracy (±1 bpm) of the reference instrument and comparable to figures reported for 
commercial monitors (Iyriboz et al., 1991; Dawson et al., 2011). As the optical sensing 
elements are the same in the EPMS and the reference, this demonstrates that the 
filtering, signal processing and peak detection algorithms employed are capable of 
extracting accurate beat-to-beat periods from which a measure of HR can be 
calculated. This would also provide a good platform for expanding the device’s 
capability to measure respiratory rate (Clifton et al., 2007) and mental stress (Srinivas 
et al., 2007), both of which may be extracted from heart rate variability. 
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As reported, there was a noticeable difference in acquisition time between the 
EPMS and reference pulse oximeter. This would appear to demonstrate the essential 
differences in the processing of beat-to-beat frequencies, the EPMS employing an 
nine-sample moving median whereas the reference would appear to use a moving 
average with a relatively wide (or dynamic) sampling window– hence the extended 
equilibration time. This supposition is further reinforced by the time lag between the 
devices’ data presented in Figure 6-7 and observed in many of the datasets (an 
example of which is shown in Figure 6-6). If the sampling window is too short, whether 
time or sample-based, the resulting readings may appear unstable. Too wide however 
and lower readings can be over emphasised, damping the response and eliminating 
detail, while introducing a temporal offset in displayed data (Jennings et al., 1981).  
The most likely reason for employing a wide sampling window is to minimise the 
influence of motion artefacts on displayed data. Although resting rather than 
ambulatory measurements were recorded during the study, the degree of motion 
determined from the EPMS’ activity level scoring was investigated. There was little 
evidence however to support this contributing to changes in recorded HR data in 
either the reference or EPMS results. 
The differences observed between readings would appear to be primarily due to 
the different data processing techniques employed. The EPMS, with its rapidity of 
response, is arguably better able to track dynamic HR in a resting subject than the 
reference, which provides a good measure of the underlying mean. If the EPMS has a 
place in periodic patient assessment, rapid acquisition and equilibration are key 
attributes for successful operation. In the case of HR measurement, the study amply 
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demonstrates that a one minute sampling window has proved to be sufficient to 
deliver a representative measure of a subject’s mean HR. 
6.4.2 Blood Oxygen Saturation 
The performance of the SpO2 sensing was disappointing though not unexpected. 
There was no correlation between the EPMS and the reference (Figure 6-13, R2 = 
0.020), suggesting inconsistency and considerable variation, and a large mean 
difference (Figure 6-14, bias = -12.412).  
Sources of Error 
First and foremost, sensor and hardware errors may be ruled out as four examples 
of the EPMS v4 design exhibited the same problem, the connections to the AFE4490 
oximeter chip closely following those of reference designs. There was little variation in 
the EPMS response (or the reference data for that matter) in any of the dataset’s 
individual time history plots, suggesting noise was not the problem. The study results 
are suggestive of two problems, which may be related: (i) inconsistency and (ii), the 
scale of the difference in the readings. 
Section 5.4.2 reports the issues experienced with SpO2 derivation which had been 
problematic from the outset. The magnitude and rate of change of DC offset in the red 
and IR waveforms defeated attempts to resolve a viable saturation reading in the first 
three EPMS variants as the signals were too erratic, ambient light and motion artefacts 
being mostly responsible. The additional processing power and improved digital signal 
processing in EPMS v4 improved stability although it was still prone to DC drift effects.  
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It was noted that the R value (red/IR absorption ratio) returned after performing 
the calculation given in Equation 5-1 was close to unity, whereas a value of 0.4 to 0.6 
would be expected for SpO2 levels above 95%. Applying the formula in Equation 5-2 
gave an estimation of SpO2 for a given R value, the EPMS giving readings of 
approximately 85%. Although this was low it wouldn’t have been a problem had there 
been good correlation with the reference, as it would have allowed a compensation 
factor to be calculated from the study data to effect calibration. The degree of 
inconsistency observed between EPMS and reference readings demonstrates the 
problem is not an arithmetic one, but is related to variability in the original waveform’s 
DC voltage component. 
The R value is a ratio of the AC:DC ratios of the red and IR signals (Equation 5-1), 
which comprise of a small AC response on a large and variable DC offset. Thus it is 
clear that the minimisation of DC drift is essential for robust SpO2 measurement and 
critical for the future development of the EPMS device.  
On examination (post trial) a number of differences were found between the 
AFE4490 product datasheets used in the original design (Texas Instruments Inc., 2013) 
and that most recently published (Texas Instruments Inc., 2014) – the list of 
documented revisions being two pages long. Of particular interest were changes to the 
control registers of the PPG signal’s second internal gain stage, where new features 
have been introduced. These directly affect the DC offset and facilitate control of an 
‘ambient cancellation scheme’ in which ambient light readings are used to provide 
dynamic DAC offset adjustments to the PPG second gain stage, thus maintaining an 
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even DC threshold. The ambient light readings could also be used to rapidly adjust LED 
drive levels to the same end. 
Another possibility is to evaluate in-ear sensing with a side-facing reflective sensor 
mounted on the device’s ear probe. This would have dual benefit of reduced motion 
artefact and the elimination of most ambient light, directly addressing two of the 
biggest complications in SpO2 monitoring.  
6.4.3 Temperature 
The results of the study show mixed success for temperature measurement, but 
nevertheless demonstrates the EPMS’ potential. EPMS ear temperatures were 
remarkably stable, showing little variation in any of the datasets and returning a 
marginally better mean range than the reference (0.214°C versus 0.238°C). The device 
was found to consistently under read by a mean of -0.970°C, the range of errors being 
from -0.443°C to –2.223°C. This compares with the stated accuracy of ±0.2°C of the 
reference ear thermometer (Braun GmbH., -) which, although challenging, 
demonstrates the exacting requirements for medical thermometry. 
As two of the EPMS temperature readings (H21 and S21) were below 35°C and 
stood out in Figure 6-18 (and 6-19) there was a case for considering them as outliers 
and ripe for removal. With these exceptions removed the mean difference improved 
to -0.890°C. Adding this to EPMS temperature readings as a compensation factor 
zeroed the offset and improved both correlation (Figure 6-21, R2 = 0.659 as opposed to 
0.448) and bias (Figure 6-22). Had the grouping on the regression plot (Figure 6-21) 
been tightly aligned to the trend line and R2 close to unity, there would be some 
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justification for applying the compensation factor to adjust temperature calibration. 
The range and degree of variability however are too great for this to be viable, 
demonstrating the problem is not one of calibration but design. 
Sources of Error 
With any IR thermometer a clear optical path is critical for accurate measurement; 
though this was nominally provided by the EPMS probe, the path may still be impeded 
by hair and cerumen (ear wax) to give low readings (Gallimore, 2004; Doezema et al., 
1995). As there was no specific provision for ensuring subjects’ ear cleanliness during 
the trial (a deficiency of the study) there remains the probability that this may have 
been a factor with some readings. In addition, as EPMS temperature readings were 
collected prior to those of the reference ear thermometer, the degree and distribution 
of cerumen in the ear canal may have changed between the two sets of readings. 
Although the sensor has a calibrated digital output its quoted accuracy is given as 
±0.5°C, which could account for some of the error. Skin emissivity is close to unity (see 
section 5.2.1) and therefore unlikely to be responsible for errors of this magnitude.  
A more likely culprit is the design of the probe itself. As this was made from rigid 
ABS there was no compliance to accommodate ear canals of different shapes and 
sizes, therefore affecting the fit and aim of the sensor. Although the viewing angle was 
relatively generous (100° to 50% thermopile signal) and unobstructed by the ABS 
probe housing itself (see section 5.4.1, p197), the lens may not be pointing directly at 
the tympanic membrane, but rather the wall of the ear canal itself. This hypothesis is 
supported by feedback from the study and research describing the range of cross-
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sectional areas, curvature, lengths and temperature profiles of the adult ear canal 
(Arsenault and Ducharme, 2001; Braun GmbH., -). This could be largely addressed with 
a redesigned probe. 
6.4.4 Usability 
There were no technical concerns, with the EPMS performing flawlessly for the 
study’s duration and from the operator’s perspective the system proved to be easy to 
use for data collection. The EPMS was consistently faster than the reference pulse 
oximeter in acquiring and presenting stable HR and SpO2 readings, possibly a result of 
the differences in the signal processing methods employed.  
From a user’s perspective however, restrictions placed upon the study by the Ethics 
Committee, though understandable and necessary, prevented the use of direct 
feedback from the host tablet as a fitting aid, instead relying on verbal instruction from 
the investigator. The tablet would have provided the necessary affirmation that the 
device was correctly seated for reliable measurement. This compromised usability in 
the author’s opinion despite attracting little negative feedback.  
Some participants found the EPMS’ pulse oximeter clip was difficult to fit, requiring 
the use of both hands, a degree of manual dexterity and in one instance, a mirror. 
Ideally the clip should be eliminated and incorporated into a redesigned in-ear probe 
providing a better and more comfortable fit for a wide cohort of users.  
Probe Design 
The fit of the in-ear thermometer probe was not ideal; some participants found the 
diameter to large and experienced slight discomfort. As the probe was made from rigid 
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ABS there was no compliance to accommodate ear canals of different shapes and sizes 
(see section 6.4.3, page 249). The probe would benefit from a slight extension (no 
more than 5 mm), a general reduction in diameter (to produce a concave form with a 
gradual taper from the sensing tip) and a degree of flexibility. A thin layer of compliant 
material (e.g. a soft hypoallergenic silicone) could also be incorporated, ensuring an 
improved fit and providing improved user comfort. 
6.5 Conclusions 
The work reported in this study meets two of this thesis’ stated objectives: 
 A pilot study of the prototype EPMS on healthy subjects was carried out in order to 
allow comparison with a reference device. 
 This provided a representative test of the device’s telemonitoring capability. 
 
Results from the study demonstrate the following points: 
 The EPMS’ HR readings showed an excellent agreement with those from the 
reference pulse oximeter in terms of overall range (53 – 87 bpm v. 54 – 87 bpm), 
means (67.235 bpm v. 67.869 bpm), with a strong relationship (R2 = 0.980,  
p <0.001, mean bias = -0.633, limits of agreement ±2.021 bpm). The mean 
measurement error (mean bias) compared favourably with the ±1 bpm accuracy 
quoted for the reference. 
 The SpO2 readings were disappointing and showed a poor relationship between 
the EPMS and reference readings. This was apparent from the discrepancies in 
overall range (82.70 – 88.53% v. 95 – 99%), means (85.142% v. 97.554%) and lack 
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of correlation (R2 = 0.020, p = 0.489, mean bias = -12.412, limits of agreement 
±2.432%). The magnitude of DC drift, whether from ambient light effects or motion 
artefacts, was identified as the cause of the poor SpO2 readings. The AFE4490 pulse 
oximeter signal conditioning chip is suspected to be (at least in part) responsible, 
something that changes to the silicon relating to DC offset control in recent 
revisions might attest to. 
 The temperature readings recorded by the EPMS were lower than the reference. 
This was evident in the overall range (34.6 – 36.7 ˚C v. 35.4 – 37.5 ˚C) and means 
(35.737 ˚C v. 36.782 ˚C). The regression and Bland Altman plot data (R2 = 0.448,  
p <0.001, mean bias = -0.970, limits of agreement ±0.701 ˚C) demonstrated a clear 
(but weak) relationship between the datasets which, even allowing for 
compensation, did not provide the level of accuracy required for medical 
thermometry.  
 Evidence suggests that problems with the EPMS’ temperature measurement are 
due to the profile and design of the in-ear probe. Its shape is unable to 
accommodate the variety of shapes and sizes of ear canals and thus although the 
IR pyrometer’s lens has an unobstructed view, it may not be pointing at the 
tympanic membrane.  
 The BLE wireless system worked flawlessly, broadcasting real-time EPMS data to a 
host tablet for the duration of the study. 
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 If developed as a product, the EPMS has the potential to extend routine VS 
monitoring into the community where it could greatly benefit the wellbeing of 
vulnerable individuals. 
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7  C o n c l u s i o n s  a n d  Re c o m m e n d a t i o n s  
7.1 Conclusions 
This research was prompted by an unmet need identified by senior medical 
professionals for community-based routine VS monitoring as an aid to wellbeing in 
vulnerable groups. The literature review uncovered the importance of VS monitoring in 
supporting health and wellbeing, and its use in the diagnosis and management of 
disease and infection. It underpins hospital care as part of EWS track and trigger 
systems, but there is no mechanism for routine monitoring and reporting in the 
community. The review also identified a paucity of respiratory sensors and a need for 
devices capable of one-stop simultaneous VS monitoring, whether for use by 
healthcare professionals or patients in the community. This helped define the aim and 
objectives of this project which led to the development of the CRS and EPMS devices. 
7.1.1 CRS 
The pilot study demonstrated the potential of clavicular respiratory sensing and its 
superiority to a similar thoracic sensor in measuring respiration rate. The device is 
minimally intrusive, especially when compared to direct exhalatory monitoring, 
providing a response based upon respiratory motion without out the need for thoracic 
belts. The study also revealed the potential for monitoring respiratory depth (tidal 
volume) from the relative magnitude of the response. Although further research is 
required to quantify the relationship, this feature would increase its clinical value. 
A commercialised version of the CRS, particularly if a patient’s ventilatory condition 
can be resolved, could find use in the management of chronic respiratory conditions 
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(e.g. COPD). If paired with a pulse oximeter (perhaps in an integrated package), it could 
offer an excellent assessment of respiratory efficiency by examining RR and estimated 
tidal volume versus blood oxygen saturation.  
7.1.2 EPMS 
The EPMS demonstrated its capability in capturing a set of readings, when worn for 
no more than two minutes, and wirelessly uploading these to a host mobile device. A 
pilot study established that HR readings were comparable with industry standards and 
closely matched the reference, although temperature and SpO2 measurement was less 
successful.  
Temperature readings were a typically a degree lower than the reference, though 
stable. The use of temperature compensation was investigated but ruled out as the 
range of readings was too great with some participants. It became clear that the 
problem was with design of the in-ear probe and a failure to account for a range of 
different ear canal shapes and sizes, thus measuring the temperature of the ear canal 
rather than the tympanic membrane. 
Problems with DC drift had prevented SpO2 measurement in early variants of the 
EPMS, and although the final version was much improved the readings were still 
unsatisfactory. The study readings were low (by around 12%), but a correction factor 
could have been used had correlation with the reference been acceptable. 
Unfortunately this was not the case, there being no discernible correlation between 
the two methods.  
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Development Program Issues 
The direction of the research was driven, at least in part, by interests in securing 
research funding and commercialising the EPMS device. In hindsight, from a purely 
academic perspective, some of the time spent on these activities may have been more 
effectively used in resolving some of the identified issues, e.g. refining SpO2 signal 
processing offline and developing an algorithm for the estimation of RR from the RR 
signal using MATLAB.  
Potential EPMS Applications 
This section discusses some example applications where the EPMS could provide 
real patient benefit if successfully deployed. 
Monitoring Infection in the Elderly 
With the general increase in life expectancy in most of the developed world the 
elderly population is increasing with an estimated 500 million, or seven percent 
globally, aged sixty-five or older. These numbers are predicted to further increase over 
the next few years with the ‘oldest old’ (at 85 plus) showing the most rapid rise 
(Kinsella and He, 2009). As a group the elderly are more likely to suffer from chronic 
long term conditions and many will suffer the misfortune of comorbidities (Fortin et 
al., 2005; Britt et al., 2008). This leaves them at an increased risk of infection, the 
consequences of which may be severe (Garibaldi, 1999; Gijsen et al., 2001). If the 
burden of frailty is added (Fillit and Butler, 2009), it is apparent that older people are 
especially vulnerable.  
It is those aged over sixty-five that place the heaviest demand on healthcare 
resources, occupying as much as 65% of available hospital beds for acute care (Philp, 
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2007). Regular vital signs monitoring of the vulnerable elderly, whether in the 
community or care setting, would help in the management of chronic long term 
conditions and could reduce hospital admissions (Goodwin et al., 2010). The timely 
identification and treatment of infection would also be more certain if more vital signs 
readings were available. 
This is an area where a discrete monitoring device such as the EPMS, that can easily 
and rapidly capture multiple vital signs, could find use in general practice, care 
institutions or in the home. 
Post-operative and Outpatient Care 
The literature review revealed the incidence of nosocomial infections, including 
those in post-operative patients (Owens and Stoessel, 2008; Weigelt et al., 2010). 
These are at an increased risk of infection, as indeed are the immunocompromised 
such as patients undergoing chemotherapy (CDC, 2014). Whilst monitored regularly in 
hospital, once released as an outpatient it is the non-expert patient or their family who 
typically assesses their wellbeing and whether to seek medical assistance.  
Given access to an EPMS or similar device upon release, outpatients could self-
monitor their vital signs. This could help in detecting the early signs of infection, 
providing evidential readings to assist clinicians in their diagnoses. It would assist in 
early intervention, improving the outcome for patients and reducing the number of 
readmissions due to severe infection. 
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7.1.3 Summary 
The work reported in this thesis has successfully achieved the aim and objectives set 
out in section 1.5.1, namely: 
 A novel accelerometer-based prototype sensor (CRS) monitoring clavicular 
respiratory motion was designed and developed. 
 A pilot study comparing the performance of the CRS and a reference device on 
healthy subjects was carried out, showing outstanding agreement. This also 
revealed the potential for the estimation of tidal volume via the magnitude of the 
breath response. 
 A novel prototype ear-worn wireless multisensor device (EPMS) was iteratively 
designed and developed to simultaneously measure VS readings. This combined 
tympanic thermometry and pulse oximetry sensing in a single ear-worn wireless-
enabled device for the first time. 
 A pilot study comparing the performance of the prototype EPMS and reference 
devices on healthy subjects was completed. This demonstrated that HR monitoring 
performance was comparable to industry standards, but temperature readings 
were a degree below reference readings and SpO2 measurement was poor. 
 The EPMS successfully demonstrated its capability in successfully and reliably 
capturing a set of readings when worn for no more than two minutes. The 
telemonitoring facility worked flawlessly, broadcasting real-time EPMS data to a 
host tablet over a maximum range of 10 metres. 
 The EPMS meets the identified unmet need for a device capable of routine remote 
VS monitoring in the community.  
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7.2 Recommendations 
Here the future development of the CRS and EPMS is discussed, establishing the 
nature of any further work that would be necessary prior to successful exploitation. 
The final section discusses the field of personal VS monitoring and proposes the 
application of a personalised EWS system for use with personal monitoring devices in 
the community. 
7.2.1 CRS 
The device used in the pilot study was a triaxial accelerometer with analogue 
outputs. The use of both triaxial accelerometers and gyros may be worthy of 
investigation, the gyro providing angular acceleration for a measure of rotational 
clavicular respiratory forces. The CRS would benefit from the addition of an on-board 
microcontroller running embedded signal processing algorithms. This would include a 
digital or wireless interface to external devices such that respiratory readings could be 
displayed and archived. 
The pilot study revealed a relationship between signal magnitude and respiratory 
depth, providing the potential of calculating an estimation of tidal volume. Further 
research is recommended to better understand this relationship. A future study 
involving the CRS, spirometry and physical measurements may offer a method of 
quantifying respiratory depth together with estimations of tidal and minute volumes 
for a more complete ventilatory assessment of patients, including indirect quasi-real 
time monitoring.  
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7.2.2 EPMS 
Although the EPMS has been shown to perform well, SpO2 monitoring aside, 
usability would be greatly improved and ambient light effects be reduced if the pulse 
oximeter ear clip could be omitted. The study provides prima facie evidence for a 
redesign of the in-ear thermometer probe for improved accuracy and user comfort. 
Ideally, this would feature an integrated side-facing reflectance pulse oximeter sensor, 
with the probe itself being re-profiled for an improved fit in the ear canal for enhanced 
accuracy in temperature sensing. 
A critical area of focus is to get to the bottom of the problems encountered with 
SpO2 measurement. This might be resolved by fitting the latest version of the AFE4490 
signal conditioning chip and modifying the signal processing software accordingly (see 
page 247). The HR readings were very encouraging, suggesting that the waveform is 
robust and peak detection returning accurate beat-to-beat periods. This raises the 
possibility of investigating heart rate variability (HRV) analysis to determine whether 
an estimation of respiratory rate can be reliably extracted. Another area for future 
study is the analysis of HRV to determine mental stress. 
On the engineering front, the testing and evaluation of the wireless charger should 
be completed. Use of this technology would allow the case to be sealed (IP68), 
facilitating cleaning and simplifying day to day charging. With capital investment, the 
size of the circuitry and case could be much reduced to suit a range of different form 
factors and reduce costs. 
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Usability 
The fit of both the in-ear probe and the pulse oximeter clip presented challenges for 
some test subjects, partly due to design issues and partly from a lack of software 
feedback offering confirmation that the EPMS was correctly seated. The latter issue 
was largely a result of an Ethics Committee’s stipulation that subjects should not be 
able to view their VS readings, the necessary feedback being available from the host 
tablet. Problems with the profile of the ear probe affected both user comfort and 
measurement accuracy, both of which require demand a redesigned probe. 
Elimination of the ear clip would also simplify device fitting, thus it is proposed that the 
pulse oximeter sensor is integrated within the ear probe. 
7.2.3 Personal Monitoring Systems- A Proposal 
Whether using the EPMS or other monitoring devices to acquire vital signs and 
physiological data, this should be considered as just one part of a monitoring system. A 
sensing device paired with a mobile platform is just the start as the host, being a 
powerful internet-enabled wireless computer, has the potential to provide a range of 
additional benefits, acting as a health hub. This allows apps providing appointment and 
medication reminders, medical information services and teleconsultations to be added 
and potentially integrated with vital signs monitoring and data services. Whether for 
personal use or community use by a healthcare professional, this could greatly benefit 
the management of long-term conditions in the community. For best effect, the apps 
would connect to servers at a monitoring centre and be accessible by healthcare 
professionals allowing them to view and assess patients’ vital signs data and update 
prescriptions as necessary. 
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Personal EWS 
Early Warning Scoring (EWS) systems have been shown to greatly improve patient 
outcome in hospital. With regular monitoring this could be rolled out into the 
community. It is the author’s belief that to be truly effective the scoring should be 
based upon relative rather than absolute measures, essentially providing a personal 
EWS system (PEWS).  
Regular home monitoring allows an individual’s normal resting readings to be 
established; these would act as a datum for PEWS scoring which would be assessed 
relative to these marks. Table 7-1 shows an example of the PEWS chart, which includes 
the five vital signs and weight (as a marker for heart disease and frailty) instead of an 
AVPU consciousness score. Here only the highest score in each category uses absolute 
measures while others are within a range of the norm. The availability of BLE-equipped 
bathroom scales (available from Salter, Fitbit, Withings etc.) facilitates measurement 
which could be controlled via a mobile device. Normal readings could be continually 
assessed and the indices adjusted to account for changes in condition and medication. 
PEWS chart values could also be adjusted (with clinical approval) to more appropriately 
reflect individual patient condition and better address risk. 
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 PEWS Scores 
Parameter 3 2 1 0 1 2 3 
Temp (°C) 35.5.5 -1.0 -0.5 norm +0.5 +1.0 38.5 
HR (bpm 50 -20% - norm +10% +20% 100 
RR (bpm) <8 -4 - norm +4 +8 >25 
SBP <80 -30 -20 norm +20 +40 >190 
SpO2 % <85 -10 -5 norm - - - 
Weight (kg) -3 -2 -1 norm - - - 
Table 7-1: The proposed scores for a personal early warning scoring (PEWS) system for 
community-based monitoring 
Table 7-2 presents a proposition for a PEWS risk and response chart. Modelled on 
that currently implemented in the NEWS system (Royal College of Physicians, 2012), 
this matches risk and response. The system is based on the supposition that daily vital 
signs readings are routinely taken via a tablet or smartphone, where PEWS scores are 
calculated, and uploaded together with the physiological data to a central server for 
storage and assessment.  
A score of zero suggests good health and attracts little attention. A score between 
one and four raises the level of risk, which would still be classified as low, would result 
in an increase in measurement frequency and the status being flagged a monitoring 
centre. The patient would also be prompted to complete a brief online health 
assessment, providing qualitative feedback to back up the quantitative data. Entering 
the medium risk category (a score 4 – 7) would trigger a teleconsultation with a 
healthcare professional (telephone or Skype video call) to allow a direct assessment of 
a patient’s condition; this could mean the patient is asked to change their medication, 
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visit their GP or admitted to hospital. A score of seven or above, or three on a single 
parameter, indicating the patient is at high risk, could result in a home visit from 
healthcare professional or admission to hospital. 
PEWS Score Risk Frequency Response 
0 
LOW 
Daily Readings routinely uploaded to server 
1-4 4-6 hours 
Readings uploaded; patient prompted to 
complete online health assessment; 
flagged at monitoring centre 
4-7 MEDIUM 2-4 hours 
As above; teleconsultation with health 
professional 
>7 
HIGH Real time 
As above; visit from health professional 
or ambulance sent to admit patient to 
hospital 
>3 in any 
category 
Table 7-2: The proposed PEWS risk and response chart 
An integrated system such as proposed here would benefit the delivery of 
healthcare in the community, whether based in the home or a care facility. It would 
provide a targeted response for outpatients, vulnerable individuals and the elderly 
based upon clinical need, for improved outcomes, reduced hospitalisation and better 
quality of life while maintaining independence.  
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